id	sid	tid	token	lemma	pos
ajlm-2845	1	1	abstract	abstract	ADJ
ajlm-2845	1	2	introduction	introduction	NOUN
ajlm-2845	1	3	methods	method	NOUN
ajlm-2845	1	4	results	result	VERB
ajlm-2845	1	5	discussion	discussion	NOUN
ajlm-2845	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2845	1	7	references	reference	NOUN
ajlm-2845	1	8	about	about	ADP
ajlm-2845	1	9	the	the	DET
ajlm-2845	1	10	author(s	author(s	NOUN
ajlm-2845	1	11	)	)	PUNCT
ajlm-2845	1	12	miguel	miguel	PROPN
ajlm-2845	1	13	j.	j.	PROPN
ajlm-2845	1	14	teixeira	teixeira	PROPN
ajlm-2845	1	15	ampath	ampath	PROPN
ajlm-2845	1	16	allergy	allergy	PROPN
ajlm-2845	1	17	clinic	clinic	PROPN
ajlm-2845	1	18	,	,	PUNCT
ajlm-2845	1	19	pretoria	pretoria	PROPN
ajlm-2845	1	20	,	,	PUNCT
ajlm-2845	1	21	south	south	PROPN
ajlm-2845	1	22	africa	africa	PROPN
ajlm-2845	1	23	vian	vian	PROPN
ajlm-2845	1	24	pretorius	pretorius	PROPN
ajlm-2845	1	25	department	department	PROPN
ajlm-2845	1	26	of	of	ADP
ajlm-2845	1	27	internal	internal	ADJ
ajlm-2845	1	28	medicine	medicine	NOUN
ajlm-2845	1	29	,	,	PUNCT
ajlm-2845	1	30	chris	chris	PROPN
ajlm-2845	1	31	hani	hani	PROPN
ajlm-2845	1	32	baragwanath	baragwanath	PROPN
ajlm-2845	1	33	academic	academic	PROPN
ajlm-2845	1	34	hospital	hospital	PROPN
ajlm-2845	1	35	,	,	PUNCT
ajlm-2845	1	36	johannesburg	johannesburg	PROPN
ajlm-2845	1	37	,	,	PUNCT
ajlm-2845	1	38	south	south	PROPN
ajlm-2845	1	39	africa	africa	PROPN
ajlm-2845	1	40	robert	robert	PROPN
ajlm-2845	1	41	c.j.g	c.j.g	PROPN
ajlm-2845	1	42	.	.	PUNCT
ajlm-2845	2	1	hunt	hunt	PROPN
ajlm-2845	2	2	department	department	PROPN
ajlm-2845	2	3	of	of	ADP
ajlm-2845	2	4	internal	internal	ADJ
ajlm-2845	2	5	medicine	medicine	NOUN
ajlm-2845	2	6	,	,	PUNCT
ajlm-2845	2	7	klerksdorp	klerksdorp	PROPN
ajlm-2845	2	8	-	-	PUNCT
ajlm-2845	2	9	tshepong	tshepong	PROPN
ajlm-2845	2	10	complex	complex	ADJ
ajlm-2845	2	11	academic	academic	ADJ
ajlm-2845	2	12	hospital	hospital	NOUN
ajlm-2845	2	13	,	,	PUNCT
ajlm-2845	2	14	klerksdorp	klerksdorp	PROPN
ajlm-2845	2	15	,	,	PUNCT
ajlm-2845	2	16	south	south	PROPN
ajlm-2845	2	17	africa	africa	PROPN
ajlm-2845	2	18	sanam	sanam	PROPN
ajlm-2845	2	19	morar	morar	PROPN
ajlm-2845	2	20	department	department	PROPN
ajlm-2845	2	21	of	of	ADP
ajlm-2845	2	22	chemical	chemical	PROPN
ajlm-2845	2	23	pathology	pathology	PROPN
ajlm-2845	2	24	,	,	PUNCT
ajlm-2845	2	25	faculty	faculty	NOUN
ajlm-2845	2	26	of	of	ADP
ajlm-2845	2	27	health	health	NOUN
ajlm-2845	2	28	sciences	sciences	PROPN
ajlm-2845	2	29	,	,	PUNCT
ajlm-2845	2	30	university	university	NOUN
ajlm-2845	2	31	of	of	ADP
ajlm-2845	2	32	pretoria	pretoria	PROPN
ajlm-2845	2	33	,	,	PUNCT
ajlm-2845	2	34	pretoria	pretoria	PROPN
ajlm-2845	2	35	,	,	PUNCT
ajlm-2845	2	36	south	south	PROPN
ajlm-2845	2	37	africa	africa	PROPN
ajlm-2845	2	38	department	department	PROPN
ajlm-2845	2	39	of	of	ADP
ajlm-2845	2	40	chemical	chemical	PROPN
ajlm-2845	2	41	pathology	pathology	PROPN
ajlm-2845	2	42	,	,	PUNCT
ajlm-2845	2	43	faculty	faculty	NOUN
ajlm-2845	2	44	of	of	ADP
ajlm-2845	2	45	health	health	NOUN
ajlm-2845	2	46	sciences	sciences	PROPN
ajlm-2845	2	47	,	,	PUNCT
ajlm-2845	2	48	national	national	PROPN
ajlm-2845	2	49	health	health	PROPN
ajlm-2845	2	50	laboratory	laboratory	PROPN
ajlm-2845	2	51	service	service	NOUN
ajlm-2845	2	52	,	,	PUNCT
ajlm-2845	2	53	tshwane	tshwane	NOUN
ajlm-2845	2	54	academic	academic	ADJ
ajlm-2845	2	55	division	division	NOUN
ajlm-2845	2	56	,	,	PUNCT
ajlm-2845	2	57	pretoria	pretoria	PROPN
ajlm-2845	2	58	,	,	PUNCT
ajlm-2845	2	59	south	south	PROPN
ajlm-2845	2	60	africa	africa	PROPN
ajlm-2845	2	61	jamie	jamie	PROPN
ajlm-2845	2	62	l.	l.	PROPN
ajlm-2845	2	63	colloty	colloty	PROPN
ajlm-2845	2	64	department	department	PROPN
ajlm-2845	2	65	of	of	ADP
ajlm-2845	2	66	microbiology	microbiology	NOUN
ajlm-2845	2	67	,	,	PUNCT
ajlm-2845	2	68	faculty	faculty	NOUN
ajlm-2845	2	69	of	of	ADP
ajlm-2845	2	70	health	health	NOUN
ajlm-2845	2	71	sciences	sciences	PROPN
ajlm-2845	2	72	,	,	PUNCT
ajlm-2845	2	73	national	national	PROPN
ajlm-2845	2	74	health	health	PROPN
ajlm-2845	2	75	laboratory	laboratory	PROPN
ajlm-2845	2	76	service	service	NOUN
ajlm-2845	2	77	,	,	PUNCT
ajlm-2845	2	78	tshwane	tshwane	NOUN
ajlm-2845	2	79	academic	academic	ADJ
ajlm-2845	2	80	division	division	NOUN
ajlm-2845	2	81	,	,	PUNCT
ajlm-2845	2	82	pretoria	pretoria	PROPN
ajlm-2845	2	83	,	,	PUNCT
ajlm-2845	2	84	south	south	PROPN
ajlm-2845	2	85	africa	africa	PROPN
ajlm-2845	2	86	department	department	PROPN
ajlm-2845	2	87	of	of	ADP
ajlm-2845	2	88	medical	medical	ADJ
ajlm-2845	2	89	microbiology	microbiology	NOUN
ajlm-2845	2	90	,	,	PUNCT
ajlm-2845	2	91	faculty	faculty	NOUN
ajlm-2845	2	92	of	of	ADP
ajlm-2845	2	93	health	health	NOUN
ajlm-2845	2	94	sciences	sciences	PROPN
ajlm-2845	2	95	,	,	PUNCT
ajlm-2845	2	96	university	university	NOUN
ajlm-2845	2	97	of	of	ADP
ajlm-2845	2	98	pretoria	pretoria	PROPN
ajlm-2845	2	99	,	,	PUNCT
ajlm-2845	2	100	pretoria	pretoria	PROPN
ajlm-2845	2	101	,	,	PUNCT
ajlm-2845	2	102	south	south	PROPN
ajlm-2845	2	103	africa	africa	PROPN
ajlm-2845	2	104	caleb	caleb	PROPN
ajlm-2845	2	105	m.	m.	PROPN
ajlm-2845	2	106	radebe	radebe	PROPN
ajlm-2845	2	107	department	department	PROPN
ajlm-2845	2	108	of	of	ADP
ajlm-2845	2	109	internal	internal	ADJ
ajlm-2845	2	110	medicine	medicine	NOUN
ajlm-2845	2	111	,	,	PUNCT
ajlm-2845	2	112	faculty	faculty	NOUN
ajlm-2845	2	113	of	of	ADP
ajlm-2845	2	114	health	health	NOUN
ajlm-2845	2	115	sciences	sciences	PROPN
ajlm-2845	2	116	,	,	PUNCT
ajlm-2845	2	117	potchefstroom	potchefstroom	NOUN
ajlm-2845	2	118	hospital	hospital	NOUN
ajlm-2845	2	119	,	,	PUNCT
ajlm-2845	2	120	potchefstroom	potchefstroom	NOUN
ajlm-2845	2	121	,	,	PUNCT
ajlm-2845	2	122	south	south	PROPN
ajlm-2845	2	123	africa	africa	PROPN
ajlm-2845	2	124	rajen	rajen	PROPN
ajlm-2845	2	125	morar	morar	PROPN
ajlm-2845	2	126	department	department	PROPN
ajlm-2845	2	127	of	of	ADP
ajlm-2845	2	128	internal	internal	ADJ
ajlm-2845	2	129	medicine	medicine	NOUN
ajlm-2845	2	130	,	,	PUNCT
ajlm-2845	2	131	faculty	faculty	NOUN
ajlm-2845	2	132	of	of	ADP
ajlm-2845	2	133	health	health	NOUN
ajlm-2845	2	134	sciences	sciences	PROPN
ajlm-2845	2	135	,	,	PUNCT
ajlm-2845	2	136	school	school	NOUN
ajlm-2845	2	137	of	of	ADP
ajlm-2845	2	138	medicine	medicine	NOUN
ajlm-2845	2	139	,	,	PUNCT
ajlm-2845	2	140	university	university	NOUN
ajlm-2845	2	141	of	of	ADP
ajlm-2845	2	142	the	the	DET
ajlm-2845	2	143	witwatersrand	witwatersrand	NOUN
ajlm-2845	2	144	,	,	PUNCT
ajlm-2845	2	145	johannesburg	johannesburg	PROPN
ajlm-2845	2	146	,	,	PUNCT
ajlm-2845	2	147	south	south	PROPN
ajlm-2845	2	148	africa	africa	PROPN
ajlm-2845	2	149	department	department	PROPN
ajlm-2845	2	150	of	of	ADP
ajlm-2845	2	151	internal	internal	ADJ
ajlm-2845	2	152	medicine	medicine	NOUN
ajlm-2845	2	153	,	,	PUNCT
ajlm-2845	2	154	faculty	faculty	NOUN
ajlm-2845	2	155	of	of	ADP
ajlm-2845	2	156	health	health	NOUN
ajlm-2845	2	157	sciences	sciences	PROPN
ajlm-2845	2	158	,	,	PUNCT
ajlm-2845	2	159	charlotte	charlotte	PROPN
ajlm-2845	2	160	maxeke	maxeke	PROPN
ajlm-2845	2	161	johannesburg	johannesburg	PROPN
ajlm-2845	2	162	academic	academic	PROPN
ajlm-2845	2	163	hospital	hospital	PROPN
ajlm-2845	2	164	,	,	PUNCT
ajlm-2845	2	165	johannesburg	johannesburg	PROPN
ajlm-2845	2	166	,	,	PUNCT
ajlm-2845	2	167	south	south	PROPN
ajlm-2845	2	168	africa	africa	PROPN
ajlm-2845	2	169	citation	citation	PROPN
ajlm-2845	2	170	teixeira	teixeira	PROPN
ajlm-2845	2	171	mj	mj	PROPN
ajlm-2845	2	172	,	,	PUNCT
ajlm-2845	2	173	pretorius	pretorius	PROPN
ajlm-2845	2	174	v	v	NOUN
ajlm-2845	2	175	,	,	PUNCT
ajlm-2845	2	176	hunt	hunt	NOUN
ajlm-2845	2	177	rcjg	rcjg	NOUN
ajlm-2845	2	178	,	,	PUNCT
ajlm-2845	2	179	et	et	PROPN
ajlm-2845	2	180	al	al	PROPN
ajlm-2845	2	181	.	.	PUNCT
ajlm-2845	3	1	a	a	DET
ajlm-2845	3	2	retrospective	retrospective	ADJ
ajlm-2845	3	3	analysis	analysis	NOUN
ajlm-2845	3	4	of	of	ADP
ajlm-2845	3	5	uropathogens	uropathogen	NOUN
ajlm-2845	3	6	isolated	isolated	ADJ
ajlm-2845	3	7	and	and	CCONJ
ajlm-2845	3	8	antimicrobial	antimicrobial	ADJ
ajlm-2845	3	9	susceptibility	susceptibility	NOUN
ajlm-2845	3	10	patterns	pattern	NOUN
ajlm-2845	3	11	at	at	ADP
ajlm-2845	3	12	a	a	DET
ajlm-2845	3	13	regional	regional	ADJ
ajlm-2845	3	14	hospital	hospital	NOUN
ajlm-2845	3	15	in	in	ADP
ajlm-2845	3	16	north	north	PROPN
ajlm-2845	3	17	west	west	PROPN
ajlm-2845	3	18	province	province	PROPN
ajlm-2845	3	19	,	,	PUNCT
ajlm-2845	3	20	south	south	PROPN
ajlm-2845	3	21	africa	africa	PROPN
ajlm-2845	3	22	.	.	PUNCT
ajlm-2845	4	1	afr	afr	PROPN
ajlm-2845	4	2	j	j	PROPN
ajlm-2845	4	3	lab	lab	PROPN
ajlm-2845	4	4	med	med	PROPN
ajlm-2845	4	5	.	.	PUNCT
ajlm-2845	5	1	2025;14(1	2025;14(1	NUM
ajlm-2845	5	2	)	)	PUNCT
ajlm-2845	5	3	,	,	PUNCT
ajlm-2845	5	4	a2845	a2845	PROPN
ajlm-2845	5	5	.	.	PROPN
ajlm-2845	5	6	https://doi.org/10.4102/ajlm.v14i1.2845	https://doi.org/10.4102/ajlm.v14i1.2845	VERB
ajlm-2845	5	7	original	original	ADJ
ajlm-2845	5	8	research	research	NOUN
ajlm-2845	5	9	a	a	DET
ajlm-2845	5	10	retrospective	retrospective	ADJ
ajlm-2845	5	11	analysis	analysis	NOUN
ajlm-2845	5	12	of	of	ADP
ajlm-2845	5	13	uropathogens	uropathogen	NOUN
ajlm-2845	5	14	isolated	isolated	ADJ
ajlm-2845	5	15	and	and	CCONJ
ajlm-2845	5	16	antimicrobial	antimicrobial	ADJ
ajlm-2845	5	17	susceptibility	susceptibility	NOUN
ajlm-2845	5	18	patterns	pattern	NOUN
ajlm-2845	5	19	at	at	ADP
ajlm-2845	5	20	a	a	DET
ajlm-2845	5	21	regional	regional	ADJ
ajlm-2845	5	22	hospital	hospital	NOUN
ajlm-2845	5	23	in	in	ADP
ajlm-2845	5	24	north	north	PROPN
ajlm-2845	5	25	west	west	PROPN
ajlm-2845	5	26	province	province	PROPN
ajlm-2845	5	27	,	,	PUNCT
ajlm-2845	5	28	south	south	PROPN
ajlm-2845	5	29	africa	africa	PROPN
ajlm-2845	5	30	miguel	miguel	PROPN
ajlm-2845	5	31	j.	j.	PROPN
ajlm-2845	5	32	teixeira	teixeira	PROPN
ajlm-2845	5	33	,	,	PUNCT
ajlm-2845	5	34	vian	vian	PROPN
ajlm-2845	5	35	pretorius	pretorius	PROPN
ajlm-2845	5	36	,	,	PUNCT
ajlm-2845	5	37	robert	robert	PROPN
ajlm-2845	5	38	c.j.g	c.j.g	PROPN
ajlm-2845	5	39	.	.	PUNCT
ajlm-2845	6	1	hunt	hunt	PROPN
ajlm-2845	6	2	,	,	PUNCT
ajlm-2845	6	3	sanam	sanam	PROPN
ajlm-2845	6	4	morar	morar	PROPN
ajlm-2845	6	5	,	,	PUNCT
ajlm-2845	6	6	jamie	jamie	PROPN
ajlm-2845	6	7	l.	l.	PROPN
ajlm-2845	6	8	colloty	colloty	PROPN
ajlm-2845	6	9	,	,	PUNCT
ajlm-2845	6	10	caleb	caleb	PROPN
ajlm-2845	6	11	m.	m.	NOUN
ajlm-2845	6	12	radebe	radebe	PROPN
ajlm-2845	6	13	,	,	PUNCT
ajlm-2845	6	14	rajen	rajen	PROPN
ajlm-2845	6	15	morar	morar	PROPN
ajlm-2845	6	16	received	receive	VERB
ajlm-2845	6	17	:	:	PUNCT
ajlm-2845	6	18	23	23	NUM
ajlm-2845	6	19	apr	apr	NOUN
ajlm-2845	6	20	.	.	PUNCT
ajlm-2845	6	21	2025	2025	NUM
ajlm-2845	6	22	;	;	PUNCT
ajlm-2845	6	23	accepted	accept	VERB
ajlm-2845	6	24	:	:	PUNCT
ajlm-2845	6	25	16	16	NUM
ajlm-2845	6	26	sept	sept	PROPN
ajlm-2845	6	27	.	.	PROPN
ajlm-2845	6	28	2025	2025	NUM
ajlm-2845	6	29	;	;	PUNCT
ajlm-2845	6	30	published	publish	VERB
ajlm-2845	6	31	:	:	PUNCT
ajlm-2845	6	32	30	30	NUM
ajlm-2845	6	33	nov	nov	NOUN
ajlm-2845	6	34	.	.	PROPN
ajlm-2845	6	35	2025	2025	NUM
ajlm-2845	6	36	copyright	copyright	NOUN
ajlm-2845	6	37	:	:	PUNCT
ajlm-2845	6	38	©	©	PROPN
ajlm-2845	6	39	2025	2025	NUM
ajlm-2845	6	40	.	.	PUNCT
ajlm-2845	7	1	the	the	DET
ajlm-2845	7	2	author(s	author(s	PROPN
ajlm-2845	7	3	)	)	PUNCT
ajlm-2845	7	4	.	.	PUNCT
ajlm-2845	8	1	licensee	licensee	NOUN
ajlm-2845	8	2	:	:	PUNCT
ajlm-2845	8	3	aosis	aosis	NOUN
ajlm-2845	8	4	.	.	PUNCT
ajlm-2845	9	1	this	this	DET
ajlm-2845	9	2	work	work	NOUN
ajlm-2845	9	3	is	be	AUX
ajlm-2845	9	4	licensed	license	VERB
ajlm-2845	9	5	under	under	ADP
ajlm-2845	9	6	the	the	DET
ajlm-2845	9	7	creative	creative	ADJ
ajlm-2845	9	8	commons	common	NOUN
ajlm-2845	9	9	attribution	attribution	NOUN
ajlm-2845	9	10	4.0	4.0	NUM
ajlm-2845	9	11	international	international	NOUN
ajlm-2845	9	12	(	(	PUNCT
ajlm-2845	9	13	cc	cc	NOUN
ajlm-2845	9	14	by	by	ADP
ajlm-2845	9	15	4.0	4.0	NUM
ajlm-2845	9	16	)	)	PUNCT
ajlm-2845	9	17	license	license	NOUN
ajlm-2845	9	18	(	(	PUNCT
ajlm-2845	9	19	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ajlm-2845	9	20	)	)	PUNCT
ajlm-2845	9	21	.	.	PUNCT
ajlm-2845	10	1	abstract	abstract	ADJ
ajlm-2845	10	2	background	background	NOUN
ajlm-2845	10	3	:	:	PUNCT
ajlm-2845	10	4	urinary	urinary	ADJ
ajlm-2845	10	5	tract	tract	NOUN
ajlm-2845	10	6	infections	infection	NOUN
ajlm-2845	10	7	are	be	AUX
ajlm-2845	10	8	among	among	ADP
ajlm-2845	10	9	the	the	DET
ajlm-2845	10	10	most	most	ADV
ajlm-2845	10	11	common	common	ADJ
ajlm-2845	10	12	infections	infection	NOUN
ajlm-2845	10	13	affecting	affect	VERB
ajlm-2845	10	14	the	the	DET
ajlm-2845	10	15	general	general	ADJ
ajlm-2845	10	16	population	population	NOUN
ajlm-2845	10	17	.	.	PUNCT
ajlm-2845	11	1	their	their	PRON
ajlm-2845	11	2	high	high	ADJ
ajlm-2845	11	3	incidence	incidence	NOUN
ajlm-2845	11	4	,	,	PUNCT
ajlm-2845	11	5	as	as	ADV
ajlm-2845	11	6	well	well	ADV
ajlm-2845	11	7	as	as	ADP
ajlm-2845	11	8	frequent	frequent	ADJ
ajlm-2845	11	9	antimicrobial	antimicrobial	ADJ
ajlm-2845	11	10	use	use	NOUN
ajlm-2845	11	11	,	,	PUNCT
ajlm-2845	11	12	contribute	contribute	VERB
ajlm-2845	11	13	significantly	significantly	ADV
ajlm-2845	11	14	to	to	ADP
ajlm-2845	11	15	the	the	DET
ajlm-2845	11	16	development	development	NOUN
ajlm-2845	11	17	of	of	ADP
ajlm-2845	11	18	antimicrobial	antimicrobial	ADJ
ajlm-2845	11	19	resistance	resistance	NOUN
ajlm-2845	11	20	(	(	PUNCT
ajlm-2845	11	21	amr	amr	NOUN
ajlm-2845	11	22	)	)	PUNCT
ajlm-2845	11	23	.	.	PUNCT
ajlm-2845	12	1	objective	objective	NOUN
ajlm-2845	12	2	:	:	PUNCT
ajlm-2845	12	3	to	to	PART
ajlm-2845	12	4	determine	determine	VERB
ajlm-2845	12	5	the	the	DET
ajlm-2845	12	6	profile	profile	NOUN
ajlm-2845	12	7	and	and	CCONJ
ajlm-2845	12	8	prevalence	prevalence	NOUN
ajlm-2845	12	9	of	of	ADP
ajlm-2845	12	10	uropathogens	uropathogen	NOUN
ajlm-2845	12	11	isolated	isolate	VERB
ajlm-2845	12	12	from	from	ADP
ajlm-2845	12	13	urine	urine	NOUN
ajlm-2845	12	14	specimens	specimen	NOUN
ajlm-2845	12	15	at	at	ADP
ajlm-2845	12	16	a	a	DET
ajlm-2845	12	17	regional	regional	ADJ
ajlm-2845	12	18	hospital	hospital	NOUN
ajlm-2845	12	19	and	and	CCONJ
ajlm-2845	12	20	assess	assess	VERB
ajlm-2845	12	21	susceptibility	susceptibility	NOUN
ajlm-2845	12	22	patterns	pattern	NOUN
ajlm-2845	12	23	to	to	PART
ajlm-2845	12	24	commonly	commonly	ADV
ajlm-2845	12	25	used	use	VERB
ajlm-2845	12	26	antimicrobials	antimicrobial	NOUN
ajlm-2845	12	27	recommended	recommend	VERB
ajlm-2845	12	28	by	by	ADP
ajlm-2845	12	29	the	the	DET
ajlm-2845	12	30	national	national	ADJ
ajlm-2845	12	31	essential	essential	ADJ
ajlm-2845	12	32	medicines	medicine	NOUN
ajlm-2845	12	33	list	list	NOUN
ajlm-2845	12	34	(	(	PUNCT
ajlm-2845	12	35	neml	neml	ADJ
ajlm-2845	12	36	)	)	PUNCT
ajlm-2845	12	37	.	.	PUNCT
ajlm-2845	13	1	methods	method	NOUN
ajlm-2845	13	2	:	:	PUNCT
ajlm-2845	13	3	this	this	PRON
ajlm-2845	13	4	was	be	AUX
ajlm-2845	13	5	a	a	DET
ajlm-2845	13	6	retrospective	retrospective	ADJ
ajlm-2845	13	7	evaluation	evaluation	NOUN
ajlm-2845	13	8	of	of	ADP
ajlm-2845	13	9	laboratory	laboratory	NOUN
ajlm-2845	13	10	reports	report	NOUN
ajlm-2845	13	11	for	for	ADP
ajlm-2845	13	12	all	all	DET
ajlm-2845	13	13	urine	urine	NOUN
ajlm-2845	13	14	specimens	specimen	NOUN
ajlm-2845	13	15	submitted	submit	VERB
ajlm-2845	13	16	between	between	ADP
ajlm-2845	13	17	01	01	NUM
ajlm-2845	13	18	january	january	PROPN
ajlm-2845	13	19	2020	2020	NUM
ajlm-2845	13	20	and	and	CCONJ
ajlm-2845	13	21	31	31	NUM
ajlm-2845	13	22	december	december	PROPN
ajlm-2845	13	23	2023	2023	NUM
ajlm-2845	13	24	.	.	PUNCT
ajlm-2845	14	1	results	result	NOUN
ajlm-2845	14	2	:	:	PUNCT
ajlm-2845	14	3	the	the	DET
ajlm-2845	14	4	most	most	ADV
ajlm-2845	14	5	frequently	frequently	ADV
ajlm-2845	14	6	cultured	cultured	ADJ
ajlm-2845	14	7	organisms	organism	NOUN
ajlm-2845	14	8	were	be	AUX
ajlm-2845	14	9	escherichia	escherichia	NOUN
ajlm-2845	14	10	coli	coli	NOUN
ajlm-2845	14	11	(	(	PUNCT
ajlm-2845	14	12	n	n	NOUN
ajlm-2845	14	13	=	=	SYM
ajlm-2845	14	14	1481	1481	NUM
ajlm-2845	14	15	;	;	PUNCT
ajlm-2845	14	16	42	42	NUM
ajlm-2845	14	17	%	%	NOUN
ajlm-2845	14	18	)	)	PUNCT
ajlm-2845	14	19	;	;	PUNCT
ajlm-2845	14	20	klebsiella	klebsiella	NOUN
ajlm-2845	14	21	pneumoniae	pneumoniae	NOUN
ajlm-2845	14	22	(	(	PUNCT
ajlm-2845	14	23	n	n	NOUN
ajlm-2845	14	24	=	=	SYM
ajlm-2845	14	25	568	568	NUM
ajlm-2845	14	26	;	;	PUNCT
ajlm-2845	14	27	16	16	NUM
ajlm-2845	14	28	%	%	NOUN
ajlm-2845	14	29	)	)	PUNCT
ajlm-2845	14	30	;	;	PUNCT
ajlm-2845	14	31	enterococcus	enterococcus	NOUN
ajlm-2845	14	32	faecalis	faecalis	NOUN
ajlm-2845	14	33	(	(	PUNCT
ajlm-2845	14	34	n	n	NOUN
ajlm-2845	14	35	=	=	SYM
ajlm-2845	14	36	249	249	NUM
ajlm-2845	14	37	;	;	PUNCT
ajlm-2845	14	38	7	7	NUM
ajlm-2845	14	39	%	%	NOUN
ajlm-2845	14	40	)	)	PUNCT
ajlm-2845	14	41	;	;	PUNCT
ajlm-2845	14	42	proteus	proteus	NOUN
ajlm-2845	14	43	mirabilis	mirabilis	PROPN
ajlm-2845	14	44	(	(	PUNCT
ajlm-2845	14	45	n	n	NOUN
ajlm-2845	14	46	=	=	SYM
ajlm-2845	14	47	229	229	NUM
ajlm-2845	14	48	;	;	PUNCT
ajlm-2845	14	49	7	7	NUM
ajlm-2845	14	50	%	%	NOUN
ajlm-2845	14	51	)	)	PUNCT
ajlm-2845	14	52	,	,	PUNCT
ajlm-2845	14	53	enterobacter	enterobacter	ADJ
ajlm-2845	14	54	cloacae	cloacae	NOUN
ajlm-2845	14	55	(	(	PUNCT
ajlm-2845	14	56	n	n	NOUN
ajlm-2845	14	57	=	=	SYM
ajlm-2845	14	58	137	137	NUM
ajlm-2845	14	59	;	;	PUNCT
ajlm-2845	14	60	4	4	NUM
ajlm-2845	14	61	%	%	NOUN
ajlm-2845	14	62	)	)	PUNCT
ajlm-2845	14	63	,	,	PUNCT
ajlm-2845	14	64	and	and	CCONJ
ajlm-2845	14	65	candida	candida	PROPN
ajlm-2845	14	66	albicans	albican	NOUN
ajlm-2845	14	67	(	(	PUNCT
ajlm-2845	14	68	n	n	NOUN
ajlm-2845	14	69	=	=	SYM
ajlm-2845	14	70	119	119	NUM
ajlm-2845	14	71	;	;	PUNCT
ajlm-2845	14	72	3	3	NUM
ajlm-2845	14	73	%	%	NOUN
ajlm-2845	14	74	)	)	PUNCT
ajlm-2845	14	75	.	.	PUNCT
ajlm-2845	15	1	escherichia	escherichia	NOUN
ajlm-2845	15	2	coli	coli	NOUN
ajlm-2845	15	3	maintained	maintain	VERB
ajlm-2845	15	4	high	high	ADJ
ajlm-2845	15	5	sensitivity	sensitivity	NOUN
ajlm-2845	15	6	to	to	ADP
ajlm-2845	15	7	antimicrobials	antimicrobial	NOUN
ajlm-2845	15	8	such	such	ADJ
ajlm-2845	15	9	as	as	ADP
ajlm-2845	15	10	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	15	11	(	(	PUNCT
ajlm-2845	15	12	92.2	92.2	NUM
ajlm-2845	15	13	%	%	NOUN
ajlm-2845	15	14	)	)	PUNCT
ajlm-2845	15	15	and	and	CCONJ
ajlm-2845	15	16	gentamicin	gentamicin	NOUN
ajlm-2845	15	17	(	(	PUNCT
ajlm-2845	15	18	90.6	90.6	NUM
ajlm-2845	15	19	%	%	NOUN
ajlm-2845	15	20	)	)	PUNCT
ajlm-2845	15	21	,	,	PUNCT
ajlm-2845	15	22	whilst	whilst	SCONJ
ajlm-2845	15	23	k.	k.	PROPN
ajlm-2845	15	24	pneumoniae	pneumoniae	PROPN
ajlm-2845	15	25	had	have	AUX
ajlm-2845	15	26	decreased	decrease	VERB
ajlm-2845	15	27	sensitivities	sensitivity	NOUN
ajlm-2845	15	28	of	of	ADP
ajlm-2845	15	29	40	40	NUM
ajlm-2845	15	30	%	%	NOUN
ajlm-2845	15	31	and	and	CCONJ
ajlm-2845	15	32	77	77	NUM
ajlm-2845	15	33	%	%	NOUN
ajlm-2845	15	34	,	,	PUNCT
ajlm-2845	15	35	respectively	respectively	ADV
ajlm-2845	15	36	.	.	PUNCT
ajlm-2845	16	1	cumulative	cumulative	ADJ
ajlm-2845	16	2	sensitivities	sensitivity	NOUN
ajlm-2845	16	3	of	of	ADP
ajlm-2845	16	4	commonly	commonly	ADV
ajlm-2845	16	5	used	use	VERB
ajlm-2845	16	6	first	first	ADJ
ajlm-2845	16	7	-	-	PUNCT
ajlm-2845	16	8	line	line	NOUN
ajlm-2845	16	9	antimicrobials	antimicrobial	NOUN
ajlm-2845	16	10	showed	show	VERB
ajlm-2845	16	11	low	low	ADJ
ajlm-2845	16	12	rates	rate	NOUN
ajlm-2845	16	13	of	of	ADP
ajlm-2845	16	14	susceptibility	susceptibility	NOUN
ajlm-2845	16	15	to	to	ADP
ajlm-2845	16	16	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	16	17	(	(	PUNCT
ajlm-2845	16	18	77	77	NUM
ajlm-2845	16	19	%	%	NOUN
ajlm-2845	16	20	)	)	PUNCT
ajlm-2845	16	21	,	,	PUNCT
ajlm-2845	16	22	nitrofurantoin	nitrofurantoin	X
ajlm-2845	16	23	(	(	PUNCT
ajlm-2845	16	24	67	67	NUM
ajlm-2845	16	25	%	%	NOUN
ajlm-2845	16	26	)	)	PUNCT
ajlm-2845	16	27	,	,	PUNCT
ajlm-2845	16	28	and	and	CCONJ
ajlm-2845	16	29	amoxicillin	amoxicillin	PROPN
ajlm-2845	16	30	/	/	SYM
ajlm-2845	16	31	clavulanate	clavulanate	NOUN
ajlm-2845	16	32	(	(	PUNCT
ajlm-2845	16	33	68.7	68.7	NUM
ajlm-2845	16	34	%	%	NOUN
ajlm-2845	16	35	)	)	PUNCT
ajlm-2845	16	36	.	.	PUNCT
ajlm-2845	17	1	conclusion	conclusion	NOUN
ajlm-2845	17	2	:	:	PUNCT
ajlm-2845	17	3	escherichia	escherichia	NOUN
ajlm-2845	17	4	coli	coli	NOUN
ajlm-2845	17	5	was	be	AUX
ajlm-2845	17	6	the	the	DET
ajlm-2845	17	7	most	most	ADV
ajlm-2845	17	8	commonly	commonly	ADV
ajlm-2845	17	9	identified	identify	VERB
ajlm-2845	17	10	isolate	isolate	NOUN
ajlm-2845	17	11	and	and	CCONJ
ajlm-2845	17	12	remains	remain	VERB
ajlm-2845	17	13	sensitive	sensitive	ADJ
ajlm-2845	17	14	to	to	ADP
ajlm-2845	17	15	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	17	16	.	.	PUNCT
ajlm-2845	18	1	it	it	PRON
ajlm-2845	18	2	was	be	AUX
ajlm-2845	18	3	,	,	PUNCT
ajlm-2845	18	4	however	however	ADV
ajlm-2845	18	5	,	,	PUNCT
ajlm-2845	18	6	resistant	resistant	ADJ
ajlm-2845	18	7	to	to	ADP
ajlm-2845	18	8	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	18	9	,	,	PUNCT
ajlm-2845	18	10	amoxicillin	amoxicillin	PROPN
ajlm-2845	18	11	/	/	SYM
ajlm-2845	18	12	clavulanate	clavulanate	NOUN
ajlm-2845	18	13	,	,	PUNCT
ajlm-2845	18	14	and	and	CCONJ
ajlm-2845	18	15	trimethoprim	trimethoprim	ADJ
ajlm-2845	18	16	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-2845	18	17	,	,	PUNCT
ajlm-2845	18	18	as	as	SCONJ
ajlm-2845	18	19	were	be	AUX
ajlm-2845	18	20	all	all	DET
ajlm-2845	18	21	the	the	DET
ajlm-2845	18	22	other	other	ADJ
ajlm-2845	18	23	gram	gram	ADJ
ajlm-2845	18	24	-	-	PUNCT
ajlm-2845	18	25	negative	negative	ADJ
ajlm-2845	18	26	organisms	organism	NOUN
ajlm-2845	18	27	.	.	PUNCT
ajlm-2845	19	1	these	these	DET
ajlm-2845	19	2	sensitivity	sensitivity	NOUN
ajlm-2845	19	3	patterns	pattern	NOUN
ajlm-2845	19	4	do	do	AUX
ajlm-2845	19	5	not	not	PART
ajlm-2845	19	6	align	align	VERB
ajlm-2845	19	7	with	with	ADP
ajlm-2845	19	8	the	the	DET
ajlm-2845	19	9	antimicrobials	antimicrobial	NOUN
ajlm-2845	19	10	recommended	recommend	VERB
ajlm-2845	19	11	in	in	ADP
ajlm-2845	19	12	the	the	DET
ajlm-2845	19	13	current	current	ADJ
ajlm-2845	19	14	neml	neml	ADJ
ajlm-2845	19	15	guidelines	guideline	NOUN
ajlm-2845	19	16	,	,	PUNCT
ajlm-2845	19	17	and	and	CCONJ
ajlm-2845	19	18	highlight	highlight	VERB
ajlm-2845	19	19	the	the	DET
ajlm-2845	19	20	need	need	NOUN
ajlm-2845	19	21	for	for	ADP
ajlm-2845	19	22	targeted	target	VERB
ajlm-2845	19	23	therapy	therapy	NOUN
ajlm-2845	19	24	and	and	CCONJ
ajlm-2845	19	25	interventions	intervention	NOUN
ajlm-2845	19	26	.	.	PUNCT
ajlm-2845	20	1	what	what	PRON
ajlm-2845	20	2	this	this	DET
ajlm-2845	20	3	study	study	NOUN
ajlm-2845	20	4	adds	add	VERB
ajlm-2845	20	5	:	:	PUNCT
ajlm-2845	20	6	this	this	DET
ajlm-2845	20	7	retrospective	retrospective	ADJ
ajlm-2845	20	8	analysis	analysis	NOUN
ajlm-2845	20	9	identifies	identify	VERB
ajlm-2845	20	10	predominant	predominant	ADJ
ajlm-2845	20	11	uropathogens	uropathogen	NOUN
ajlm-2845	20	12	’	'	PUNCT
ajlm-2845	20	13	updated	update	VERB
ajlm-2845	20	14	antimicrobial	antimicrobial	ADJ
ajlm-2845	20	15	susceptibility	susceptibility	NOUN
ajlm-2845	20	16	profiles	profile	NOUN
ajlm-2845	20	17	,	,	PUNCT
ajlm-2845	20	18	some	some	PRON
ajlm-2845	20	19	of	of	ADP
ajlm-2845	20	20	which	which	PRON
ajlm-2845	20	21	misalign	misalign	VERB
ajlm-2845	20	22	with	with	ADP
ajlm-2845	20	23	neml	neml	ADJ
ajlm-2845	20	24	guidelines	guideline	NOUN
ajlm-2845	20	25	.	.	PUNCT
ajlm-2845	21	1	insights	insight	NOUN
ajlm-2845	21	2	will	will	AUX
ajlm-2845	21	3	guide	guide	VERB
ajlm-2845	21	4	targeted	target	VERB
ajlm-2845	21	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	21	6	stewardship	stewardship	NOUN
ajlm-2845	21	7	,	,	PUNCT
ajlm-2845	21	8	empiric	empiric	NOUN
ajlm-2845	21	9	therapy	therapy	NOUN
ajlm-2845	21	10	,	,	PUNCT
ajlm-2845	21	11	and	and	CCONJ
ajlm-2845	21	12	local	local	ADJ
ajlm-2845	21	13	surveillance	surveillance	NOUN
ajlm-2845	21	14	to	to	PART
ajlm-2845	21	15	curb	curb	VERB
ajlm-2845	21	16	amr	amr	NOUN
ajlm-2845	21	17	.	.	PROPN
ajlm-2845	21	18	keywords	keyword	NOUN
ajlm-2845	21	19	:	:	PUNCT
ajlm-2845	21	20	urinary	urinary	ADJ
ajlm-2845	21	21	tract	tract	NOUN
ajlm-2845	21	22	infections	infection	NOUN
ajlm-2845	21	23	;	;	PUNCT
ajlm-2845	21	24	antimicrobial	antimicrobial	ADJ
ajlm-2845	21	25	resistance	resistance	NOUN
ajlm-2845	21	26	;	;	PUNCT
ajlm-2845	21	27	escherichia	escherichia	NOUN
ajlm-2845	21	28	coli	coli	NOUN
ajlm-2845	21	29	;	;	PUNCT
ajlm-2845	21	30	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	21	31	;	;	PUNCT
ajlm-2845	21	32	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	21	33	.	.	PUNCT
ajlm-2845	22	1	introduction	introduction	NOUN
ajlm-2845	22	2	urinary	urinary	ADJ
ajlm-2845	22	3	tract	tract	NOUN
ajlm-2845	22	4	infections	infection	NOUN
ajlm-2845	22	5	(	(	PUNCT
ajlm-2845	22	6	utis	utis	NOUN
ajlm-2845	22	7	)	)	PUNCT
ajlm-2845	22	8	represent	represent	VERB
ajlm-2845	22	9	a	a	DET
ajlm-2845	22	10	significant	significant	ADJ
ajlm-2845	22	11	health	health	NOUN
ajlm-2845	22	12	concern	concern	NOUN
ajlm-2845	22	13	globally	globally	ADV
ajlm-2845	22	14	,	,	PUNCT
ajlm-2845	22	15	affecting	affect	VERB
ajlm-2845	22	16	an	an	DET
ajlm-2845	22	17	estimated	estimate	VERB
ajlm-2845	22	18	404.6	404.6	NUM
ajlm-2845	22	19	million	million	NUM
ajlm-2845	22	20	individuals	individual	NOUN
ajlm-2845	22	21	in	in	ADP
ajlm-2845	22	22	2019	2019	NUM
ajlm-2845	22	23	,	,	PUNCT
ajlm-2845	22	24	and	and	CCONJ
ajlm-2845	22	25	contributing	contribute	VERB
ajlm-2845	22	26	to	to	ADP
ajlm-2845	22	27	5.2	5.2	NUM
ajlm-2845	22	28	million	million	NUM
ajlm-2845	22	29	disability	disability	NOUN
ajlm-2845	22	30	-	-	PUNCT
ajlm-2845	22	31	adjusted	adjust	VERB
ajlm-2845	22	32	life	life	NOUN
ajlm-2845	22	33	years.1	years.1	PROPN
ajlm-2845	22	34	a	a	DET
ajlm-2845	22	35	systematic	systematic	ADJ
ajlm-2845	22	36	review	review	NOUN
ajlm-2845	22	37	of	of	ADP
ajlm-2845	22	38	the	the	DET
ajlm-2845	22	39	aetiology	aetiology	NOUN
ajlm-2845	22	40	and	and	CCONJ
ajlm-2845	22	41	prevalence	prevalence	NOUN
ajlm-2845	22	42	in	in	ADP
ajlm-2845	22	43	sub	sub	ADJ
ajlm-2845	22	44	-	-	ADJ
ajlm-2845	22	45	saharan	saharan	ADJ
ajlm-2845	22	46	africa	africa	PROPN
ajlm-2845	22	47	found	find	VERB
ajlm-2845	22	48	the	the	DET
ajlm-2845	22	49	prevalence	prevalence	NOUN
ajlm-2845	22	50	to	to	PART
ajlm-2845	22	51	be	be	AUX
ajlm-2845	22	52	32.1	32.1	NUM
ajlm-2845	22	53	%	%	NOUN
ajlm-2845	22	54	,	,	PUNCT
ajlm-2845	22	55	with	with	ADP
ajlm-2845	22	56	south	south	PROPN
ajlm-2845	22	57	africa	africa	PROPN
ajlm-2845	22	58	recording	record	VERB
ajlm-2845	22	59	the	the	DET
ajlm-2845	22	60	highest	high	ADJ
ajlm-2845	22	61	prevalence	prevalence	NOUN
ajlm-2845	22	62	at	at	ADP
ajlm-2845	22	63	67.1%.2	67.1%.2	ADJ
ajlm-2845	22	64	women	woman	NOUN
ajlm-2845	22	65	have	have	VERB
ajlm-2845	22	66	a	a	DET
ajlm-2845	22	67	higher	high	ADJ
ajlm-2845	22	68	incidence	incidence	NOUN
ajlm-2845	22	69	compared	compare	VERB
ajlm-2845	22	70	with	with	ADP
ajlm-2845	22	71	men	man	NOUN
ajlm-2845	22	72	;	;	PUNCT
ajlm-2845	22	73	in	in	ADP
ajlm-2845	22	74	their	their	PRON
ajlm-2845	22	75	lifetime	lifetime	NOUN
ajlm-2845	22	76	,	,	PUNCT
ajlm-2845	22	77	approximately	approximately	ADV
ajlm-2845	22	78	50	50	NUM
ajlm-2845	22	79	%	%	NOUN
ajlm-2845	22	80	of	of	ADP
ajlm-2845	22	81	women	woman	NOUN
ajlm-2845	22	82	will	will	AUX
ajlm-2845	22	83	be	be	AUX
ajlm-2845	22	84	diagnosed	diagnose	VERB
ajlm-2845	22	85	with	with	ADP
ajlm-2845	22	86	a	a	DET
ajlm-2845	22	87	uti	uti	PROPN
ajlm-2845	22	88	,	,	PUNCT
ajlm-2845	22	89	with	with	ADP
ajlm-2845	22	90	20	20	NUM
ajlm-2845	22	91	%	%	NOUN
ajlm-2845	22	92	–	–	PUNCT
ajlm-2845	22	93	40	40	NUM
ajlm-2845	22	94	%	%	NOUN
ajlm-2845	22	95	experiencing	experience	VERB
ajlm-2845	22	96	recurrences.3	recurrences.3	NOUN
ajlm-2845	22	97	globally	globally	ADV
ajlm-2845	22	98	,	,	PUNCT
ajlm-2845	22	99	the	the	DET
ajlm-2845	22	100	most	most	ADV
ajlm-2845	22	101	common	common	ADJ
ajlm-2845	22	102	causative	causative	ADJ
ajlm-2845	22	103	organisms	organism	NOUN
ajlm-2845	22	104	of	of	ADP
ajlm-2845	22	105	community	community	NOUN
ajlm-2845	22	106	-	-	PUNCT
ajlm-2845	22	107	acquired	acquire	VERB
ajlm-2845	22	108	utis	utis	NOUN
ajlm-2845	22	109	are	be	AUX
ajlm-2845	22	110	gram	gram	NUM
ajlm-2845	22	111	-	-	PUNCT
ajlm-2845	22	112	negative	negative	ADJ
ajlm-2845	22	113	bacteria	bacteria	NOUN
ajlm-2845	22	114	,	,	PUNCT
ajlm-2845	22	115	predominantly	predominantly	ADV
ajlm-2845	22	116	escherichia	escherichia	NOUN
ajlm-2845	22	117	coli	coli	NOUN
ajlm-2845	22	118	and	and	CCONJ
ajlm-2845	22	119	klebsiella	klebsiella	PROPN
ajlm-2845	22	120	pneumoniae.4	pneumoniae.4	PROPN
ajlm-2845	22	121	the	the	DET
ajlm-2845	22	122	high	high	ADJ
ajlm-2845	22	123	incidence	incidence	NOUN
ajlm-2845	22	124	of	of	ADP
ajlm-2845	22	125	a	a	DET
ajlm-2845	22	126	positive	positive	ADJ
ajlm-2845	22	127	urinary	urinary	ADJ
ajlm-2845	22	128	culture	culture	NOUN
ajlm-2845	22	129	frequently	frequently	ADV
ajlm-2845	22	130	results	result	VERB
ajlm-2845	22	131	in	in	ADP
ajlm-2845	22	132	the	the	DET
ajlm-2845	22	133	prescription	prescription	NOUN
ajlm-2845	22	134	of	of	ADP
ajlm-2845	22	135	an	an	DET
ajlm-2845	22	136	antimicrobial	antimicrobial	NOUN
ajlm-2845	22	137	,	,	PUNCT
ajlm-2845	22	138	which	which	PRON
ajlm-2845	22	139	is	be	AUX
ajlm-2845	22	140	often	often	ADV
ajlm-2845	22	141	unnecessary	unnecessary	ADJ
ajlm-2845	22	142	,	,	PUNCT
ajlm-2845	22	143	as	as	ADP
ajlm-2845	22	144	in	in	ADP
ajlm-2845	22	145	the	the	DET
ajlm-2845	22	146	case	case	NOUN
ajlm-2845	22	147	of	of	ADP
ajlm-2845	22	148	asymptomatic	asymptomatic	ADJ
ajlm-2845	22	149	bacteriuria	bacteriuria	NOUN
ajlm-2845	22	150	.	.	PUNCT
ajlm-2845	23	1	this	this	PRON
ajlm-2845	23	2	has	have	VERB
ajlm-2845	23	3	the	the	DET
ajlm-2845	23	4	effect	effect	NOUN
ajlm-2845	23	5	of	of	ADP
ajlm-2845	23	6	increasing	increase	VERB
ajlm-2845	23	7	the	the	DET
ajlm-2845	23	8	antimicrobial	antimicrobial	ADJ
ajlm-2845	23	9	load	load	NOUN
ajlm-2845	23	10	in	in	ADP
ajlm-2845	23	11	the	the	DET
ajlm-2845	23	12	environment	environment	NOUN
ajlm-2845	23	13	,	,	PUNCT
ajlm-2845	23	14	and	and	CCONJ
ajlm-2845	23	15	exacerbation	exacerbation	NOUN
ajlm-2845	23	16	of	of	ADP
ajlm-2845	23	17	the	the	DET
ajlm-2845	23	18	pandemic	pandemic	NOUN
ajlm-2845	23	19	of	of	ADP
ajlm-2845	23	20	antimicrobial	antimicrobial	ADJ
ajlm-2845	23	21	resistance	resistance	NOUN
ajlm-2845	23	22	(	(	PUNCT
ajlm-2845	23	23	amr	amr	NOUN
ajlm-2845	23	24	)	)	PUNCT
ajlm-2845	23	25	,	,	PUNCT
ajlm-2845	23	26	which	which	PRON
ajlm-2845	23	27	has	have	AUX
ajlm-2845	23	28	steadily	steadily	ADV
ajlm-2845	23	29	increased	increase	VERB
ajlm-2845	23	30	internationally	internationally	ADV
ajlm-2845	23	31	because	because	SCONJ
ajlm-2845	23	32	of	of	ADP
ajlm-2845	23	33	overand	overand	PROPN
ajlm-2845	23	34	misuse	misuse	NOUN
ajlm-2845	23	35	of	of	ADP
ajlm-2845	23	36	antimicrobials	antimicrobial	NOUN
ajlm-2845	23	37	,	,	PUNCT
ajlm-2845	23	38	both	both	CCONJ
ajlm-2845	23	39	in	in	ADP
ajlm-2845	23	40	humans	human	NOUN
ajlm-2845	23	41	and	and	CCONJ
ajlm-2845	23	42	animals.5	animals.5	PROPN
ajlm-2845	23	43	concurrently	concurrently	ADV
ajlm-2845	23	44	,	,	PUNCT
ajlm-2845	23	45	the	the	DET
ajlm-2845	23	46	development	development	NOUN
ajlm-2845	23	47	of	of	ADP
ajlm-2845	23	48	novel	novel	ADJ
ajlm-2845	23	49	antimicrobial	antimicrobial	ADJ
ajlm-2845	23	50	therapies	therapy	NOUN
ajlm-2845	23	51	has	have	AUX
ajlm-2845	23	52	lagged	lag	VERB
ajlm-2845	23	53	significantly	significantly	ADV
ajlm-2845	23	54	behind	behind	ADP
ajlm-2845	23	55	the	the	DET
ajlm-2845	23	56	development	development	NOUN
ajlm-2845	23	57	of	of	ADP
ajlm-2845	23	58	amr	amr	NOUN
ajlm-2845	23	59	,	,	PUNCT
ajlm-2845	23	60	highlighting	highlight	VERB
ajlm-2845	23	61	the	the	DET
ajlm-2845	23	62	need	need	NOUN
ajlm-2845	23	63	for	for	ADP
ajlm-2845	23	64	intensification	intensification	NOUN
ajlm-2845	23	65	of	of	ADP
ajlm-2845	23	66	antimicrobial	antimicrobial	ADJ
ajlm-2845	23	67	stewardship.5,6	stewardship.5,6	VERB
ajlm-2845	23	68	a	a	DET
ajlm-2845	23	69	recent	recent	ADJ
ajlm-2845	23	70	systematic	systematic	ADJ
ajlm-2845	23	71	analysis	analysis	NOUN
ajlm-2845	23	72	of	of	ADP
ajlm-2845	23	73	the	the	DET
ajlm-2845	23	74	burden	burden	NOUN
ajlm-2845	23	75	of	of	ADP
ajlm-2845	23	76	amr	amr	PROPN
ajlm-2845	23	77	has	have	AUX
ajlm-2845	23	78	reported	report	VERB
ajlm-2845	23	79	the	the	DET
ajlm-2845	23	80	alarming	alarming	ADJ
ajlm-2845	23	81	statistic	statistic	NOUN
ajlm-2845	23	82	of	of	ADP
ajlm-2845	23	83	4.95	4.95	NUM
ajlm-2845	23	84	million	million	NUM
ajlm-2845	23	85	deaths	death	NOUN
ajlm-2845	23	86	worldwide	worldwide	ADV
ajlm-2845	23	87	related	relate	VERB
ajlm-2845	23	88	to	to	ADP
ajlm-2845	23	89	amr	amr	PROPN
ajlm-2845	23	90	in	in	ADP
ajlm-2845	23	91	2019	2019	NUM
ajlm-2845	23	92	alone.7	alone.7	PROPN
ajlm-2845	23	93	the	the	DET
ajlm-2845	23	94	highest	high	ADJ
ajlm-2845	23	95	mortality	mortality	NOUN
ajlm-2845	23	96	rates	rate	NOUN
ajlm-2845	23	97	were	be	AUX
ajlm-2845	23	98	reported	report	VERB
ajlm-2845	23	99	in	in	ADP
ajlm-2845	23	100	western	western	ADJ
ajlm-2845	23	101	and	and	CCONJ
ajlm-2845	23	102	sub	sub	ADJ
ajlm-2845	23	103	-	-	ADJ
ajlm-2845	23	104	saharan	saharan	ADJ
ajlm-2845	23	105	africa	africa	PROPN
ajlm-2845	23	106	,	,	PUNCT
ajlm-2845	23	107	at	at	ADP
ajlm-2845	23	108	approximately	approximately	ADV
ajlm-2845	23	109	27.3	27.3	NUM
ajlm-2845	23	110	deaths	death	NOUN
ajlm-2845	23	111	per	per	ADP
ajlm-2845	23	112	100	100	NUM
ajlm-2845	23	113	000	000	NUM
ajlm-2845	23	114	individuals	individual	NOUN
ajlm-2845	23	115	.	.	PUNCT
ajlm-2845	24	1	the	the	DET
ajlm-2845	24	2	need	need	NOUN
ajlm-2845	24	3	to	to	PART
ajlm-2845	24	4	implement	implement	VERB
ajlm-2845	24	5	changes	change	NOUN
ajlm-2845	24	6	that	that	PRON
ajlm-2845	24	7	combat	combat	NOUN
ajlm-2845	24	8	and	and	CCONJ
ajlm-2845	24	9	reduce	reduce	VERB
ajlm-2845	24	10	amr	amr	NOUN
ajlm-2845	24	11	,	,	PUNCT
ajlm-2845	24	12	both	both	PRON
ajlm-2845	24	13	globally	globally	ADV
ajlm-2845	24	14	and	and	CCONJ
ajlm-2845	24	15	in	in	ADP
ajlm-2845	24	16	south	south	PROPN
ajlm-2845	24	17	africa	africa	PROPN
ajlm-2845	24	18	,	,	PUNCT
ajlm-2845	24	19	is	be	AUX
ajlm-2845	24	20	therefore	therefore	ADV
ajlm-2845	24	21	urgent.8	urgent.8	PROPN
ajlm-2845	24	22	once	once	SCONJ
ajlm-2845	24	23	infection	infection	NOUN
ajlm-2845	24	24	has	have	AUX
ajlm-2845	24	25	been	be	AUX
ajlm-2845	24	26	confirmed	confirm	VERB
ajlm-2845	24	27	,	,	PUNCT
ajlm-2845	24	28	the	the	DET
ajlm-2845	24	29	use	use	NOUN
ajlm-2845	24	30	of	of	ADP
ajlm-2845	24	31	antibiogram	antibiogram	PROPN
ajlm-2845	24	32	to	to	PART
ajlm-2845	24	33	guide	guide	VERB
ajlm-2845	24	34	treatment	treatment	NOUN
ajlm-2845	24	35	of	of	ADP
ajlm-2845	24	36	susceptible	susceptible	ADJ
ajlm-2845	24	37	organisms	organism	NOUN
ajlm-2845	24	38	is	be	AUX
ajlm-2845	24	39	recommended	recommend	VERB
ajlm-2845	24	40	by	by	ADP
ajlm-2845	24	41	the	the	DET
ajlm-2845	24	42	society	society	NOUN
ajlm-2845	24	43	for	for	ADP
ajlm-2845	24	44	healthcare	healthcare	PROPN
ajlm-2845	24	45	epidemiology	epidemiology	PROPN
ajlm-2845	24	46	of	of	ADP
ajlm-2845	24	47	america	america	PROPN
ajlm-2845	24	48	,	,	PUNCT
ajlm-2845	24	49	the	the	DET
ajlm-2845	24	50	infectious	infectious	ADJ
ajlm-2845	24	51	diseases	disease	NOUN
ajlm-2845	24	52	society	society	NOUN
ajlm-2845	24	53	of	of	ADP
ajlm-2845	24	54	america	america	PROPN
ajlm-2845	24	55	,	,	PUNCT
ajlm-2845	24	56	and	and	CCONJ
ajlm-2845	24	57	the	the	DET
ajlm-2845	24	58	clinical	clinical	ADJ
ajlm-2845	24	59	and	and	CCONJ
ajlm-2845	24	60	laboratory	laboratory	NOUN
ajlm-2845	24	61	standards	standard	NOUN
ajlm-2845	24	62	institute	institute	PROPN
ajlm-2845	24	63	(	(	PUNCT
ajlm-2845	24	64	clsi	clsi	PROPN
ajlm-2845	24	65	)	)	PUNCT
ajlm-2845	24	66	.	.	PUNCT
ajlm-2845	25	1	local	local	ADJ
ajlm-2845	25	2	susceptibility	susceptibility	NOUN
ajlm-2845	25	3	patterns	pattern	NOUN
ajlm-2845	25	4	should	should	AUX
ajlm-2845	25	5	be	be	AUX
ajlm-2845	25	6	determined	determine	VERB
ajlm-2845	25	7	such	such	ADJ
ajlm-2845	25	8	that	that	PRON
ajlm-2845	25	9	appropriate	appropriate	ADJ
ajlm-2845	25	10	empiric	empiric	ADJ
ajlm-2845	25	11	therapy	therapy	NOUN
ajlm-2845	25	12	can	can	AUX
ajlm-2845	25	13	be	be	AUX
ajlm-2845	25	14	utilised.9	utilised.9	NOUN
ajlm-2845	25	15	this	this	DET
ajlm-2845	25	16	study	study	NOUN
ajlm-2845	25	17	aimed	aim	VERB
ajlm-2845	25	18	to	to	PART
ajlm-2845	25	19	determine	determine	VERB
ajlm-2845	25	20	the	the	DET
ajlm-2845	25	21	rate	rate	NOUN
ajlm-2845	25	22	of	of	ADP
ajlm-2845	25	23	culture	culture	NOUN
ajlm-2845	25	24	positivity	positivity	NOUN
ajlm-2845	25	25	for	for	ADP
ajlm-2845	25	26	uropathogens	uropathogen	NOUN
ajlm-2845	25	27	and	and	CCONJ
ajlm-2845	25	28	the	the	DET
ajlm-2845	25	29	antimicrobial	antimicrobial	ADJ
ajlm-2845	25	30	susceptibility	susceptibility	NOUN
ajlm-2845	25	31	patterns	pattern	NOUN
ajlm-2845	25	32	.	.	PUNCT
ajlm-2845	26	1	this	this	PRON
ajlm-2845	26	2	is	be	AUX
ajlm-2845	26	3	to	to	PART
ajlm-2845	26	4	guide	guide	VERB
ajlm-2845	26	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	26	6	stewardship	stewardship	NOUN
ajlm-2845	26	7	and	and	CCONJ
ajlm-2845	26	8	prescribing	prescribing	NOUN
ajlm-2845	26	9	practices	practice	NOUN
ajlm-2845	26	10	at	at	ADP
ajlm-2845	26	11	potchefstroom	potchefstroom	NOUN
ajlm-2845	26	12	hospital	hospital	NOUN
ajlm-2845	26	13	;	;	PUNCT
ajlm-2845	26	14	a	a	DET
ajlm-2845	26	15	regional	regional	ADJ
ajlm-2845	26	16	hospital	hospital	NOUN
ajlm-2845	26	17	servicing	servicing	NOUN
ajlm-2845	26	18	the	the	DET
ajlm-2845	26	19	jb	jb	PROPN
ajlm-2845	26	20	marks	marks	PROPN
ajlm-2845	26	21	municipality	municipality	NOUN
ajlm-2845	26	22	and	and	CCONJ
ajlm-2845	26	23	drainage	drainage	NOUN
ajlm-2845	26	24	area	area	NOUN
ajlm-2845	26	25	in	in	ADP
ajlm-2845	26	26	the	the	DET
ajlm-2845	26	27	north	north	NOUN
ajlm-2845	26	28	west	west	PROPN
ajlm-2845	26	29	province	province	PROPN
ajlm-2845	26	30	,	,	PUNCT
ajlm-2845	26	31	south	south	PROPN
ajlm-2845	26	32	africa	africa	PROPN
ajlm-2845	26	33	.	.	PUNCT
ajlm-2845	27	1	in	in	ADP
ajlm-2845	27	2	addition	addition	NOUN
ajlm-2845	27	3	,	,	PUNCT
ajlm-2845	27	4	the	the	DET
ajlm-2845	27	5	results	result	NOUN
ajlm-2845	27	6	were	be	AUX
ajlm-2845	27	7	compared	compare	VERB
ajlm-2845	27	8	with	with	ADP
ajlm-2845	27	9	the	the	DET
ajlm-2845	27	10	national	national	PROPN
ajlm-2845	27	11	department	department	PROPN
ajlm-2845	27	12	of	of	ADP
ajlm-2845	27	13	health	health	PROPN
ajlm-2845	27	14	’s	’s	PART
ajlm-2845	27	15	standard	standard	ADJ
ajlm-2845	27	16	treatment	treatment	NOUN
ajlm-2845	27	17	guidelines	guideline	NOUN
ajlm-2845	27	18	and	and	CCONJ
ajlm-2845	27	19	national	national	ADJ
ajlm-2845	27	20	essential	essential	ADJ
ajlm-2845	27	21	medicines	medicine	NOUN
ajlm-2845	27	22	list	list	NOUN
ajlm-2845	27	23	(	(	PUNCT
ajlm-2845	27	24	neml)10	neml)10	NOUN
ajlm-2845	27	25	for	for	ADP
ajlm-2845	27	26	empiric	empiric	ADJ
ajlm-2845	27	27	antimicrobial	antimicrobial	ADJ
ajlm-2845	27	28	management	management	NOUN
ajlm-2845	27	29	of	of	ADP
ajlm-2845	27	30	confirmed	confirm	VERB
ajlm-2845	27	31	utis	utis	NOUN
ajlm-2845	27	32	.	.	PUNCT
ajlm-2845	28	1	the	the	DET
ajlm-2845	28	2	neml	neml	PROPN
ajlm-2845	28	3	currently	currently	ADV
ajlm-2845	28	4	recommends	recommend	VERB
ajlm-2845	28	5	the	the	DET
ajlm-2845	28	6	following	following	NOUN
ajlm-2845	28	7	for	for	ADP
ajlm-2845	28	8	treatment	treatment	NOUN
ajlm-2845	28	9	of	of	ADP
ajlm-2845	28	10	an	an	DET
ajlm-2845	28	11	uncomplicated	uncomplicated	ADJ
ajlm-2845	28	12	uti10	uti10	NOUN
ajlm-2845	28	13	:	:	PUNCT
ajlm-2845	28	14	gentamicin	gentamicin	NOUN
ajlm-2845	28	15	160	160	NUM
ajlm-2845	28	16	mg	mg	ADV
ajlm-2845	28	17	intramuscular	intramuscular	ADV
ajlm-2845	28	18	as	as	ADP
ajlm-2845	28	19	a	a	DET
ajlm-2845	28	20	single	single	ADJ
ajlm-2845	28	21	dose	dose	NOUN
ajlm-2845	28	22	fosfomycin	fosfomycin	PROPN
ajlm-2845	28	23	3	3	NUM
ajlm-2845	28	24	g	g	PROPN
ajlm-2845	28	25	po	po	PROPN
ajlm-2845	29	1	[	[	X
ajlm-2845	29	2	per	per	ADP
ajlm-2845	29	3	os	os	NOUN
ajlm-2845	29	4	,	,	PUNCT
ajlm-2845	29	5	by	by	ADP
ajlm-2845	29	6	mouth	mouth	NOUN
ajlm-2845	29	7	]	]	PUNCT
ajlm-2845	29	8	as	as	ADP
ajlm-2845	29	9	a	a	DET
ajlm-2845	29	10	single	single	ADJ
ajlm-2845	29	11	dose	dose	NOUN
ajlm-2845	29	12	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	29	13	100	100	NUM
ajlm-2845	29	14	mg	mg	PROPN
ajlm-2845	29	15	po	po	PROPN
ajlm-2845	29	16	four	four	NUM
ajlm-2845	29	17	times	time	NOUN
ajlm-2845	29	18	a	a	DET
ajlm-2845	29	19	day	day	NOUN
ajlm-2845	29	20	for	for	ADP
ajlm-2845	29	21	5	5	NUM
ajlm-2845	29	22	days	day	NOUN
ajlm-2845	29	23	additionally	additionally	ADV
ajlm-2845	29	24	,	,	PUNCT
ajlm-2845	29	25	the	the	DET
ajlm-2845	29	26	neml	neml	NOUN
ajlm-2845	29	27	recommends	recommend	VERB
ajlm-2845	29	28	the	the	DET
ajlm-2845	29	29	following	following	NOUN
ajlm-2845	29	30	for	for	ADP
ajlm-2845	29	31	treatment	treatment	NOUN
ajlm-2845	29	32	of	of	ADP
ajlm-2845	29	33	a	a	DET
ajlm-2845	29	34	complicated	complicated	ADJ
ajlm-2845	29	35	uti10	uti10	NOUN
ajlm-2845	29	36	:	:	PUNCT
ajlm-2845	29	37	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2845	29	38	500	500	NUM
ajlm-2845	29	39	mg	mg	PROPN
ajlm-2845	29	40	po	po	PROPN
ajlm-2845	29	41	twice	twice	DET
ajlm-2845	29	42	a	a	DET
ajlm-2845	29	43	day	day	NOUN
ajlm-2845	29	44	for	for	ADP
ajlm-2845	29	45	7–10	7–10	PROPN
ajlm-2845	29	46	days	day	NOUN
ajlm-2845	29	47	for	for	ADP
ajlm-2845	29	48	pregnant	pregnant	ADJ
ajlm-2845	29	49	women	woman	NOUN
ajlm-2845	29	50	,	,	PUNCT
ajlm-2845	29	51	the	the	DET
ajlm-2845	29	52	following	following	NOUN
ajlm-2845	29	53	has	have	AUX
ajlm-2845	29	54	been	be	AUX
ajlm-2845	29	55	recommended10	recommended10	PROPN
ajlm-2845	29	56	:	:	PUNCT
ajlm-2845	29	57	fosfomycin	fosfomycin	PROPN
ajlm-2845	29	58	3	3	NUM
ajlm-2845	29	59	g	g	PROPN
ajlm-2845	29	60	po	po	PROPN
ajlm-2845	29	61	as	as	ADP
ajlm-2845	29	62	a	a	DET
ajlm-2845	29	63	single	single	ADJ
ajlm-2845	29	64	dose	dose	NOUN
ajlm-2845	29	65	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	29	66	100	100	NUM
ajlm-2845	29	67	mg	mg	PROPN
ajlm-2845	29	68	po	po	PROPN
ajlm-2845	29	69	four	four	NUM
ajlm-2845	29	70	times	time	NOUN
ajlm-2845	29	71	a	a	DET
ajlm-2845	29	72	day	day	NOUN
ajlm-2845	29	73	for	for	ADP
ajlm-2845	29	74	5	5	NUM
ajlm-2845	29	75	days	day	NOUN
ajlm-2845	29	76	methods	method	NOUN
ajlm-2845	29	77	ethical	ethical	ADJ
ajlm-2845	29	78	considerations	consideration	NOUN
ajlm-2845	29	79	the	the	DET
ajlm-2845	29	80	research	research	NOUN
ajlm-2845	29	81	was	be	AUX
ajlm-2845	29	82	approved	approve	VERB
ajlm-2845	29	83	by	by	ADP
ajlm-2845	29	84	the	the	DET
ajlm-2845	29	85	human	human	PROPN
ajlm-2845	29	86	research	research	PROPN
ajlm-2845	29	87	ethics	ethic	NOUN
ajlm-2845	29	88	committee	committee	PROPN
ajlm-2845	29	89	(	(	PUNCT
ajlm-2845	29	90	medical	medical	ADJ
ajlm-2845	29	91	)	)	PUNCT
ajlm-2845	29	92	of	of	ADP
ajlm-2845	29	93	the	the	DET
ajlm-2845	29	94	university	university	NOUN
ajlm-2845	29	95	of	of	ADP
ajlm-2845	29	96	the	the	DET
ajlm-2845	29	97	witwatersrand	witwatersrand	NOUN
ajlm-2845	29	98	(	(	PUNCT
ajlm-2845	29	99	reference	reference	NOUN
ajlm-2845	29	100	number	number	NOUN
ajlm-2845	29	101	:	:	PUNCT
ajlm-2845	29	102	m230502	m230502	NOUN
ajlm-2845	29	103	m230810	m230810	NOUN
ajlm-2845	29	104	-	-	PUNCT
ajlm-2845	29	105	a-0011	a-0011	ADJ
ajlm-2845	29	106	)	)	PUNCT
ajlm-2845	29	107	.	.	PUNCT
ajlm-2845	30	1	additionally	additionally	ADV
ajlm-2845	30	2	,	,	PUNCT
ajlm-2845	30	3	institutional	institutional	ADJ
ajlm-2845	30	4	approval	approval	NOUN
ajlm-2845	30	5	was	be	AUX
ajlm-2845	30	6	granted	grant	VERB
ajlm-2845	30	7	by	by	ADP
ajlm-2845	30	8	the	the	DET
ajlm-2845	30	9	potchefstroom	potchefstroom	NOUN
ajlm-2845	30	10	hospital	hospital	NOUN
ajlm-2845	30	11	ethics	ethic	NOUN
ajlm-2845	30	12	committee	committee	PROPN
ajlm-2845	30	13	.	.	PUNCT
ajlm-2845	31	1	provincial	provincial	ADJ
ajlm-2845	31	2	approval	approval	NOUN
ajlm-2845	31	3	was	be	AUX
ajlm-2845	31	4	provided	provide	VERB
ajlm-2845	31	5	by	by	ADP
ajlm-2845	31	6	the	the	DET
ajlm-2845	31	7	north	north	PROPN
ajlm-2845	31	8	west	west	PROPN
ajlm-2845	31	9	department	department	PROPN
ajlm-2845	31	10	of	of	ADP
ajlm-2845	31	11	health	health	NOUN
ajlm-2845	31	12	,	,	PUNCT
ajlm-2845	31	13	and	and	CCONJ
ajlm-2845	31	14	national	national	ADJ
ajlm-2845	31	15	approval	approval	NOUN
ajlm-2845	31	16	by	by	ADP
ajlm-2845	31	17	the	the	DET
ajlm-2845	31	18	national	national	PROPN
ajlm-2845	31	19	department	department	PROPN
ajlm-2845	31	20	of	of	ADP
ajlm-2845	31	21	health	health	PROPN
ajlm-2845	31	22	.	.	PUNCT
ajlm-2845	32	1	informed	inform	VERB
ajlm-2845	32	2	consent	consent	NOUN
ajlm-2845	32	3	was	be	AUX
ajlm-2845	32	4	not	not	PART
ajlm-2845	32	5	deemed	deem	VERB
ajlm-2845	32	6	necessary	necessary	ADJ
ajlm-2845	32	7	because	because	SCONJ
ajlm-2845	32	8	of	of	ADP
ajlm-2845	32	9	the	the	DET
ajlm-2845	32	10	absence	absence	NOUN
ajlm-2845	32	11	of	of	ADP
ajlm-2845	32	12	identifiable	identifiable	ADJ
ajlm-2845	32	13	patient	patient	ADJ
ajlm-2845	32	14	data	datum	NOUN
ajlm-2845	32	15	and	and	CCONJ
ajlm-2845	32	16	information	information	NOUN
ajlm-2845	32	17	being	be	AUX
ajlm-2845	32	18	provided	provide	VERB
ajlm-2845	32	19	by	by	ADP
ajlm-2845	32	20	the	the	DET
ajlm-2845	32	21	national	national	PROPN
ajlm-2845	32	22	health	health	PROPN
ajlm-2845	32	23	laboratory	laboratory	PROPN
ajlm-2845	32	24	service	service	NOUN
ajlm-2845	32	25	(	(	PUNCT
ajlm-2845	32	26	nhls	nhls	PROPN
ajlm-2845	32	27	)	)	PUNCT
ajlm-2845	32	28	academic	academic	ADJ
ajlm-2845	32	29	affairs	affairs	PROPN
ajlm-2845	32	30	and	and	CCONJ
ajlm-2845	32	31	research	research	NOUN
ajlm-2845	32	32	management	management	NOUN
ajlm-2845	32	33	systems	system	NOUN
ajlm-2845	32	34	for	for	ADP
ajlm-2845	32	35	analysis	analysis	NOUN
ajlm-2845	32	36	.	.	PUNCT
ajlm-2845	33	1	data	datum	NOUN
ajlm-2845	33	2	confidentiality	confidentiality	NOUN
ajlm-2845	33	3	was	be	AUX
ajlm-2845	33	4	maintained	maintain	VERB
ajlm-2845	33	5	in	in	ADP
ajlm-2845	33	6	accordance	accordance	NOUN
ajlm-2845	33	7	with	with	ADP
ajlm-2845	33	8	the	the	DET
ajlm-2845	33	9	declaration	declaration	NOUN
ajlm-2845	33	10	of	of	ADP
ajlm-2845	33	11	helsinki	helsinki	PROPN
ajlm-2845	33	12	and	and	CCONJ
ajlm-2845	33	13	the	the	DET
ajlm-2845	33	14	protection	protection	NOUN
ajlm-2845	33	15	of	of	ADP
ajlm-2845	33	16	personal	personal	ADJ
ajlm-2845	33	17	information	information	NOUN
ajlm-2845	33	18	act	act	NOUN
ajlm-2845	33	19	of	of	ADP
ajlm-2845	33	20	2013	2013	NUM
ajlm-2845	33	21	.	.	PUNCT
ajlm-2845	34	1	study	study	NOUN
ajlm-2845	34	2	design	design	NOUN
ajlm-2845	34	3	and	and	CCONJ
ajlm-2845	34	4	setting	set	VERB
ajlm-2845	34	5	the	the	DET
ajlm-2845	34	6	study	study	NOUN
ajlm-2845	34	7	was	be	AUX
ajlm-2845	34	8	a	a	DET
ajlm-2845	34	9	retrospective	retrospective	ADJ
ajlm-2845	34	10	analysis	analysis	NOUN
ajlm-2845	34	11	of	of	ADP
ajlm-2845	34	12	urine	urine	NOUN
ajlm-2845	34	13	microscopy	microscopy	NOUN
ajlm-2845	34	14	,	,	PUNCT
ajlm-2845	34	15	culture	culture	NOUN
ajlm-2845	34	16	and	and	CCONJ
ajlm-2845	34	17	sensitivity	sensitivity	NOUN
ajlm-2845	34	18	specimens	specimen	NOUN
ajlm-2845	34	19	submitted	submit	VERB
ajlm-2845	34	20	to	to	ADP
ajlm-2845	34	21	the	the	DET
ajlm-2845	34	22	nhls	nhls	NOUN
ajlm-2845	34	23	at	at	ADP
ajlm-2845	34	24	potchefstroom	potchefstroom	NOUN
ajlm-2845	34	25	hospital	hospital	NOUN
ajlm-2845	34	26	.	.	PUNCT
ajlm-2845	35	1	the	the	DET
ajlm-2845	35	2	nhls	nhls	PROPN
ajlm-2845	35	3	in	in	ADP
ajlm-2845	35	4	south	south	PROPN
ajlm-2845	35	5	africa	africa	PROPN
ajlm-2845	35	6	is	be	AUX
ajlm-2845	35	7	a	a	DET
ajlm-2845	35	8	public	public	ADJ
ajlm-2845	35	9	entity	entity	NOUN
ajlm-2845	35	10	providing	provide	VERB
ajlm-2845	35	11	diagnostic	diagnostic	ADJ
ajlm-2845	35	12	pathology	pathology	NOUN
ajlm-2845	35	13	services	service	NOUN
ajlm-2845	35	14	,	,	PUNCT
ajlm-2845	35	15	research	research	NOUN
ajlm-2845	35	16	,	,	PUNCT
ajlm-2845	35	17	and	and	CCONJ
ajlm-2845	35	18	health	health	NOUN
ajlm-2845	35	19	surveillance	surveillance	NOUN
ajlm-2845	35	20	,	,	PUNCT
ajlm-2845	35	21	accredited	accredit	VERB
ajlm-2845	35	22	by	by	ADP
ajlm-2845	35	23	the	the	DET
ajlm-2845	35	24	south	south	ADJ
ajlm-2845	35	25	african	african	ADJ
ajlm-2845	35	26	national	national	ADJ
ajlm-2845	35	27	accreditation	accreditation	NOUN
ajlm-2845	35	28	system	system	NOUN
ajlm-2845	35	29	under	under	ADP
ajlm-2845	35	30	iso	iso	NOUN
ajlm-2845	35	31	15189	15189	NUM
ajlm-2845	35	32	for	for	ADP
ajlm-2845	35	33	medical	medical	ADJ
ajlm-2845	35	34	laboratories	laboratory	NOUN
ajlm-2845	35	35	.	.	PUNCT
ajlm-2845	36	1	potchefstroom	potchefstroom	NOUN
ajlm-2845	36	2	hospital	hospital	NOUN
ajlm-2845	36	3	is	be	AUX
ajlm-2845	36	4	a	a	DET
ajlm-2845	36	5	state	state	NOUN
ajlm-2845	36	6	-	-	PUNCT
ajlm-2845	36	7	funded	fund	VERB
ajlm-2845	36	8	,	,	PUNCT
ajlm-2845	36	9	335	335	NUM
ajlm-2845	36	10	-	-	PUNCT
ajlm-2845	36	11	bed	bed	NOUN
ajlm-2845	36	12	regional	regional	ADJ
ajlm-2845	36	13	healthcare	healthcare	NOUN
ajlm-2845	36	14	facility	facility	NOUN
ajlm-2845	36	15	in	in	ADP
ajlm-2845	36	16	the	the	DET
ajlm-2845	36	17	kenneth	kenneth	PROPN
ajlm-2845	36	18	kaunda	kaunda	PROPN
ajlm-2845	36	19	district	district	PROPN
ajlm-2845	36	20	of	of	ADP
ajlm-2845	36	21	south	south	PROPN
ajlm-2845	36	22	africa	africa	PROPN
ajlm-2845	36	23	’s	’s	PART
ajlm-2845	36	24	north	north	PROPN
ajlm-2845	36	25	west	west	PROPN
ajlm-2845	36	26	province	province	PROPN
ajlm-2845	36	27	,	,	PUNCT
ajlm-2845	36	28	offering	offer	VERB
ajlm-2845	36	29	specialised	specialised	ADJ
ajlm-2845	36	30	inand	inand	ADJ
ajlm-2845	36	31	outpatient	outpatient	NOUN
ajlm-2845	36	32	care	care	NOUN
ajlm-2845	36	33	to	to	ADP
ajlm-2845	36	34	patients	patient	NOUN
ajlm-2845	36	35	in	in	ADP
ajlm-2845	36	36	the	the	DET
ajlm-2845	36	37	surrounding	surround	VERB
ajlm-2845	36	38	area	area	NOUN
ajlm-2845	36	39	.	.	PUNCT
ajlm-2845	37	1	inclusion	inclusion	NOUN
ajlm-2845	37	2	and	and	CCONJ
ajlm-2845	37	3	exclusion	exclusion	NOUN
ajlm-2845	37	4	criteria	criterion	NOUN
ajlm-2845	37	5	the	the	DET
ajlm-2845	37	6	urine	urine	NOUN
ajlm-2845	37	7	sample	sample	NOUN
ajlm-2845	37	8	results	result	NOUN
ajlm-2845	37	9	included	include	VERB
ajlm-2845	37	10	in	in	ADP
ajlm-2845	37	11	the	the	DET
ajlm-2845	37	12	analysis	analysis	NOUN
ajlm-2845	37	13	were	be	AUX
ajlm-2845	37	14	those	those	PRON
ajlm-2845	37	15	submitted	submit	VERB
ajlm-2845	37	16	over	over	ADP
ajlm-2845	37	17	4	4	NUM
ajlm-2845	37	18	years	year	NOUN
ajlm-2845	37	19	between	between	ADP
ajlm-2845	37	20	01	01	NUM
ajlm-2845	37	21	january	january	NOUN
ajlm-2845	37	22	2020	2020	NUM
ajlm-2845	37	23	and	and	CCONJ
ajlm-2845	37	24	31	31	NUM
ajlm-2845	37	25	december	december	PROPN
ajlm-2845	37	26	2023	2023	NUM
ajlm-2845	37	27	.	.	PUNCT
ajlm-2845	38	1	all	all	DET
ajlm-2845	38	2	inand	inand	ADJ
ajlm-2845	38	3	outpatients	outpatient	NOUN
ajlm-2845	38	4	from	from	ADP
ajlm-2845	38	5	whom	whom	PRON
ajlm-2845	38	6	urine	urine	NOUN
ajlm-2845	38	7	for	for	ADP
ajlm-2845	38	8	microscopy	microscopy	NOUN
ajlm-2845	38	9	,	,	PUNCT
ajlm-2845	38	10	culture	culture	NOUN
ajlm-2845	38	11	and	and	CCONJ
ajlm-2845	38	12	sensitivity	sensitivity	NOUN
ajlm-2845	38	13	was	be	AUX
ajlm-2845	38	14	collected	collect	VERB
ajlm-2845	38	15	were	be	AUX
ajlm-2845	38	16	included	include	VERB
ajlm-2845	38	17	.	.	PUNCT
ajlm-2845	39	1	samples	sample	NOUN
ajlm-2845	39	2	that	that	PRON
ajlm-2845	39	3	did	do	AUX
ajlm-2845	39	4	not	not	PART
ajlm-2845	39	5	yield	yield	VERB
ajlm-2845	39	6	a	a	DET
ajlm-2845	39	7	positive	positive	ADJ
ajlm-2845	39	8	microbial	microbial	ADJ
ajlm-2845	39	9	culture	culture	NOUN
ajlm-2845	39	10	,	,	PUNCT
ajlm-2845	39	11	cultures	culture	NOUN
ajlm-2845	39	12	that	that	PRON
ajlm-2845	39	13	did	do	AUX
ajlm-2845	39	14	not	not	PART
ajlm-2845	39	15	have	have	VERB
ajlm-2845	39	16	susceptibility	susceptibility	NOUN
ajlm-2845	39	17	testing	testing	NOUN
ajlm-2845	39	18	,	,	PUNCT
ajlm-2845	39	19	samples	sample	NOUN
ajlm-2845	39	20	that	that	PRON
ajlm-2845	39	21	had	have	AUX
ajlm-2845	39	22	been	be	AUX
ajlm-2845	39	23	rejected	reject	VERB
ajlm-2845	39	24	(	(	PUNCT
ajlm-2845	39	25	for	for	ADP
ajlm-2845	39	26	any	any	DET
ajlm-2845	39	27	reason	reason	NOUN
ajlm-2845	39	28	)	)	PUNCT
ajlm-2845	39	29	and	and	CCONJ
ajlm-2845	39	30	cultures	culture	NOUN
ajlm-2845	39	31	that	that	PRON
ajlm-2845	39	32	exhibited	exhibit	VERB
ajlm-2845	39	33	mixed	mixed	ADJ
ajlm-2845	39	34	microbial	microbial	ADJ
ajlm-2845	39	35	growth	growth	NOUN
ajlm-2845	39	36	were	be	AUX
ajlm-2845	39	37	excluded	exclude	VERB
ajlm-2845	39	38	.	.	PUNCT
ajlm-2845	40	1	no	no	DET
ajlm-2845	40	2	formal	formal	ADJ
ajlm-2845	40	3	prospective	prospective	ADJ
ajlm-2845	40	4	study	study	NOUN
ajlm-2845	40	5	sample	sample	NOUN
ajlm-2845	40	6	size	size	NOUN
ajlm-2845	40	7	estimates	estimate	NOUN
ajlm-2845	40	8	were	be	AUX
ajlm-2845	40	9	performed	perform	VERB
ajlm-2845	40	10	–	–	PUNCT
ajlm-2845	40	11	all	all	DET
ajlm-2845	40	12	available	available	ADJ
ajlm-2845	40	13	isolates	isolate	NOUN
ajlm-2845	40	14	were	be	AUX
ajlm-2845	40	15	included	include	VERB
ajlm-2845	40	16	.	.	PUNCT
ajlm-2845	41	1	sampling	sample	VERB
ajlm-2845	41	2	as	as	ADP
ajlm-2845	41	3	this	this	PRON
ajlm-2845	41	4	is	be	AUX
ajlm-2845	41	5	a	a	DET
ajlm-2845	41	6	retrospective	retrospective	ADJ
ajlm-2845	41	7	records	record	NOUN
ajlm-2845	41	8	review	review	NOUN
ajlm-2845	41	9	,	,	PUNCT
ajlm-2845	41	10	the	the	DET
ajlm-2845	41	11	data	datum	NOUN
ajlm-2845	41	12	were	be	AUX
ajlm-2845	41	13	acquired	acquire	VERB
ajlm-2845	41	14	from	from	ADP
ajlm-2845	41	15	the	the	DET
ajlm-2845	41	16	nhls	nhls	PROPN
ajlm-2845	41	17	academic	academic	PROPN
ajlm-2845	41	18	affairs	affairs	PROPN
ajlm-2845	41	19	and	and	CCONJ
ajlm-2845	41	20	research	research	NOUN
ajlm-2845	41	21	management	management	NOUN
ajlm-2845	41	22	systems	system	NOUN
ajlm-2845	41	23	database	database	NOUN
ajlm-2845	41	24	,	,	PUNCT
ajlm-2845	41	25	which	which	PRON
ajlm-2845	41	26	functions	function	NOUN
ajlm-2845	41	27	as	as	ADP
ajlm-2845	41	28	a	a	DET
ajlm-2845	41	29	central	central	ADJ
ajlm-2845	41	30	storage	storage	NOUN
ajlm-2845	41	31	hub	hub	NOUN
ajlm-2845	41	32	for	for	ADP
ajlm-2845	41	33	all	all	DET
ajlm-2845	41	34	the	the	DET
ajlm-2845	41	35	primary	primary	ADJ
ajlm-2845	41	36	information	information	NOUN
ajlm-2845	41	37	gathered	gather	VERB
ajlm-2845	41	38	by	by	ADP
ajlm-2845	41	39	the	the	DET
ajlm-2845	41	40	nhls	nhls	PROPN
ajlm-2845	41	41	and	and	CCONJ
ajlm-2845	41	42	its	its	PRON
ajlm-2845	41	43	subsidiaries	subsidiary	NOUN
ajlm-2845	41	44	.	.	PUNCT
ajlm-2845	42	1	once	once	ADV
ajlm-2845	42	2	the	the	DET
ajlm-2845	42	3	access	access	NOUN
ajlm-2845	42	4	for	for	ADP
ajlm-2845	42	5	the	the	DET
ajlm-2845	42	6	nhls	nhls	PROPN
ajlm-2845	42	7	academic	academic	PROPN
ajlm-2845	42	8	affairs	affairs	PROPN
ajlm-2845	42	9	and	and	CCONJ
ajlm-2845	42	10	research	research	NOUN
ajlm-2845	42	11	management	management	NOUN
ajlm-2845	42	12	systems	system	NOUN
ajlm-2845	42	13	data	datum	NOUN
ajlm-2845	42	14	was	be	AUX
ajlm-2845	42	15	granted	grant	VERB
ajlm-2845	42	16	,	,	PUNCT
ajlm-2845	42	17	consultation	consultation	NOUN
ajlm-2845	42	18	with	with	ADP
ajlm-2845	42	19	a	a	DET
ajlm-2845	42	20	data	data	NOUN
ajlm-2845	42	21	analyst	analyst	NOUN
ajlm-2845	42	22	and	and	CCONJ
ajlm-2845	42	23	nhls	nhls	PROPN
ajlm-2845	42	24	collaborator	collaborator	NOUN
ajlm-2845	42	25	was	be	AUX
ajlm-2845	42	26	utilised	utilise	VERB
ajlm-2845	42	27	to	to	PART
ajlm-2845	42	28	ensure	ensure	VERB
ajlm-2845	42	29	the	the	DET
ajlm-2845	42	30	validity	validity	NOUN
ajlm-2845	42	31	of	of	ADP
ajlm-2845	42	32	the	the	DET
ajlm-2845	42	33	data	datum	NOUN
ajlm-2845	42	34	.	.	PUNCT
ajlm-2845	43	1	since	since	SCONJ
ajlm-2845	43	2	the	the	DET
ajlm-2845	43	3	potchefstroom	potchefstroom	NOUN
ajlm-2845	43	4	nhls	nhls	NOUN
ajlm-2845	43	5	does	do	AUX
ajlm-2845	43	6	not	not	PART
ajlm-2845	43	7	have	have	VERB
ajlm-2845	43	8	the	the	DET
ajlm-2845	43	9	capability	capability	NOUN
ajlm-2845	43	10	to	to	PART
ajlm-2845	43	11	culture	culture	VERB
ajlm-2845	43	12	samples	sample	NOUN
ajlm-2845	43	13	independently	independently	ADV
ajlm-2845	43	14	,	,	PUNCT
ajlm-2845	43	15	the	the	DET
ajlm-2845	43	16	results	result	NOUN
ajlm-2845	43	17	of	of	ADP
ajlm-2845	43	18	the	the	DET
ajlm-2845	43	19	urine	urine	NOUN
ajlm-2845	43	20	microscopy	microscopy	NOUN
ajlm-2845	43	21	,	,	PUNCT
ajlm-2845	43	22	culture	culture	NOUN
ajlm-2845	43	23	and	and	CCONJ
ajlm-2845	43	24	sensitivity	sensitivity	NOUN
ajlm-2845	43	25	and	and	CCONJ
ajlm-2845	43	26	subsequent	subsequent	ADJ
ajlm-2845	43	27	primary	primary	ADJ
ajlm-2845	43	28	data	datum	NOUN
ajlm-2845	43	29	were	be	AUX
ajlm-2845	43	30	collated	collate	VERB
ajlm-2845	43	31	into	into	ADP
ajlm-2845	43	32	the	the	DET
ajlm-2845	43	33	nhls	nhls	PROPN
ajlm-2845	43	34	academic	academic	PROPN
ajlm-2845	43	35	affairs	affairs	PROPN
ajlm-2845	43	36	and	and	CCONJ
ajlm-2845	43	37	research	research	NOUN
ajlm-2845	43	38	management	management	NOUN
ajlm-2845	43	39	systems	system	NOUN
ajlm-2845	43	40	from	from	ADP
ajlm-2845	43	41	several	several	ADJ
ajlm-2845	43	42	sources	source	NOUN
ajlm-2845	43	43	.	.	PUNCT
ajlm-2845	44	1	the	the	DET
ajlm-2845	44	2	majority	majority	NOUN
ajlm-2845	44	3	of	of	ADP
ajlm-2845	44	4	urine	urine	NOUN
ajlm-2845	44	5	samples	sample	NOUN
ajlm-2845	44	6	(	(	PUNCT
ajlm-2845	44	7	n	n	NOUN
ajlm-2845	44	8	=	=	SYM
ajlm-2845	44	9	3137	3137	NUM
ajlm-2845	44	10	)	)	PUNCT
ajlm-2845	44	11	were	be	AUX
ajlm-2845	44	12	sent	send	VERB
ajlm-2845	44	13	to	to	ADP
ajlm-2845	44	14	an	an	DET
ajlm-2845	44	15	nhls	nhls	PROPN
ajlm-2845	44	16	laboratory	laboratory	NOUN
ajlm-2845	44	17	in	in	ADP
ajlm-2845	44	18	mafikeng	mafikeng	NOUN
ajlm-2845	44	19	for	for	ADP
ajlm-2845	44	20	performance	performance	NOUN
ajlm-2845	44	21	of	of	ADP
ajlm-2845	44	22	culture	culture	NOUN
ajlm-2845	44	23	.	.	PUNCT
ajlm-2845	45	1	the	the	DET
ajlm-2845	45	2	laboratory	laboratory	NOUN
ajlm-2845	45	3	at	at	ADP
ajlm-2845	45	4	tshepong	tshepong	NOUN
ajlm-2845	45	5	hospital	hospital	NOUN
ajlm-2845	45	6	analysed	analyse	VERB
ajlm-2845	45	7	a	a	DET
ajlm-2845	45	8	further	further	ADJ
ajlm-2845	45	9	371	371	NUM
ajlm-2845	45	10	samples	sample	NOUN
ajlm-2845	45	11	,	,	PUNCT
ajlm-2845	45	12	and	and	CCONJ
ajlm-2845	45	13	the	the	DET
ajlm-2845	45	14	remaining	remain	VERB
ajlm-2845	45	15	53	53	NUM
ajlm-2845	45	16	samples	sample	NOUN
ajlm-2845	45	17	were	be	AUX
ajlm-2845	45	18	sent	send	VERB
ajlm-2845	45	19	to	to	PART
ajlm-2845	45	20	nhls	nhls	PROPN
ajlm-2845	45	21	charlotte	charlotte	PROPN
ajlm-2845	45	22	maxeke	maxeke	PROPN
ajlm-2845	45	23	johannesburg	johannesburg	PROPN
ajlm-2845	45	24	academic	academic	ADJ
ajlm-2845	45	25	hospital	hospital	NOUN
ajlm-2845	45	26	for	for	ADP
ajlm-2845	45	27	processing	processing	NOUN
ajlm-2845	45	28	and	and	CCONJ
ajlm-2845	45	29	reporting	reporting	NOUN
ajlm-2845	45	30	.	.	PUNCT
ajlm-2845	46	1	laboratory	laboratory	NOUN
ajlm-2845	46	2	analysis	analysis	NOUN
ajlm-2845	46	3	the	the	DET
ajlm-2845	46	4	testing	testing	NOUN
ajlm-2845	46	5	facility	facility	NOUN
ajlm-2845	46	6	processed	process	VERB
ajlm-2845	46	7	the	the	DET
ajlm-2845	46	8	samples	sample	NOUN
ajlm-2845	46	9	according	accord	VERB
ajlm-2845	46	10	to	to	ADP
ajlm-2845	46	11	their	their	PRON
ajlm-2845	46	12	local	local	ADJ
ajlm-2845	46	13	standard	standard	ADJ
ajlm-2845	46	14	operating	operating	NOUN
ajlm-2845	46	15	procedure	procedure	NOUN
ajlm-2845	46	16	.	.	PUNCT
ajlm-2845	47	1	macconkey	macconkey	NOUN
ajlm-2845	47	2	agar	agar	NOUN
ajlm-2845	47	3	and	and	CCONJ
ajlm-2845	47	4	blood	blood	NOUN
ajlm-2845	47	5	agar	agar	NOUN
ajlm-2845	47	6	plates	plate	NOUN
ajlm-2845	47	7	are	be	AUX
ajlm-2845	47	8	inoculated	inoculate	VERB
ajlm-2845	47	9	and	and	CCONJ
ajlm-2845	47	10	aerobically	aerobically	ADV
ajlm-2845	47	11	incubated	incubate	VERB
ajlm-2845	47	12	for	for	ADP
ajlm-2845	47	13	24	24	NUM
ajlm-2845	47	14	h	h	NOUN
ajlm-2845	47	15	at	at	ADP
ajlm-2845	47	16	35	35	NUM
ajlm-2845	47	17	°	°	NOUN
ajlm-2845	47	18	c	c	NOUN
ajlm-2845	47	19	–	–	PUNCT
ajlm-2845	47	20	37	37	NUM
ajlm-2845	47	21	°	°	SYM
ajlm-2845	47	22	c	c	X
ajlm-2845	47	23	.	.	PUNCT
ajlm-2845	48	1	the	the	DET
ajlm-2845	48	2	standard	standard	ADJ
ajlm-2845	48	3	practice	practice	NOUN
ajlm-2845	48	4	is	be	AUX
ajlm-2845	48	5	that	that	SCONJ
ajlm-2845	48	6	if	if	SCONJ
ajlm-2845	48	7	a	a	DET
ajlm-2845	48	8	specimen	speciman	NOUN
ajlm-2845	48	9	collected	collect	VERB
ajlm-2845	48	10	by	by	ADP
ajlm-2845	48	11	voiding	void	VERB
ajlm-2845	48	12	or	or	CCONJ
ajlm-2845	48	13	catheterisation	catheterisation	NOUN
ajlm-2845	48	14	shows	show	VERB
ajlm-2845	48	15	no	no	DET
ajlm-2845	48	16	growth	growth	NOUN
ajlm-2845	48	17	after	after	ADP
ajlm-2845	48	18	overnight	overnight	ADJ
ajlm-2845	48	19	incubation	incubation	NOUN
ajlm-2845	48	20	,	,	PUNCT
ajlm-2845	48	21	it	it	PRON
ajlm-2845	48	22	is	be	AUX
ajlm-2845	48	23	reported	report	VERB
ajlm-2845	48	24	as	as	ADP
ajlm-2845	48	25	no	no	DET
ajlm-2845	48	26	growth	growth	NOUN
ajlm-2845	48	27	.	.	PUNCT
ajlm-2845	49	1	the	the	DET
ajlm-2845	49	2	specimen	speciman	NOUN
ajlm-2845	49	3	is	be	AUX
ajlm-2845	49	4	then	then	ADV
ajlm-2845	49	5	removed	remove	VERB
ajlm-2845	49	6	from	from	ADP
ajlm-2845	49	7	the	the	DET
ajlm-2845	49	8	incubator	incubator	NOUN
ajlm-2845	49	9	and	and	CCONJ
ajlm-2845	49	10	stored	store	VERB
ajlm-2845	49	11	at	at	ADP
ajlm-2845	49	12	room	room	NOUN
ajlm-2845	49	13	temperature	temperature	NOUN
ajlm-2845	49	14	,	,	PUNCT
ajlm-2845	49	15	should	should	AUX
ajlm-2845	49	16	further	far	ADV
ajlm-2845	49	17	tests	test	NOUN
ajlm-2845	49	18	be	be	AUX
ajlm-2845	49	19	requested	request	VERB
ajlm-2845	49	20	by	by	ADP
ajlm-2845	49	21	the	the	DET
ajlm-2845	49	22	treating	treat	VERB
ajlm-2845	49	23	doctors	doctor	NOUN
ajlm-2845	49	24	.	.	PUNCT
ajlm-2845	50	1	if	if	SCONJ
ajlm-2845	50	2	growth	growth	NOUN
ajlm-2845	50	3	is	be	AUX
ajlm-2845	50	4	detected	detect	VERB
ajlm-2845	50	5	on	on	ADP
ajlm-2845	50	6	the	the	DET
ajlm-2845	50	7	plate	plate	NOUN
ajlm-2845	50	8	,	,	PUNCT
ajlm-2845	50	9	the	the	DET
ajlm-2845	50	10	colonies	colony	NOUN
ajlm-2845	50	11	are	be	AUX
ajlm-2845	50	12	counted	count	VERB
ajlm-2845	50	13	and	and	CCONJ
ajlm-2845	50	14	the	the	DET
ajlm-2845	50	15	sample	sample	NOUN
ajlm-2845	50	16	provisionally	provisionally	ADV
ajlm-2845	50	17	resulted	result	VERB
ajlm-2845	50	18	.	.	PUNCT
ajlm-2845	51	1	bacterial	bacterial	ADJ
ajlm-2845	51	2	identification	identification	NOUN
ajlm-2845	51	3	and	and	CCONJ
ajlm-2845	51	4	antimicrobial	antimicrobial	ADJ
ajlm-2845	51	5	susceptibility	susceptibility	NOUN
ajlm-2845	51	6	testing	testing	NOUN
ajlm-2845	51	7	were	be	AUX
ajlm-2845	51	8	carried	carry	VERB
ajlm-2845	51	9	out	out	ADP
ajlm-2845	51	10	using	use	VERB
ajlm-2845	51	11	the	the	DET
ajlm-2845	51	12	vitek	vitek	NOUN
ajlm-2845	51	13	®	®	NOUN
ajlm-2845	51	14	2	2	NUM
ajlm-2845	51	15	automated	automate	VERB
ajlm-2845	51	16	system	system	NOUN
ajlm-2845	51	17	(	(	PUNCT
ajlm-2845	51	18	biomérieux	biomérieux	PROPN
ajlm-2845	51	19	,	,	PUNCT
ajlm-2845	51	20	marcy	marcy	PROPN
ajlm-2845	51	21	l’ètoile	l’ètoile	PROPN
ajlm-2845	51	22	,	,	PUNCT
ajlm-2845	51	23	rhône	rhône	PROPN
ajlm-2845	51	24	-	-	PUNCT
ajlm-2845	51	25	alpes	alpes	PROPN
ajlm-2845	51	26	,	,	PUNCT
ajlm-2845	51	27	france	france	PROPN
ajlm-2845	51	28	)	)	PUNCT
ajlm-2845	51	29	.	.	PUNCT
ajlm-2845	52	1	all	all	DET
ajlm-2845	52	2	antimicrobial	antimicrobial	ADJ
ajlm-2845	52	3	susceptibility	susceptibility	NOUN
ajlm-2845	52	4	results	result	NOUN
ajlm-2845	52	5	were	be	AUX
ajlm-2845	52	6	interpreted	interpret	VERB
ajlm-2845	52	7	using	use	VERB
ajlm-2845	52	8	the	the	DET
ajlm-2845	52	9	clsi	clsi	NOUN
ajlm-2845	52	10	guidelines.11	guidelines.11	VERB
ajlm-2845	52	11	the	the	DET
ajlm-2845	52	12	laboratory	laboratory	NOUN
ajlm-2845	52	13	adheres	adhere	VERB
ajlm-2845	52	14	to	to	ADP
ajlm-2845	52	15	the	the	DET
ajlm-2845	52	16	standards	standard	NOUN
ajlm-2845	52	17	set	set	VERB
ajlm-2845	52	18	out	out	ADP
ajlm-2845	52	19	in	in	ADP
ajlm-2845	52	20	the	the	DET
ajlm-2845	52	21	clsi	clsi	NOUN
ajlm-2845	52	22	guidelines	guideline	NOUN
ajlm-2845	52	23	.	.	PUNCT
ajlm-2845	53	1	compliance	compliance	NOUN
ajlm-2845	53	2	is	be	AUX
ajlm-2845	53	3	ensured	ensure	VERB
ajlm-2845	53	4	internally	internally	ADV
ajlm-2845	53	5	with	with	ADP
ajlm-2845	53	6	numerous	numerous	ADJ
ajlm-2845	53	7	quality	quality	NOUN
ajlm-2845	53	8	control	control	NOUN
ajlm-2845	53	9	programmes	programme	NOUN
ajlm-2845	53	10	and	and	CCONJ
ajlm-2845	53	11	externally	externally	ADV
ajlm-2845	53	12	with	with	ADP
ajlm-2845	53	13	south	south	ADJ
ajlm-2845	53	14	african	african	ADJ
ajlm-2845	53	15	national	national	ADJ
ajlm-2845	53	16	accreditation	accreditation	NOUN
ajlm-2845	53	17	system	system	NOUN
ajlm-2845	53	18	audit	audit	NOUN
ajlm-2845	53	19	.	.	PUNCT
ajlm-2845	54	1	statistical	statistical	ADJ
ajlm-2845	54	2	analysis	analysis	NOUN
ajlm-2845	54	3	the	the	DET
ajlm-2845	54	4	data	datum	NOUN
ajlm-2845	54	5	were	be	AUX
ajlm-2845	54	6	entered	enter	VERB
ajlm-2845	54	7	into	into	ADP
ajlm-2845	54	8	stata	stata	NOUN
ajlm-2845	54	9	,	,	PUNCT
ajlm-2845	54	10	basic	basic	ADJ
ajlm-2845	54	11	version	version	NOUN
ajlm-2845	54	12	18.0	18.0	NUM
ajlm-2845	54	13	(	(	PUNCT
ajlm-2845	54	14	statacorp	statacorp	PROPN
ajlm-2845	54	15	llc	llc	PROPN
ajlm-2845	54	16	,	,	PUNCT
ajlm-2845	54	17	college	college	NOUN
ajlm-2845	54	18	station	station	NOUN
ajlm-2845	54	19	,	,	PUNCT
ajlm-2845	54	20	texas	texas	PROPN
ajlm-2845	54	21	,	,	PUNCT
ajlm-2845	54	22	united	united	PROPN
ajlm-2845	54	23	states	states	PROPN
ajlm-2845	54	24	)	)	PUNCT
ajlm-2845	54	25	.	.	PUNCT
ajlm-2845	55	1	variables	variable	NOUN
ajlm-2845	55	2	included	include	VERB
ajlm-2845	55	3	in	in	ADP
ajlm-2845	55	4	the	the	DET
ajlm-2845	55	5	analysis	analysis	NOUN
ajlm-2845	55	6	were	be	AUX
ajlm-2845	55	7	the	the	DET
ajlm-2845	55	8	date	date	NOUN
ajlm-2845	55	9	the	the	DET
ajlm-2845	55	10	sample	sample	NOUN
ajlm-2845	55	11	was	be	AUX
ajlm-2845	55	12	received	receive	VERB
ajlm-2845	55	13	,	,	PUNCT
ajlm-2845	55	14	the	the	DET
ajlm-2845	55	15	department	department	NOUN
ajlm-2845	55	16	of	of	ADP
ajlm-2845	55	17	sample	sample	NOUN
ajlm-2845	55	18	origin	origin	NOUN
ajlm-2845	55	19	,	,	PUNCT
ajlm-2845	55	20	the	the	DET
ajlm-2845	55	21	organism	organism	NOUN
ajlm-2845	55	22	cultured	culture	VERB
ajlm-2845	55	23	,	,	PUNCT
ajlm-2845	55	24	and	and	CCONJ
ajlm-2845	55	25	the	the	DET
ajlm-2845	55	26	corresponding	corresponding	ADJ
ajlm-2845	55	27	antibiotic	antibiotic	ADJ
ajlm-2845	55	28	susceptibility	susceptibility	NOUN
ajlm-2845	55	29	results	result	NOUN
ajlm-2845	55	30	.	.	PUNCT
ajlm-2845	56	1	the	the	DET
ajlm-2845	56	2	frequency	frequency	NOUN
ajlm-2845	56	3	of	of	ADP
ajlm-2845	56	4	each	each	DET
ajlm-2845	56	5	organism	organism	NOUN
ajlm-2845	56	6	cultured	cultured	ADJ
ajlm-2845	56	7	,	,	PUNCT
ajlm-2845	56	8	and	and	CCONJ
ajlm-2845	56	9	the	the	DET
ajlm-2845	56	10	susceptibility	susceptibility	NOUN
ajlm-2845	56	11	profile	profile	NOUN
ajlm-2845	56	12	of	of	ADP
ajlm-2845	56	13	commonly	commonly	ADV
ajlm-2845	56	14	used	use	VERB
ajlm-2845	56	15	antimicrobials	antimicrobial	NOUN
ajlm-2845	56	16	,	,	PUNCT
ajlm-2845	56	17	were	be	AUX
ajlm-2845	56	18	determined	determine	VERB
ajlm-2845	56	19	.	.	PUNCT
ajlm-2845	57	1	subsequently	subsequently	ADV
ajlm-2845	57	2	,	,	PUNCT
ajlm-2845	57	3	the	the	DET
ajlm-2845	57	4	strength	strength	NOUN
ajlm-2845	57	5	of	of	ADP
ajlm-2845	57	6	association	association	NOUN
ajlm-2845	57	7	of	of	ADP
ajlm-2845	57	8	antimicrobial	antimicrobial	ADJ
ajlm-2845	57	9	efficacy	efficacy	NOUN
ajlm-2845	57	10	against	against	ADP
ajlm-2845	57	11	specific	specific	ADJ
ajlm-2845	57	12	organisms	organism	NOUN
ajlm-2845	57	13	was	be	AUX
ajlm-2845	57	14	determined	determine	VERB
ajlm-2845	57	15	utilising	utilise	VERB
ajlm-2845	57	16	the	the	DET
ajlm-2845	57	17	chi	chi	ADJ
ajlm-2845	57	18	-	-	PUNCT
ajlm-2845	57	19	squared	square	VERB
ajlm-2845	57	20	test	test	NOUN
ajlm-2845	57	21	and	and	CCONJ
ajlm-2845	57	22	fischer	fischer	PROPN
ajlm-2845	57	23	’s	’s	PART
ajlm-2845	57	24	exact	exact	ADJ
ajlm-2845	57	25	test	test	NOUN
ajlm-2845	57	26	(	(	PUNCT
ajlm-2845	57	27	for	for	ADP
ajlm-2845	57	28	n	n	X
ajlm-2845	57	29	<	<	X
ajlm-2845	57	30	5	5	NUM
ajlm-2845	57	31	)	)	PUNCT
ajlm-2845	57	32	,	,	PUNCT
ajlm-2845	57	33	where	where	SCONJ
ajlm-2845	57	34	a	a	PRON
ajlm-2845	57	35	p	p	NOUN
ajlm-2845	57	36	-	-	PUNCT
ajlm-2845	57	37	value	value	NOUN
ajlm-2845	57	38	<	<	X
ajlm-2845	57	39	0.05	0.05	NUM
ajlm-2845	57	40	was	be	AUX
ajlm-2845	57	41	considered	consider	VERB
ajlm-2845	57	42	statistically	statistically	ADV
ajlm-2845	57	43	significant	significant	ADJ
ajlm-2845	57	44	.	.	PUNCT
ajlm-2845	58	1	the	the	DET
ajlm-2845	58	2	clsi	clsi	NOUN
ajlm-2845	58	3	guidelines	guideline	NOUN
ajlm-2845	58	4	recommend	recommend	VERB
ajlm-2845	58	5	that	that	SCONJ
ajlm-2845	58	6	at	at	ADV
ajlm-2845	58	7	least	least	ADV
ajlm-2845	58	8	30	30	NUM
ajlm-2845	58	9	isolates	isolate	NOUN
ajlm-2845	58	10	or	or	CCONJ
ajlm-2845	58	11	organism	organism	NOUN
ajlm-2845	58	12	-	-	PUNCT
ajlm-2845	58	13	antibiotic	antibiotic	ADJ
ajlm-2845	58	14	combinations	combination	NOUN
ajlm-2845	58	15	be	be	AUX
ajlm-2845	58	16	available	available	ADJ
ajlm-2845	58	17	for	for	ADP
ajlm-2845	58	18	inclusion	inclusion	NOUN
ajlm-2845	58	19	into	into	ADP
ajlm-2845	58	20	the	the	DET
ajlm-2845	58	21	report	report	NOUN
ajlm-2845	58	22	/	/	SYM
ajlm-2845	58	23	analysis	analysis	NOUN
ajlm-2845	58	24	.	.	PUNCT
ajlm-2845	59	1	as	as	ADP
ajlm-2845	59	2	such	such	ADJ
ajlm-2845	59	3	,	,	PUNCT
ajlm-2845	59	4	only	only	ADV
ajlm-2845	59	5	the	the	DET
ajlm-2845	59	6	five	five	NUM
ajlm-2845	59	7	most	most	ADV
ajlm-2845	59	8	common	common	ADJ
ajlm-2845	59	9	organisms	organism	NOUN
ajlm-2845	59	10	,	,	PUNCT
ajlm-2845	59	11	namely	namely	ADV
ajlm-2845	59	12	e.	e.	PROPN
ajlm-2845	59	13	coli	coli	PROPN
ajlm-2845	59	14	,	,	PUNCT
ajlm-2845	59	15	k.	k.	PROPN
ajlm-2845	59	16	pneumoniae	pneumoniae	PROPN
ajlm-2845	59	17	,	,	PUNCT
ajlm-2845	59	18	proteus	proteus	NOUN
ajlm-2845	59	19	mirabilis	mirabilis	PROPN
ajlm-2845	59	20	,	,	PUNCT
ajlm-2845	59	21	enterococcus	enterococcus	NOUN
ajlm-2845	59	22	faecalis	faecalis	NOUN
ajlm-2845	59	23	,	,	PUNCT
ajlm-2845	59	24	and	and	CCONJ
ajlm-2845	59	25	enterococcus	enterococcus	NOUN
ajlm-2845	59	26	faecium	faecium	NOUN
ajlm-2845	59	27	,	,	PUNCT
ajlm-2845	59	28	consistently	consistently	ADV
ajlm-2845	59	29	reached	reach	VERB
ajlm-2845	59	30	the	the	DET
ajlm-2845	59	31	threshold	threshold	NOUN
ajlm-2845	59	32	of	of	ADP
ajlm-2845	59	33	30	30	NUM
ajlm-2845	59	34	samples	sample	NOUN
ajlm-2845	59	35	when	when	SCONJ
ajlm-2845	59	36	combined	combine	VERB
ajlm-2845	59	37	over	over	ADP
ajlm-2845	59	38	the	the	DET
ajlm-2845	59	39	study	study	NOUN
ajlm-2845	59	40	period	period	NOUN
ajlm-2845	59	41	.	.	PUNCT
ajlm-2845	60	1	the	the	DET
ajlm-2845	60	2	antimicrobials	antimicrobial	NOUN
ajlm-2845	60	3	represented	represent	VERB
ajlm-2845	60	4	were	be	AUX
ajlm-2845	60	5	selected	select	VERB
ajlm-2845	60	6	based	base	VERB
ajlm-2845	60	7	on	on	ADP
ajlm-2845	60	8	current	current	ADJ
ajlm-2845	60	9	standard	standard	ADJ
ajlm-2845	60	10	treatment	treatment	NOUN
ajlm-2845	60	11	guidelines	guideline	NOUN
ajlm-2845	60	12	,	,	PUNCT
ajlm-2845	60	13	along	along	ADP
ajlm-2845	60	14	with	with	ADP
ajlm-2845	60	15	commonly	commonly	ADV
ajlm-2845	60	16	used	use	VERB
ajlm-2845	60	17	second	second	ADJ
ajlm-2845	60	18	-	-	PUNCT
ajlm-2845	60	19	line	line	NOUN
ajlm-2845	60	20	agents	agent	NOUN
ajlm-2845	60	21	.	.	PUNCT
ajlm-2845	61	1	after	after	ADP
ajlm-2845	61	2	assessing	assess	VERB
ajlm-2845	61	3	the	the	DET
ajlm-2845	61	4	susceptibility	susceptibility	NOUN
ajlm-2845	61	5	profile	profile	NOUN
ajlm-2845	61	6	for	for	ADP
ajlm-2845	61	7	each	each	PRON
ajlm-2845	61	8	,	,	PUNCT
ajlm-2845	61	9	the	the	DET
ajlm-2845	61	10	strength	strength	NOUN
ajlm-2845	61	11	of	of	ADP
ajlm-2845	61	12	the	the	DET
ajlm-2845	61	13	association	association	NOUN
ajlm-2845	61	14	was	be	AUX
ajlm-2845	61	15	determined	determine	VERB
ajlm-2845	61	16	.	.	PUNCT
ajlm-2845	62	1	finally	finally	ADV
ajlm-2845	62	2	,	,	PUNCT
ajlm-2845	62	3	we	we	PRON
ajlm-2845	62	4	described	describe	VERB
ajlm-2845	62	5	the	the	DET
ajlm-2845	62	6	trends	trend	NOUN
ajlm-2845	62	7	in	in	ADP
ajlm-2845	62	8	susceptibility	susceptibility	NOUN
ajlm-2845	62	9	of	of	ADP
ajlm-2845	62	10	these	these	DET
ajlm-2845	62	11	organisms	organism	NOUN
ajlm-2845	62	12	over	over	ADP
ajlm-2845	62	13	the	the	DET
ajlm-2845	62	14	study	study	NOUN
ajlm-2845	62	15	period	period	NOUN
ajlm-2845	62	16	2020–2023	2020–2023	NUM
ajlm-2845	62	17	.	.	PUNCT
ajlm-2845	63	1	results	result	VERB
ajlm-2845	63	2	a	a	DET
ajlm-2845	63	3	total	total	NOUN
ajlm-2845	63	4	of	of	ADP
ajlm-2845	63	5	3561	3561	NUM
ajlm-2845	63	6	urine	urine	NOUN
ajlm-2845	63	7	cultures	culture	NOUN
ajlm-2845	63	8	were	be	AUX
ajlm-2845	63	9	identified	identify	VERB
ajlm-2845	63	10	during	during	ADP
ajlm-2845	63	11	the	the	DET
ajlm-2845	63	12	4	4	NUM
ajlm-2845	63	13	-	-	PUNCT
ajlm-2845	63	14	year	year	NOUN
ajlm-2845	63	15	period	period	NOUN
ajlm-2845	63	16	,	,	PUNCT
ajlm-2845	63	17	48	48	NUM
ajlm-2845	63	18	of	of	ADP
ajlm-2845	63	19	which	which	PRON
ajlm-2845	63	20	were	be	AUX
ajlm-2845	63	21	excluded	exclude	VERB
ajlm-2845	63	22	from	from	ADP
ajlm-2845	63	23	the	the	DET
ajlm-2845	63	24	final	final	ADJ
ajlm-2845	63	25	analysis	analysis	NOUN
ajlm-2845	63	26	because	because	SCONJ
ajlm-2845	63	27	of	of	ADP
ajlm-2845	63	28	the	the	DET
ajlm-2845	63	29	presence	presence	NOUN
ajlm-2845	63	30	of	of	ADP
ajlm-2845	63	31	more	more	ADJ
ajlm-2845	63	32	than	than	ADP
ajlm-2845	63	33	one	one	NUM
ajlm-2845	63	34	organism	organism	NOUN
ajlm-2845	63	35	cultured	cultured	ADJ
ajlm-2845	63	36	.	.	PUNCT
ajlm-2845	64	1	therefore	therefore	ADV
ajlm-2845	64	2	,	,	PUNCT
ajlm-2845	64	3	a	a	DET
ajlm-2845	64	4	total	total	NOUN
ajlm-2845	64	5	of	of	ADP
ajlm-2845	64	6	3513	3513	NUM
ajlm-2845	64	7	urine	urine	NOUN
ajlm-2845	64	8	cultures	culture	NOUN
ajlm-2845	64	9	were	be	AUX
ajlm-2845	64	10	included	include	VERB
ajlm-2845	64	11	in	in	ADP
ajlm-2845	64	12	the	the	DET
ajlm-2845	64	13	data	datum	NOUN
ajlm-2845	64	14	analysis	analysis	NOUN
ajlm-2845	64	15	.	.	PUNCT
ajlm-2845	65	1	the	the	DET
ajlm-2845	65	2	number	number	NOUN
ajlm-2845	65	3	of	of	ADP
ajlm-2845	65	4	positive	positive	ADJ
ajlm-2845	65	5	urine	urine	NOUN
ajlm-2845	65	6	cultures	culture	NOUN
ajlm-2845	65	7	per	per	ADP
ajlm-2845	65	8	year	year	NOUN
ajlm-2845	65	9	is	be	AUX
ajlm-2845	65	10	depicted	depict	VERB
ajlm-2845	65	11	in	in	ADP
ajlm-2845	65	12	figure	figure	NOUN
ajlm-2845	65	13	1	1	NUM
ajlm-2845	65	14	.	.	PUNCT
ajlm-2845	66	1	during	during	ADP
ajlm-2845	66	2	the	the	DET
ajlm-2845	66	3	study	study	NOUN
ajlm-2845	66	4	period	period	NOUN
ajlm-2845	66	5	,	,	PUNCT
ajlm-2845	66	6	the	the	DET
ajlm-2845	66	7	number	number	NOUN
ajlm-2845	66	8	of	of	ADP
ajlm-2845	66	9	samples	sample	NOUN
ajlm-2845	66	10	that	that	PRON
ajlm-2845	66	11	were	be	AUX
ajlm-2845	66	12	positive	positive	ADJ
ajlm-2845	66	13	for	for	ADP
ajlm-2845	66	14	an	an	DET
ajlm-2845	66	15	organism	organism	NOUN
ajlm-2845	66	16	decreased	decrease	VERB
ajlm-2845	66	17	from	from	ADP
ajlm-2845	66	18	1014	1014	NUM
ajlm-2845	66	19	samples	sample	NOUN
ajlm-2845	66	20	in	in	ADP
ajlm-2845	66	21	2020	2020	NUM
ajlm-2845	66	22	to	to	ADP
ajlm-2845	66	23	an	an	DET
ajlm-2845	66	24	average	average	NOUN
ajlm-2845	66	25	of	of	ADP
ajlm-2845	66	26	833	833	NUM
ajlm-2845	66	27	per	per	ADP
ajlm-2845	66	28	year	year	NOUN
ajlm-2845	66	29	for	for	ADP
ajlm-2845	66	30	the	the	DET
ajlm-2845	66	31	following	follow	VERB
ajlm-2845	66	32	3	3	NUM
ajlm-2845	66	33	years	year	NOUN
ajlm-2845	66	34	(	(	PUNCT
ajlm-2845	66	35	832	832	NUM
ajlm-2845	66	36	for	for	ADP
ajlm-2845	66	37	2021	2021	NUM
ajlm-2845	66	38	;	;	PUNCT
ajlm-2845	66	39	820	820	NUM
ajlm-2845	66	40	for	for	ADP
ajlm-2845	66	41	2022	2022	NUM
ajlm-2845	66	42	;	;	PUNCT
ajlm-2845	66	43	and	and	CCONJ
ajlm-2845	66	44	847	847	NUM
ajlm-2845	66	45	for	for	ADP
ajlm-2845	66	46	2023	2023	NUM
ajlm-2845	66	47	)	)	PUNCT
ajlm-2845	66	48	(	(	PUNCT
ajlm-2845	66	49	figure	figure	NOUN
ajlm-2845	66	50	1	1	NUM
ajlm-2845	66	51	)	)	PUNCT
ajlm-2845	66	52	.	.	PUNCT
ajlm-2845	67	1	figure	figure	VERB
ajlm-2845	67	2	1	1	NUM
ajlm-2845	67	3	:	:	PUNCT
ajlm-2845	67	4	number	number	NOUN
ajlm-2845	67	5	of	of	ADP
ajlm-2845	67	6	positive	positive	ADJ
ajlm-2845	67	7	urine	urine	NOUN
ajlm-2845	67	8	cultures	culture	NOUN
ajlm-2845	67	9	per	per	ADP
ajlm-2845	67	10	year	year	NOUN
ajlm-2845	67	11	submitted	submit	VERB
ajlm-2845	67	12	from	from	ADP
ajlm-2845	67	13	potchefstroom	potchefstroom	NOUN
ajlm-2845	67	14	hospital	hospital	NOUN
ajlm-2845	67	15	,	,	PUNCT
ajlm-2845	67	16	south	south	PROPN
ajlm-2845	67	17	africa	africa	PROPN
ajlm-2845	67	18	,	,	PUNCT
ajlm-2845	67	19	january	january	PROPN
ajlm-2845	67	20	2020	2020	NUM
ajlm-2845	67	21	–	–	PUNCT
ajlm-2845	67	22	december	december	PROPN
ajlm-2845	67	23	2023	2023	NUM
ajlm-2845	67	24	.	.	PUNCT
ajlm-2845	68	1	as	as	SCONJ
ajlm-2845	68	2	outlined	outline	VERB
ajlm-2845	68	3	in	in	ADP
ajlm-2845	68	4	figure	figure	NOUN
ajlm-2845	68	5	2	2	NUM
ajlm-2845	68	6	,	,	PUNCT
ajlm-2845	68	7	the	the	DET
ajlm-2845	68	8	most	most	ADV
ajlm-2845	68	9	frequently	frequently	ADV
ajlm-2845	68	10	cultured	cultured	ADJ
ajlm-2845	68	11	organisms	organism	NOUN
ajlm-2845	68	12	were	be	AUX
ajlm-2845	68	13	e.	e.	PROPN
ajlm-2845	68	14	coli	coli	PROPN
ajlm-2845	68	15	(	(	PUNCT
ajlm-2845	68	16	n	n	NOUN
ajlm-2845	68	17	=	=	SYM
ajlm-2845	68	18	1481	1481	NUM
ajlm-2845	68	19	;	;	PUNCT
ajlm-2845	68	20	42.2	42.2	NUM
ajlm-2845	68	21	%	%	NOUN
ajlm-2845	68	22	)	)	PUNCT
ajlm-2845	68	23	,	,	PUNCT
ajlm-2845	68	24	k.	k.	PROPN
ajlm-2845	69	1	pneumoniae	pneumoniae	ADJ
ajlm-2845	69	2	(	(	PUNCT
ajlm-2845	69	3	n	n	NOUN
ajlm-2845	69	4	=	=	SYM
ajlm-2845	69	5	568	568	NUM
ajlm-2845	69	6	;	;	PUNCT
ajlm-2845	69	7	16.2	16.2	NUM
ajlm-2845	69	8	%	%	NOUN
ajlm-2845	69	9	)	)	PUNCT
ajlm-2845	69	10	,	,	PUNCT
ajlm-2845	69	11	e.	e.	PROPN
ajlm-2845	69	12	faecalis	faecalis	PROPN
ajlm-2845	69	13	(	(	PUNCT
ajlm-2845	69	14	n	n	NOUN
ajlm-2845	69	15	=	=	SYM
ajlm-2845	69	16	249	249	NUM
ajlm-2845	69	17	;	;	PUNCT
ajlm-2845	69	18	7.1	7.1	NUM
ajlm-2845	69	19	%	%	NOUN
ajlm-2845	69	20	)	)	PUNCT
ajlm-2845	69	21	,	,	PUNCT
ajlm-2845	69	22	p.	p.	NOUN
ajlm-2845	69	23	mirabilis	mirabilis	PROPN
ajlm-2845	69	24	(	(	PUNCT
ajlm-2845	69	25	n	n	NOUN
ajlm-2845	69	26	=	=	SYM
ajlm-2845	69	27	229	229	NUM
ajlm-2845	69	28	;	;	PUNCT
ajlm-2845	69	29	6.5	6.5	NUM
ajlm-2845	69	30	%	%	NOUN
ajlm-2845	69	31	)	)	PUNCT
ajlm-2845	69	32	,	,	PUNCT
ajlm-2845	69	33	enterobacter	enterobacter	ADJ
ajlm-2845	69	34	cloacae	cloacae	NOUN
ajlm-2845	69	35	(	(	PUNCT
ajlm-2845	69	36	n	n	NOUN
ajlm-2845	69	37	=	=	SYM
ajlm-2845	69	38	137	137	NUM
ajlm-2845	69	39	;	;	PUNCT
ajlm-2845	69	40	3.9	3.9	NUM
ajlm-2845	69	41	%	%	NOUN
ajlm-2845	69	42	)	)	PUNCT
ajlm-2845	69	43	,	,	PUNCT
ajlm-2845	69	44	and	and	CCONJ
ajlm-2845	69	45	candida	candida	PROPN
ajlm-2845	69	46	albicans	albican	NOUN
ajlm-2845	69	47	(	(	PUNCT
ajlm-2845	69	48	n	n	NOUN
ajlm-2845	69	49	=	=	SYM
ajlm-2845	69	50	119	119	NUM
ajlm-2845	69	51	;	;	PUNCT
ajlm-2845	69	52	3.4	3.4	NUM
ajlm-2845	69	53	%	%	NOUN
ajlm-2845	69	54	)	)	PUNCT
ajlm-2845	69	55	.	.	PUNCT
ajlm-2845	70	1	figure	figure	NOUN
ajlm-2845	70	2	2	2	NUM
ajlm-2845	70	3	:	:	PUNCT
ajlm-2845	70	4	spectrum	spectrum	NOUN
ajlm-2845	70	5	of	of	ADP
ajlm-2845	70	6	microorganisms	microorganism	NOUN
ajlm-2845	70	7	isolated	isolate	VERB
ajlm-2845	70	8	from	from	ADP
ajlm-2845	70	9	urine	urine	NOUN
ajlm-2845	70	10	samples	sample	NOUN
ajlm-2845	70	11	submitted	submit	VERB
ajlm-2845	70	12	from	from	ADP
ajlm-2845	70	13	potchefstroom	potchefstroom	NOUN
ajlm-2845	70	14	hospital	hospital	NOUN
ajlm-2845	70	15	,	,	PUNCT
ajlm-2845	70	16	south	south	PROPN
ajlm-2845	70	17	africa	africa	PROPN
ajlm-2845	70	18	,	,	PUNCT
ajlm-2845	70	19	january	january	PROPN
ajlm-2845	70	20	2020	2020	NUM
ajlm-2845	70	21	–	–	PUNCT
ajlm-2845	70	22	december	december	PROPN
ajlm-2845	70	23	2023	2023	NUM
ajlm-2845	70	24	.	.	PUNCT
ajlm-2845	71	1	regarding	regard	VERB
ajlm-2845	71	2	first	first	ADJ
ajlm-2845	71	3	-	-	PUNCT
ajlm-2845	71	4	line	line	NOUN
ajlm-2845	71	5	antimicrobials	antimicrobial	NOUN
ajlm-2845	71	6	(	(	PUNCT
ajlm-2845	71	7	table	table	NOUN
ajlm-2845	71	8	1	1	NUM
ajlm-2845	71	9	and	and	CCONJ
ajlm-2845	71	10	figure	figure	VERB
ajlm-2845	71	11	3	3	NUM
ajlm-2845	71	12	)	)	PUNCT
ajlm-2845	71	13	,	,	PUNCT
ajlm-2845	71	14	the	the	DET
ajlm-2845	71	15	aminoglycosides	aminoglycoside	NOUN
ajlm-2845	71	16	(	(	PUNCT
ajlm-2845	71	17	gentamicin	gentamicin	X
ajlm-2845	71	18	)	)	PUNCT
ajlm-2845	71	19	would	would	AUX
ajlm-2845	71	20	have	have	AUX
ajlm-2845	71	21	been	be	AUX
ajlm-2845	71	22	appropriate	appropriate	ADJ
ajlm-2845	71	23	for	for	ADP
ajlm-2845	71	24	87.8	87.8	NUM
ajlm-2845	71	25	%	%	NOUN
ajlm-2845	71	26	of	of	ADP
ajlm-2845	71	27	the	the	DET
ajlm-2845	71	28	cultured	cultured	ADJ
ajlm-2845	71	29	organisms	organism	NOUN
ajlm-2845	71	30	(	(	PUNCT
ajlm-2845	71	31	p	p	X
ajlm-2845	71	32	<	<	X
ajlm-2845	71	33	0.001	0.001	NUM
ajlm-2845	71	34	)	)	PUNCT
ajlm-2845	71	35	,	,	PUNCT
ajlm-2845	71	36	except	except	SCONJ
ajlm-2845	71	37	k.	k.	PROPN
ajlm-2845	71	38	pneumoniae	pneumoniae	PROPN
ajlm-2845	71	39	,	,	PUNCT
ajlm-2845	71	40	which	which	PRON
ajlm-2845	71	41	was	be	AUX
ajlm-2845	71	42	susceptible	susceptible	ADJ
ajlm-2845	71	43	in	in	ADP
ajlm-2845	71	44	only	only	ADV
ajlm-2845	71	45	77.7	77.7	NUM
ajlm-2845	71	46	%	%	NOUN
ajlm-2845	71	47	of	of	ADP
ajlm-2845	71	48	isolates	isolate	NOUN
ajlm-2845	71	49	.	.	PUNCT
ajlm-2845	72	1	more	more	ADJ
ajlm-2845	72	2	than	than	ADP
ajlm-2845	72	3	90	90	NUM
ajlm-2845	72	4	%	%	NOUN
ajlm-2845	72	5	of	of	ADP
ajlm-2845	72	6	all	all	DET
ajlm-2845	72	7	organisms	organism	NOUN
ajlm-2845	72	8	isolated	isolate	VERB
ajlm-2845	72	9	were	be	AUX
ajlm-2845	72	10	susceptible	susceptible	ADJ
ajlm-2845	72	11	to	to	ADP
ajlm-2845	72	12	amikacin	amikacin	PROPN
ajlm-2845	72	13	(	(	PUNCT
ajlm-2845	72	14	p	p	X
ajlm-2845	72	15	=	=	NOUN
ajlm-2845	72	16	0.001	0.001	NUM
ajlm-2845	72	17	)	)	PUNCT
ajlm-2845	72	18	.	.	PUNCT
ajlm-2845	73	1	figure	figure	VERB
ajlm-2845	73	2	3	3	NUM
ajlm-2845	73	3	:	:	PUNCT
ajlm-2845	73	4	antimicrobial	antimicrobial	ADJ
ajlm-2845	73	5	susceptibility	susceptibility	NOUN
ajlm-2845	73	6	of	of	ADP
ajlm-2845	73	7	the	the	DET
ajlm-2845	73	8	five	five	NUM
ajlm-2845	73	9	most	most	ADV
ajlm-2845	73	10	common	common	ADJ
ajlm-2845	73	11	uropathogens	uropathogen	NOUN
ajlm-2845	73	12	isolated	isolate	VERB
ajlm-2845	73	13	at	at	ADP
ajlm-2845	73	14	potchefstroom	potchefstroom	NOUN
ajlm-2845	73	15	hospital	hospital	NOUN
ajlm-2845	73	16	,	,	PUNCT
ajlm-2845	73	17	south	south	PROPN
ajlm-2845	73	18	africa	africa	PROPN
ajlm-2845	73	19	,	,	PUNCT
ajlm-2845	73	20	january	january	PROPN
ajlm-2845	73	21	2020	2020	NUM
ajlm-2845	73	22	–	–	PUNCT
ajlm-2845	73	23	december	december	PROPN
ajlm-2845	73	24	2023	2023	NUM
ajlm-2845	73	25	:	:	PUNCT
ajlm-2845	73	26	(	(	PUNCT
ajlm-2845	73	27	a	a	X
ajlm-2845	73	28	)	)	PUNCT
ajlm-2845	73	29	escherichia	escherichia	NOUN
ajlm-2845	73	30	coli	coli	NOUN
ajlm-2845	73	31	,	,	PUNCT
ajlm-2845	73	32	(	(	PUNCT
ajlm-2845	73	33	b	b	X
ajlm-2845	73	34	)	)	PUNCT
ajlm-2845	73	35	klebsiella	klebsiella	NOUN
ajlm-2845	73	36	pneumoniae	pneumoniae	NOUN
ajlm-2845	73	37	,	,	PUNCT
ajlm-2845	73	38	(	(	PUNCT
ajlm-2845	73	39	c	c	NOUN
ajlm-2845	73	40	)	)	PUNCT
ajlm-2845	73	41	enterococcus	enterococcus	NOUN
ajlm-2845	73	42	faecalis	faecalis	NOUN
ajlm-2845	73	43	,	,	PUNCT
ajlm-2845	73	44	(	(	PUNCT
ajlm-2845	73	45	d	d	X
ajlm-2845	73	46	)	)	PUNCT
ajlm-2845	73	47	proteus	proteus	NOUN
ajlm-2845	73	48	mirabilis	mirabilis	PROPN
ajlm-2845	73	49	,	,	PUNCT
ajlm-2845	73	50	and	and	CCONJ
ajlm-2845	73	51	(	(	PUNCT
ajlm-2845	73	52	e	e	NOUN
ajlm-2845	73	53	)	)	PUNCT
ajlm-2845	73	54	enterobacter	enterobacter	ADJ
ajlm-2845	73	55	cloacae	cloacae	NOUN
ajlm-2845	73	56	.	.	PUNCT
ajlm-2845	74	1	table	table	NOUN
ajlm-2845	74	2	1	1	NUM
ajlm-2845	74	3	:	:	PUNCT
ajlm-2845	74	4	 	 	SPACE
ajlm-2845	74	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	74	6	susceptibility	susceptibility	NOUN
ajlm-2845	74	7	patterns	pattern	NOUN
ajlm-2845	74	8	of	of	ADP
ajlm-2845	74	9	the	the	DET
ajlm-2845	74	10	most	most	ADV
ajlm-2845	74	11	commonly	commonly	ADV
ajlm-2845	74	12	isolated	isolate	VERB
ajlm-2845	74	13	organisms	organism	NOUN
ajlm-2845	74	14	in	in	ADP
ajlm-2845	74	15	urine	urine	NOUN
ajlm-2845	74	16	specimens	specimen	NOUN
ajlm-2845	74	17	at	at	ADP
ajlm-2845	74	18	potchefstroom	potchefstroom	NOUN
ajlm-2845	74	19	hospital	hospital	NOUN
ajlm-2845	74	20	,	,	PUNCT
ajlm-2845	74	21	south	south	PROPN
ajlm-2845	74	22	africa	africa	PROPN
ajlm-2845	74	23	,	,	PUNCT
ajlm-2845	74	24	january	january	PROPN
ajlm-2845	74	25	2020	2020	NUM
ajlm-2845	74	26	–	–	PUNCT
ajlm-2845	74	27	december	december	PROPN
ajlm-2845	74	28	2023	2023	NUM
ajlm-2845	74	29	.	.	PUNCT
ajlm-2845	75	1	the	the	DET
ajlm-2845	75	2	cumulative	cumulative	ADJ
ajlm-2845	75	3	susceptibility	susceptibility	NOUN
ajlm-2845	75	4	to	to	PART
ajlm-2845	75	5	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	75	6	was	be	AUX
ajlm-2845	75	7	67.5	67.5	NUM
ajlm-2845	75	8	%	%	NOUN
ajlm-2845	75	9	(	(	PUNCT
ajlm-2845	75	10	p	p	X
ajlm-2845	75	11	<	<	X
ajlm-2845	75	12	0.001	0.001	NUM
ajlm-2845	75	13	)	)	PUNCT
ajlm-2845	75	14	.	.	PUNCT
ajlm-2845	76	1	of	of	ADP
ajlm-2845	76	2	the	the	DET
ajlm-2845	76	3	five	five	NUM
ajlm-2845	76	4	most	most	ADV
ajlm-2845	76	5	commonly	commonly	ADV
ajlm-2845	76	6	isolated	isolate	VERB
ajlm-2845	76	7	organisms	organism	NOUN
ajlm-2845	76	8	,	,	PUNCT
ajlm-2845	76	9	e.	e.	PROPN
ajlm-2845	76	10	coli	coli	PROPN
ajlm-2845	76	11	isolates	isolate	NOUN
ajlm-2845	76	12	were	be	AUX
ajlm-2845	76	13	the	the	DET
ajlm-2845	76	14	only	only	ADJ
ajlm-2845	76	15	susceptible	susceptible	ADJ
ajlm-2845	76	16	organism	organism	NOUN
ajlm-2845	76	17	(	(	PUNCT
ajlm-2845	76	18	92.2	92.2	NUM
ajlm-2845	76	19	%	%	NOUN
ajlm-2845	76	20	)	)	PUNCT
ajlm-2845	76	21	.	.	PUNCT
ajlm-2845	77	1	other	other	ADJ
ajlm-2845	77	2	isolates	isolate	NOUN
ajlm-2845	77	3	,	,	PUNCT
ajlm-2845	77	4	such	such	ADJ
ajlm-2845	77	5	as	as	ADP
ajlm-2845	77	6	k.	k.	PROPN
ajlm-2845	77	7	pneumoniae	pneumoniae	NOUN
ajlm-2845	77	8	(	(	PUNCT
ajlm-2845	77	9	40	40	NUM
ajlm-2845	77	10	%	%	NOUN
ajlm-2845	77	11	)	)	PUNCT
ajlm-2845	77	12	,	,	PUNCT
ajlm-2845	77	13	e.	e.	PROPN
ajlm-2845	77	14	cloacae	cloacae	PROPN
ajlm-2845	77	15	(	(	PUNCT
ajlm-2845	77	16	23.4	23.4	NUM
ajlm-2845	77	17	%	%	NOUN
ajlm-2845	77	18	)	)	PUNCT
ajlm-2845	78	1	p.	p.	NOUN
ajlm-2845	78	2	mirabilis	mirabilis	PROPN
ajlm-2845	78	3	(	(	PUNCT
ajlm-2845	78	4	1.4	1.4	NUM
ajlm-2845	78	5	%	%	NOUN
ajlm-2845	78	6	)	)	PUNCT
ajlm-2845	78	7	,	,	PUNCT
ajlm-2845	78	8	e.	e.	PROPN
ajlm-2845	78	9	faecalis	faecalis	PROPN
ajlm-2845	78	10	(	(	PUNCT
ajlm-2845	78	11	0	0	NUM
ajlm-2845	78	12	%	%	NOUN
ajlm-2845	78	13	)	)	PUNCT
ajlm-2845	78	14	,	,	PUNCT
ajlm-2845	78	15	all	all	PRON
ajlm-2845	78	16	had	have	AUX
ajlm-2845	78	17	reduced	reduce	VERB
ajlm-2845	78	18	susceptibility	susceptibility	NOUN
ajlm-2845	78	19	to	to	PART
ajlm-2845	78	20	nitrofurantoin	nitrofurantoin	PROPN
ajlm-2845	78	21	.	.	PUNCT
ajlm-2845	79	1	a	a	DET
ajlm-2845	79	2	similar	similar	ADJ
ajlm-2845	79	3	trend	trend	NOUN
ajlm-2845	79	4	of	of	ADP
ajlm-2845	79	5	emerging	emerge	VERB
ajlm-2845	79	6	resistance	resistance	NOUN
ajlm-2845	79	7	to	to	ADP
ajlm-2845	79	8	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	79	9	was	be	AUX
ajlm-2845	79	10	observed	observe	VERB
ajlm-2845	79	11	in	in	ADP
ajlm-2845	79	12	four	four	NUM
ajlm-2845	79	13	of	of	ADP
ajlm-2845	79	14	the	the	DET
ajlm-2845	79	15	five	five	NUM
ajlm-2845	79	16	most	most	ADV
ajlm-2845	79	17	frequently	frequently	ADV
ajlm-2845	79	18	isolated	isolate	VERB
ajlm-2845	79	19	pathogens	pathogen	NOUN
ajlm-2845	79	20	in	in	ADP
ajlm-2845	79	21	this	this	DET
ajlm-2845	79	22	study	study	NOUN
ajlm-2845	79	23	;	;	PUNCT
ajlm-2845	79	24	p.	p.	PROPN
ajlm-2845	79	25	mirabilis	mirabilis	PROPN
ajlm-2845	79	26	remained	remain	VERB
ajlm-2845	79	27	the	the	DET
ajlm-2845	79	28	only	only	ADV
ajlm-2845	79	29	persistently	persistently	ADV
ajlm-2845	79	30	sensitive	sensitive	ADJ
ajlm-2845	79	31	organism	organism	NOUN
ajlm-2845	79	32	(	(	PUNCT
ajlm-2845	79	33	92.5	92.5	NUM
ajlm-2845	79	34	%	%	NOUN
ajlm-2845	79	35	)	)	PUNCT
ajlm-2845	79	36	,	,	PUNCT
ajlm-2845	79	37	while	while	SCONJ
ajlm-2845	79	38	reduced	reduce	VERB
ajlm-2845	79	39	susceptibility	susceptibility	NOUN
ajlm-2845	79	40	was	be	AUX
ajlm-2845	79	41	detected	detect	VERB
ajlm-2845	79	42	in	in	ADP
ajlm-2845	79	43	e.	e.	PROPN
ajlm-2845	79	44	cloacae	cloacae	PROPN
ajlm-2845	79	45	(	(	PUNCT
ajlm-2845	79	46	78.8	78.8	NUM
ajlm-2845	79	47	%	%	NOUN
ajlm-2845	79	48	)	)	PUNCT
ajlm-2845	79	49	,	,	PUNCT
ajlm-2845	79	50	k.	k.	PROPN
ajlm-2845	80	1	pneumoniae	pneumoniae	ADJ
ajlm-2845	80	2	(	(	PUNCT
ajlm-2845	80	3	78.2	78.2	NUM
ajlm-2845	80	4	%	%	NOUN
ajlm-2845	80	5	)	)	PUNCT
ajlm-2845	80	6	,	,	PUNCT
ajlm-2845	80	7	e.	e.	PROPN
ajlm-2845	80	8	faecalis	faecalis	PROPN
ajlm-2845	80	9	(	(	PUNCT
ajlm-2845	80	10	76.9	76.9	NUM
ajlm-2845	80	11	%	%	NOUN
ajlm-2845	80	12	)	)	PUNCT
ajlm-2845	80	13	,	,	PUNCT
ajlm-2845	80	14	and	and	CCONJ
ajlm-2845	80	15	e.	e.	PROPN
ajlm-2845	80	16	coli	coli	PROPN
ajlm-2845	80	17	(	(	PUNCT
ajlm-2845	80	18	74.3	74.3	NUM
ajlm-2845	80	19	%	%	NOUN
ajlm-2845	80	20	)	)	PUNCT
ajlm-2845	80	21	.	.	PUNCT
ajlm-2845	81	1	overall	overall	ADV
ajlm-2845	81	2	,	,	PUNCT
ajlm-2845	81	3	organisms	organism	NOUN
ajlm-2845	81	4	had	have	VERB
ajlm-2845	81	5	a	a	DET
ajlm-2845	81	6	cumulative	cumulative	ADJ
ajlm-2845	81	7	sensitivity	sensitivity	NOUN
ajlm-2845	81	8	of	of	ADP
ajlm-2845	81	9	77.2	77.2	NUM
ajlm-2845	81	10	%	%	NOUN
ajlm-2845	81	11	(	(	PUNCT
ajlm-2845	81	12	p	p	X
ajlm-2845	81	13	<	<	X
ajlm-2845	81	14	0.001	0.001	NUM
ajlm-2845	81	15	)	)	PUNCT
ajlm-2845	81	16	.	.	PUNCT
ajlm-2845	82	1	individual	individual	ADJ
ajlm-2845	82	2	sensitivity	sensitivity	NOUN
ajlm-2845	82	3	to	to	PART
ajlm-2845	82	4	trimethoprim	trimethoprim	NOUN
ajlm-2845	82	5	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-2845	82	6	were	be	AUX
ajlm-2845	82	7	as	as	SCONJ
ajlm-2845	82	8	follows	follow	VERB
ajlm-2845	82	9	:	:	PUNCT
ajlm-2845	83	1	e.	e.	PROPN
ajlm-2845	83	2	cloacae	cloacae	PROPN
ajlm-2845	83	3	(	(	PUNCT
ajlm-2845	83	4	60.3	60.3	NUM
ajlm-2845	83	5	%	%	NOUN
ajlm-2845	83	6	)	)	PUNCT
ajlm-2845	83	7	,	,	PUNCT
ajlm-2845	83	8	p.	p.	PROPN
ajlm-2845	83	9	mirabilis	mirabilis	PROPN
ajlm-2845	83	10	(	(	PUNCT
ajlm-2845	83	11	54	54	NUM
ajlm-2845	83	12	%	%	NOUN
ajlm-2845	83	13	)	)	PUNCT
ajlm-2845	83	14	,	,	PUNCT
ajlm-2845	83	15	k.	k.	PROPN
ajlm-2845	84	1	pneumoniae	pneumoniae	ADJ
ajlm-2845	84	2	(	(	PUNCT
ajlm-2845	84	3	51.5	51.5	NUM
ajlm-2845	84	4	%	%	NOUN
ajlm-2845	84	5	)	)	PUNCT
ajlm-2845	84	6	,	,	PUNCT
ajlm-2845	84	7	e.	e.	PROPN
ajlm-2845	84	8	coli	coli	PROPN
ajlm-2845	84	9	(	(	PUNCT
ajlm-2845	84	10	36.7	36.7	NUM
ajlm-2845	84	11	%	%	NOUN
ajlm-2845	84	12	)	)	PUNCT
ajlm-2845	84	13	,	,	PUNCT
ajlm-2845	84	14	and	and	CCONJ
ajlm-2845	84	15	e.	e.	PROPN
ajlm-2845	84	16	faecalis	faecalis	PROPN
ajlm-2845	84	17	(	(	PUNCT
ajlm-2845	84	18	0	0	NUM
ajlm-2845	84	19	%	%	NOUN
ajlm-2845	84	20	)	)	PUNCT
ajlm-2845	84	21	.	.	PUNCT
ajlm-2845	85	1	cumulatively	cumulatively	ADV
ajlm-2845	85	2	,	,	PUNCT
ajlm-2845	85	3	sensitivity	sensitivity	NOUN
ajlm-2845	85	4	to	to	PART
ajlm-2845	85	5	trimethoprim	trimethoprim	NOUN
ajlm-2845	85	6	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-2845	85	7	was	be	AUX
ajlm-2845	85	8	42.8	42.8	NUM
ajlm-2845	85	9	%	%	NOUN
ajlm-2845	85	10	(	(	PUNCT
ajlm-2845	85	11	p	p	X
ajlm-2845	85	12	<	<	X
ajlm-2845	85	13	0.001	0.001	NUM
ajlm-2845	85	14	)	)	PUNCT
ajlm-2845	85	15	.	.	PUNCT
ajlm-2845	86	1	significant	significant	ADJ
ajlm-2845	86	2	resistance	resistance	NOUN
ajlm-2845	86	3	to	to	ADP
ajlm-2845	86	4	amoxicillin	amoxicillin	PROPN
ajlm-2845	86	5	/	/	SYM
ajlm-2845	86	6	clavulanic	clavulanic	ADJ
ajlm-2845	86	7	acid	acid	NOUN
ajlm-2845	86	8	was	be	AUX
ajlm-2845	86	9	present	present	ADJ
ajlm-2845	86	10	in	in	ADP
ajlm-2845	86	11	e.	e.	PROPN
ajlm-2845	86	12	cloacae	cloacae	PROPN
ajlm-2845	86	13	(	(	PUNCT
ajlm-2845	86	14	3.6	3.6	NUM
ajlm-2845	86	15	%	%	NOUN
ajlm-2845	86	16	susceptible	susceptible	ADJ
ajlm-2845	86	17	)	)	PUNCT
ajlm-2845	86	18	,	,	PUNCT
ajlm-2845	86	19	k.	k.	PROPN
ajlm-2845	87	1	pneumoniae	pneumoniae	ADJ
ajlm-2845	87	2	(	(	PUNCT
ajlm-2845	87	3	65.2	65.2	NUM
ajlm-2845	87	4	%	%	NOUN
ajlm-2845	87	5	susceptible	susceptible	ADJ
ajlm-2845	87	6	)	)	PUNCT
ajlm-2845	87	7	,	,	PUNCT
ajlm-2845	87	8	and	and	CCONJ
ajlm-2845	87	9	e.	e.	PROPN
ajlm-2845	87	10	coli	coli	PROPN
ajlm-2845	87	11	(	(	PUNCT
ajlm-2845	87	12	79.6	79.6	NUM
ajlm-2845	87	13	%	%	NOUN
ajlm-2845	87	14	susceptible	susceptible	ADJ
ajlm-2845	87	15	)	)	PUNCT
ajlm-2845	87	16	,	,	PUNCT
ajlm-2845	87	17	with	with	ADP
ajlm-2845	87	18	72.3	72.3	NUM
ajlm-2845	87	19	%	%	NOUN
ajlm-2845	87	20	of	of	ADP
ajlm-2845	87	21	all	all	DET
ajlm-2845	87	22	organisms	organism	NOUN
ajlm-2845	87	23	isolated	isolate	VERB
ajlm-2845	87	24	being	be	AUX
ajlm-2845	87	25	susceptible	susceptible	ADJ
ajlm-2845	87	26	(	(	PUNCT
ajlm-2845	87	27	p	p	X
ajlm-2845	87	28	<	<	X
ajlm-2845	87	29	0.001	0.001	NUM
ajlm-2845	87	30	)	)	PUNCT
ajlm-2845	87	31	.	.	PUNCT
ajlm-2845	88	1	there	there	PRON
ajlm-2845	88	2	was	be	VERB
ajlm-2845	88	3	a	a	DET
ajlm-2845	88	4	similar	similar	ADJ
ajlm-2845	88	5	pattern	pattern	NOUN
ajlm-2845	88	6	with	with	ADP
ajlm-2845	88	7	ampicillin	ampicillin	NOUN
ajlm-2845	88	8	,	,	PUNCT
ajlm-2845	88	9	with	with	ADP
ajlm-2845	88	10	an	an	DET
ajlm-2845	88	11	overall	overall	ADJ
ajlm-2845	88	12	susceptibility	susceptibility	NOUN
ajlm-2845	88	13	of	of	ADP
ajlm-2845	88	14	30.6	30.6	NUM
ajlm-2845	88	15	%	%	NOUN
ajlm-2845	88	16	of	of	ADP
ajlm-2845	88	17	all	all	DET
ajlm-2845	88	18	the	the	DET
ajlm-2845	88	19	cultured	cultured	ADJ
ajlm-2845	88	20	organisms	organism	NOUN
ajlm-2845	88	21	(	(	PUNCT
ajlm-2845	88	22	p	p	X
ajlm-2845	88	23	<	<	X
ajlm-2845	88	24	0.001	0.001	NUM
ajlm-2845	88	25	)	)	PUNCT
ajlm-2845	88	26	.	.	PUNCT
ajlm-2845	89	1	the	the	DET
ajlm-2845	89	2	susceptibility	susceptibility	NOUN
ajlm-2845	89	3	of	of	ADP
ajlm-2845	89	4	individual	individual	ADJ
ajlm-2845	89	5	organisms	organism	NOUN
ajlm-2845	89	6	to	to	ADP
ajlm-2845	89	7	amoxicillin	amoxicillin	NOUN
ajlm-2845	89	8	/	/	SYM
ajlm-2845	89	9	clavulanic	clavulanic	ADJ
ajlm-2845	89	10	acid	acid	NOUN
ajlm-2845	89	11	was	be	AUX
ajlm-2845	89	12	also	also	ADV
ajlm-2845	89	13	greatly	greatly	ADV
ajlm-2845	89	14	reduced	reduce	VERB
ajlm-2845	89	15	,	,	PUNCT
ajlm-2845	89	16	namely	namely	ADV
ajlm-2845	89	17	,	,	PUNCT
ajlm-2845	89	18	k.	k.	PROPN
ajlm-2845	90	1	pneumoniae	pneumoniae	ADJ
ajlm-2845	90	2	(	(	PUNCT
ajlm-2845	90	3	1.6	1.6	NUM
ajlm-2845	90	4	%	%	NOUN
ajlm-2845	90	5	)	)	PUNCT
ajlm-2845	90	6	,	,	PUNCT
ajlm-2845	91	1	e.	e.	PROPN
ajlm-2845	91	2	cloacae	cloacae	PROPN
ajlm-2845	91	3	(	(	PUNCT
ajlm-2845	91	4	27.3	27.3	NUM
ajlm-2845	91	5	%	%	NOUN
ajlm-2845	91	6	)	)	PUNCT
ajlm-2845	91	7	,	,	PUNCT
ajlm-2845	91	8	e.	e.	PROPN
ajlm-2845	91	9	coli	coli	PROPN
ajlm-2845	91	10	(	(	PUNCT
ajlm-2845	91	11	28.8	28.8	NUM
ajlm-2845	91	12	%	%	NOUN
ajlm-2845	91	13	)	)	PUNCT
ajlm-2845	91	14	,	,	PUNCT
ajlm-2845	91	15	and	and	CCONJ
ajlm-2845	91	16	p.	p.	PROPN
ajlm-2845	91	17	mirabilis	mirabilis	PROPN
ajlm-2845	91	18	(	(	PUNCT
ajlm-2845	91	19	55.1	55.1	NUM
ajlm-2845	91	20	%	%	NOUN
ajlm-2845	91	21	)	)	PUNCT
ajlm-2845	91	22	.	.	PUNCT
ajlm-2845	92	1	ampicillin	ampicillin	PROPN
ajlm-2845	92	2	showed	show	VERB
ajlm-2845	92	3	continued	continue	VERB
ajlm-2845	92	4	sensitivity	sensitivity	NOUN
ajlm-2845	92	5	of	of	ADP
ajlm-2845	92	6	93.5	93.5	NUM
ajlm-2845	92	7	%	%	NOUN
ajlm-2845	92	8	for	for	ADP
ajlm-2845	92	9	e.	e.	PROPN
ajlm-2845	92	10	faecalis	faecalis	PROPN
ajlm-2845	92	11	.	.	PUNCT
ajlm-2845	93	1	for	for	ADP
ajlm-2845	93	2	second	second	ADJ
ajlm-2845	93	3	-	-	PUNCT
ajlm-2845	93	4	line	line	NOUN
ajlm-2845	93	5	antimicrobials	antimicrobial	NOUN
ajlm-2845	93	6	,	,	PUNCT
ajlm-2845	93	7	the	the	DET
ajlm-2845	93	8	cumulative	cumulative	ADJ
ajlm-2845	93	9	susceptibility	susceptibility	NOUN
ajlm-2845	93	10	of	of	ADP
ajlm-2845	93	11	the	the	DET
ajlm-2845	93	12	organisms	organism	NOUN
ajlm-2845	93	13	to	to	PART
ajlm-2845	93	14	cefuroxime	cefuroxime	VERB
ajlm-2845	93	15	was	be	AUX
ajlm-2845	93	16	70.6	70.6	NUM
ajlm-2845	93	17	%	%	NOUN
ajlm-2845	93	18	(	(	PUNCT
ajlm-2845	93	19	p	p	X
ajlm-2845	93	20	<	<	X
ajlm-2845	93	21	0.001	0.001	NUM
ajlm-2845	93	22	)	)	PUNCT
ajlm-2845	93	23	,	,	PUNCT
ajlm-2845	93	24	cefotaxime	cefotaxime	NOUN
ajlm-2845	93	25	/	/	SYM
ajlm-2845	93	26	ceftriaxone	ceftriaxone	NOUN
ajlm-2845	93	27	(	(	PUNCT
ajlm-2845	93	28	79.5	79.5	NUM
ajlm-2845	93	29	%	%	NOUN
ajlm-2845	93	30	;	;	PUNCT
ajlm-2845	93	31	p	p	X
ajlm-2845	93	32	<	<	X
ajlm-2845	93	33	0.001	0.001	NUM
ajlm-2845	93	34	)	)	PUNCT
ajlm-2845	93	35	,	,	PUNCT
ajlm-2845	93	36	and	and	CCONJ
ajlm-2845	93	37	cefepime	cefepime	NOUN
ajlm-2845	93	38	(	(	PUNCT
ajlm-2845	93	39	77.9	77.9	NUM
ajlm-2845	93	40	%	%	NOUN
ajlm-2845	93	41	;	;	PUNCT
ajlm-2845	93	42	p	p	X
ajlm-2845	93	43	<	<	X
ajlm-2845	93	44	0.001	0.001	NUM
ajlm-2845	93	45	)	)	PUNCT
ajlm-2845	93	46	(	(	PUNCT
ajlm-2845	93	47	table	table	NOUN
ajlm-2845	93	48	1	1	NUM
ajlm-2845	93	49	)	)	PUNCT
ajlm-2845	93	50	.	.	PUNCT
ajlm-2845	94	1	the	the	DET
ajlm-2845	94	2	thirdand	thirdand	NOUN
ajlm-2845	94	3	fourth	fourth	ADJ
ajlm-2845	94	4	generation	generation	NOUN
ajlm-2845	94	5	cephalosporins	cephalosporin	NOUN
ajlm-2845	94	6	were	be	AUX
ajlm-2845	94	7	effective	effective	ADJ
ajlm-2845	94	8	against	against	ADP
ajlm-2845	94	9	p.	p.	PROPN
ajlm-2845	94	10	mirabilis	mirabilis	PROPN
ajlm-2845	94	11	,	,	PUNCT
ajlm-2845	94	12	with	with	ADP
ajlm-2845	94	13	sensitivities	sensitivity	NOUN
ajlm-2845	94	14	as	as	ADV
ajlm-2845	94	15	high	high	ADJ
ajlm-2845	94	16	as	as	ADP
ajlm-2845	94	17	96	96	NUM
ajlm-2845	94	18	%	%	NOUN
ajlm-2845	94	19	(	(	PUNCT
ajlm-2845	94	20	third	third	ADJ
ajlm-2845	94	21	generation	generation	NOUN
ajlm-2845	94	22	)	)	PUNCT
ajlm-2845	94	23	and	and	CCONJ
ajlm-2845	94	24	95.2	95.2	NUM
ajlm-2845	94	25	%	%	NOUN
ajlm-2845	94	26	(	(	PUNCT
ajlm-2845	94	27	fourth	fourth	ADJ
ajlm-2845	94	28	generation	generation	NOUN
ajlm-2845	94	29	)	)	PUNCT
ajlm-2845	94	30	.	.	PUNCT
ajlm-2845	95	1	the	the	DET
ajlm-2845	95	2	sensitivity	sensitivity	NOUN
ajlm-2845	95	3	of	of	ADP
ajlm-2845	95	4	e.	e.	PROPN
ajlm-2845	95	5	coli	coli	PROPN
ajlm-2845	95	6	to	to	ADP
ajlm-2845	95	7	third	third	ADJ
ajlm-2845	95	8	generation	generation	NOUN
ajlm-2845	95	9	cephalosporins	cephalosporin	NOUN
ajlm-2845	95	10	was	be	AUX
ajlm-2845	95	11	82.2	82.2	NUM
ajlm-2845	95	12	%	%	NOUN
ajlm-2845	95	13	,	,	PUNCT
ajlm-2845	95	14	and	and	CCONJ
ajlm-2845	95	15	to	to	ADP
ajlm-2845	95	16	fourth	fourth	ADJ
ajlm-2845	95	17	generation	generation	NOUN
ajlm-2845	95	18	,	,	PUNCT
ajlm-2845	95	19	81.8	81.8	NUM
ajlm-2845	95	20	%	%	NOUN
ajlm-2845	95	21	and	and	CCONJ
ajlm-2845	95	22	66.4	66.4	NUM
ajlm-2845	95	23	%	%	NOUN
ajlm-2845	95	24	(	(	PUNCT
ajlm-2845	95	25	third	third	ADJ
ajlm-2845	95	26	generation	generation	NOUN
ajlm-2845	95	27	)	)	PUNCT
ajlm-2845	95	28	and	and	CCONJ
ajlm-2845	95	29	62.8	62.8	NUM
ajlm-2845	95	30	%	%	NOUN
ajlm-2845	95	31	(	(	PUNCT
ajlm-2845	95	32	fourth	fourth	ADJ
ajlm-2845	95	33	generation	generation	NOUN
ajlm-2845	95	34	)	)	PUNCT
ajlm-2845	95	35	for	for	ADP
ajlm-2845	95	36	k.	k.	PROPN
ajlm-2845	95	37	pneumoniae	pneumoniae	PROPN
ajlm-2845	95	38	.	.	PUNCT
ajlm-2845	96	1	similar	similar	ADJ
ajlm-2845	96	2	rates	rate	NOUN
ajlm-2845	96	3	of	of	ADP
ajlm-2845	96	4	resistance	resistance	NOUN
ajlm-2845	96	5	were	be	AUX
ajlm-2845	96	6	seen	see	VERB
ajlm-2845	96	7	in	in	ADP
ajlm-2845	96	8	e.	e.	PROPN
ajlm-2845	96	9	cloacae	cloacae	PROPN
ajlm-2845	96	10	,	,	PUNCT
ajlm-2845	96	11	with	with	ADP
ajlm-2845	96	12	susceptibilities	susceptibility	NOUN
ajlm-2845	96	13	of	of	ADP
ajlm-2845	96	14	77.6	77.6	NUM
ajlm-2845	96	15	%	%	NOUN
ajlm-2845	96	16	(	(	PUNCT
ajlm-2845	96	17	third	third	ADJ
ajlm-2845	96	18	generation	generation	NOUN
ajlm-2845	96	19	)	)	PUNCT
ajlm-2845	96	20	and	and	CCONJ
ajlm-2845	96	21	63	63	NUM
ajlm-2845	96	22	%	%	NOUN
ajlm-2845	96	23	(	(	PUNCT
ajlm-2845	96	24	fourth	fourth	ADJ
ajlm-2845	96	25	generation	generation	NOUN
ajlm-2845	96	26	)	)	PUNCT
ajlm-2845	96	27	.	.	PUNCT
ajlm-2845	97	1	the	the	DET
ajlm-2845	97	2	overall	overall	ADJ
ajlm-2845	97	3	cumulative	cumulative	ADJ
ajlm-2845	97	4	sensitivity	sensitivity	NOUN
ajlm-2845	97	5	to	to	PART
ajlm-2845	97	6	meropenem	meropenem	PROPN
ajlm-2845	97	7	was	be	AUX
ajlm-2845	97	8	94.1	94.1	NUM
ajlm-2845	97	9	%	%	NOUN
ajlm-2845	97	10	(	(	PUNCT
ajlm-2845	97	11	p	p	NOUN
ajlm-2845	97	12	=	=	NOUN
ajlm-2845	97	13	0.004	0.004	NUM
ajlm-2845	97	14	)	)	PUNCT
ajlm-2845	97	15	,	,	PUNCT
ajlm-2845	97	16	and	and	CCONJ
ajlm-2845	97	17	87.5	87.5	NUM
ajlm-2845	97	18	%	%	NOUN
ajlm-2845	97	19	(	(	PUNCT
ajlm-2845	97	20	p	p	X
ajlm-2845	97	21	<	<	X
ajlm-2845	97	22	0.001	0.001	NUM
ajlm-2845	97	23	)	)	PUNCT
ajlm-2845	97	24	to	to	ADP
ajlm-2845	97	25	imipenem	imipenem	PROPN
ajlm-2845	97	26	.	.	PUNCT
ajlm-2845	98	1	proteus	proteus	PROPN
ajlm-2845	98	2	mirabilis	mirabilis	PROPN
ajlm-2845	98	3	was	be	AUX
ajlm-2845	98	4	only	only	ADV
ajlm-2845	98	5	sensitive	sensitive	ADJ
ajlm-2845	98	6	in	in	ADP
ajlm-2845	98	7	96.3	96.3	NUM
ajlm-2845	98	8	%	%	NOUN
ajlm-2845	98	9	of	of	ADP
ajlm-2845	98	10	cases	case	NOUN
ajlm-2845	98	11	to	to	ADP
ajlm-2845	98	12	meropenem	meropenem	NOUN
ajlm-2845	98	13	,	,	PUNCT
ajlm-2845	98	14	and	and	CCONJ
ajlm-2845	98	15	to	to	ADP
ajlm-2845	98	16	imipenem	imipenem	PROPN
ajlm-2845	98	17	in	in	ADP
ajlm-2845	98	18	21.4	21.4	NUM
ajlm-2845	98	19	%	%	NOUN
ajlm-2845	98	20	of	of	ADP
ajlm-2845	98	21	cases	case	NOUN
ajlm-2845	98	22	.	.	PUNCT
ajlm-2845	99	1	e.	e.	PROPN
ajlm-2845	99	2	coli	coli	PROPN
ajlm-2845	99	3	,	,	PUNCT
ajlm-2845	99	4	k.	k.	NOUN
ajlm-2845	100	1	pneumoniae	pneumoniae	PROPN
ajlm-2845	100	2	and	and	CCONJ
ajlm-2845	100	3	e.	e.	PROPN
ajlm-2845	100	4	cloacae	cloacae	PROPN
ajlm-2845	100	5	had	have	VERB
ajlm-2845	100	6	sensitivities	sensitivity	NOUN
ajlm-2845	100	7	of	of	ADP
ajlm-2845	100	8	over	over	ADP
ajlm-2845	100	9	83	83	NUM
ajlm-2845	100	10	%	%	NOUN
ajlm-2845	100	11	to	to	ADP
ajlm-2845	100	12	bothimipenem	bothimipenem	PROPN
ajlm-2845	100	13	and	and	CCONJ
ajlm-2845	100	14	meropenem	meropenem	PROPN
ajlm-2845	100	15	.	.	PUNCT
ajlm-2845	101	1	the	the	DET
ajlm-2845	101	2	cumulative	cumulative	ADJ
ajlm-2845	101	3	sensitivity	sensitivity	NOUN
ajlm-2845	101	4	to	to	ADP
ajlm-2845	101	5	piperacillin	piperacillin	VERB
ajlm-2845	101	6	–	–	PUNCT
ajlm-2845	101	7	tazobactam	tazobactam	NOUN
ajlm-2845	101	8	was	be	AUX
ajlm-2845	101	9	87.1	87.1	NUM
ajlm-2845	101	10	%	%	NOUN
ajlm-2845	101	11	(	(	PUNCT
ajlm-2845	101	12	p	p	NOUN
ajlm-2845	101	13	=	=	NOUN
ajlm-2845	101	14	0.017	0.017	NUM
ajlm-2845	101	15	)	)	PUNCT
ajlm-2845	101	16	.	.	PUNCT
ajlm-2845	102	1	escherichia	escherichia	NOUN
ajlm-2845	102	2	coli	coli	NOUN
ajlm-2845	102	3	was	be	AUX
ajlm-2845	102	4	relatively	relatively	ADV
ajlm-2845	102	5	sensitive	sensitive	ADJ
ajlm-2845	102	6	,	,	PUNCT
ajlm-2845	102	7	at	at	ADP
ajlm-2845	102	8	89.4	89.4	NUM
ajlm-2845	102	9	%	%	NOUN
ajlm-2845	102	10	,	,	PUNCT
ajlm-2845	102	11	as	as	SCONJ
ajlm-2845	102	12	was	be	AUX
ajlm-2845	102	13	p.	p.	PROPN
ajlm-2845	102	14	mirabilis	mirabilis	PROPN
ajlm-2845	102	15	,	,	PUNCT
ajlm-2845	102	16	at	at	ADP
ajlm-2845	102	17	96.4	96.4	NUM
ajlm-2845	102	18	%	%	NOUN
ajlm-2845	102	19	,	,	PUNCT
ajlm-2845	102	20	whereas	whereas	SCONJ
ajlm-2845	102	21	k.	k.	PROPN
ajlm-2845	102	22	pneumoniae	pneumoniae	NOUN
ajlm-2845	102	23	(	(	PUNCT
ajlm-2845	102	24	76.5	76.5	NUM
ajlm-2845	102	25	%	%	NOUN
ajlm-2845	102	26	)	)	PUNCT
ajlm-2845	102	27	and	and	CCONJ
ajlm-2845	102	28	e.	e.	PROPN
ajlm-2845	102	29	cloacae	cloacae	PROPN
ajlm-2845	102	30	(	(	PUNCT
ajlm-2845	102	31	72.7	72.7	NUM
ajlm-2845	102	32	%	%	NOUN
ajlm-2845	102	33	)	)	PUNCT
ajlm-2845	102	34	both	both	PRON
ajlm-2845	102	35	had	have	AUX
ajlm-2845	102	36	reduced	reduce	VERB
ajlm-2845	102	37	sensitivity	sensitivity	NOUN
ajlm-2845	102	38	.	.	PUNCT
ajlm-2845	103	1	candida	candida	PROPN
ajlm-2845	103	2	albicans	albican	VERB
ajlm-2845	103	3	isolates	isolate	NOUN
ajlm-2845	103	4	were	be	AUX
ajlm-2845	103	5	,	,	PUNCT
ajlm-2845	103	6	as	as	SCONJ
ajlm-2845	103	7	expected	expect	VERB
ajlm-2845	103	8	,	,	PUNCT
ajlm-2845	103	9	relatively	relatively	ADV
ajlm-2845	103	10	sensitive	sensitive	ADJ
ajlm-2845	103	11	to	to	ADP
ajlm-2845	103	12	fluconazole	fluconazole	NOUN
ajlm-2845	103	13	(	(	PUNCT
ajlm-2845	103	14	92.9	92.9	NUM
ajlm-2845	103	15	%	%	NOUN
ajlm-2845	103	16	;	;	PUNCT
ajlm-2845	103	17	p	p	X
ajlm-2845	103	18	<	<	X
ajlm-2845	103	19	0.001	0.001	NUM
ajlm-2845	103	20	)	)	PUNCT
ajlm-2845	103	21	,	,	PUNCT
ajlm-2845	103	22	amphotericin	amphotericin	ADP
ajlm-2845	103	23	b	b	X
ajlm-2845	103	24	(	(	PUNCT
ajlm-2845	103	25	92.9	92.9	NUM
ajlm-2845	103	26	%	%	NOUN
ajlm-2845	103	27	;	;	PUNCT
ajlm-2845	103	28	p	p	X
ajlm-2845	103	29	<	<	X
ajlm-2845	103	30	0.001	0.001	NUM
ajlm-2845	103	31	)	)	PUNCT
ajlm-2845	103	32	and	and	CCONJ
ajlm-2845	103	33	voriconazole	voriconazole	NOUN
ajlm-2845	103	34	(	(	PUNCT
ajlm-2845	103	35	94.9	94.9	NUM
ajlm-2845	103	36	%	%	NOUN
ajlm-2845	103	37	;	;	PUNCT
ajlm-2845	103	38	p	p	X
ajlm-2845	103	39	<	<	X
ajlm-2845	103	40	0.001	0.001	NUM
ajlm-2845	103	41	)	)	PUNCT
ajlm-2845	103	42	(	(	PUNCT
ajlm-2845	103	43	table	table	NOUN
ajlm-2845	103	44	3	3	NUM
ajlm-2845	103	45	)	)	PUNCT
ajlm-2845	103	46	.	.	PUNCT
ajlm-2845	104	1	during	during	ADP
ajlm-2845	104	2	the	the	DET
ajlm-2845	104	3	study	study	NOUN
ajlm-2845	104	4	period	period	NOUN
ajlm-2845	104	5	,	,	PUNCT
ajlm-2845	104	6	pseudomonas	pseudomona	NOUN
ajlm-2845	104	7	aeruginosa	aeruginosa	NOUN
ajlm-2845	104	8	was	be	AUX
ajlm-2845	104	9	isolated	isolate	VERB
ajlm-2845	104	10	on	on	ADP
ajlm-2845	104	11	33	33	NUM
ajlm-2845	104	12	occasions	occasion	NOUN
ajlm-2845	104	13	.	.	PUNCT
ajlm-2845	105	1	susceptibility	susceptibility	NOUN
ajlm-2845	105	2	testing	testing	NOUN
ajlm-2845	105	3	reached	reach	VERB
ajlm-2845	105	4	the	the	DET
ajlm-2845	105	5	threshold	threshold	NOUN
ajlm-2845	105	6	of	of	ADP
ajlm-2845	105	7	30	30	NUM
ajlm-2845	105	8	or	or	CCONJ
ajlm-2845	105	9	more	more	ADJ
ajlm-2845	105	10	isolates	isolate	NOUN
ajlm-2845	105	11	for	for	ADP
ajlm-2845	105	12	four	four	NUM
ajlm-2845	105	13	antibiotics	antibiotic	NOUN
ajlm-2845	105	14	:	:	PUNCT
ajlm-2845	105	15	amikacin	amikacin	PROPN
ajlm-2845	105	16	(	(	PUNCT
ajlm-2845	105	17	sensitivity	sensitivity	NOUN
ajlm-2845	105	18	97	97	NUM
ajlm-2845	105	19	%	%	NOUN
ajlm-2845	105	20	)	)	PUNCT
ajlm-2845	105	21	,	,	PUNCT
ajlm-2845	105	22	gentamicin	gentamicin	NOUN
ajlm-2845	105	23	(	(	PUNCT
ajlm-2845	105	24	sensitivity	sensitivity	NOUN
ajlm-2845	105	25	50	50	NUM
ajlm-2845	105	26	%	%	NOUN
ajlm-2845	105	27	)	)	PUNCT
ajlm-2845	105	28	,	,	PUNCT
ajlm-2845	105	29	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2845	105	30	(	(	PUNCT
ajlm-2845	105	31	sensitivity	sensitivity	NOUN
ajlm-2845	105	32	76	76	NUM
ajlm-2845	105	33	%	%	NOUN
ajlm-2845	105	34	)	)	PUNCT
ajlm-2845	105	35	,	,	PUNCT
ajlm-2845	105	36	and	and	CCONJ
ajlm-2845	105	37	piperacillin	piperacillin	PROPN
ajlm-2845	105	38	–	–	PUNCT
ajlm-2845	105	39	tazobactam	tazobactam	NOUN
ajlm-2845	105	40	(	(	PUNCT
ajlm-2845	105	41	sensitivity	sensitivity	NOUN
ajlm-2845	105	42	94	94	NUM
ajlm-2845	105	43	%	%	NOUN
ajlm-2845	105	44	)	)	PUNCT
ajlm-2845	105	45	(	(	PUNCT
ajlm-2845	105	46	table	table	NOUN
ajlm-2845	105	47	2	2	NUM
ajlm-2845	105	48	)	)	PUNCT
ajlm-2845	105	49	.	.	PUNCT
ajlm-2845	106	1	acinetobacter	acinetobacter	PROPN
ajlm-2845	106	2	baumannii	baumannii	PROPN
ajlm-2845	106	3	was	be	AUX
ajlm-2845	106	4	isolated	isolate	VERB
ajlm-2845	106	5	47	47	NUM
ajlm-2845	106	6	times	time	NOUN
ajlm-2845	106	7	,	,	PUNCT
ajlm-2845	106	8	but	but	CCONJ
ajlm-2845	106	9	only	only	ADV
ajlm-2845	106	10	three	three	NUM
ajlm-2845	106	11	antibiotics	antibiotic	NOUN
ajlm-2845	106	12	were	be	AUX
ajlm-2845	106	13	tested	test	VERB
ajlm-2845	106	14	in	in	ADP
ajlm-2845	106	15	30	30	NUM
ajlm-2845	106	16	or	or	CCONJ
ajlm-2845	106	17	more	more	ADJ
ajlm-2845	106	18	isolates	isolate	NOUN
ajlm-2845	106	19	.	.	PUNCT
ajlm-2845	107	1	these	these	PRON
ajlm-2845	107	2	included	include	VERB
ajlm-2845	107	3	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2845	107	4	(	(	PUNCT
ajlm-2845	107	5	37	37	NUM
ajlm-2845	107	6	%	%	NOUN
ajlm-2845	107	7	sensitivity	sensitivity	NOUN
ajlm-2845	107	8	)	)	PUNCT
ajlm-2845	107	9	,	,	PUNCT
ajlm-2845	107	10	gentamicin	gentamicin	NOUN
ajlm-2845	107	11	(	(	PUNCT
ajlm-2845	107	12	42	42	NUM
ajlm-2845	107	13	%	%	NOUN
ajlm-2845	107	14	sensitivity	sensitivity	NOUN
ajlm-2845	107	15	)	)	PUNCT
ajlm-2845	107	16	,	,	PUNCT
ajlm-2845	107	17	and	and	CCONJ
ajlm-2845	107	18	piperacillin	piperacillin	PROPN
ajlm-2845	107	19	–	–	PUNCT
ajlm-2845	107	20	tazobactam	tazobactam	NOUN
ajlm-2845	107	21	(	(	PUNCT
ajlm-2845	107	22	28	28	NUM
ajlm-2845	107	23	%	%	NOUN
ajlm-2845	107	24	sensitivity	sensitivity	NOUN
ajlm-2845	107	25	)	)	PUNCT
ajlm-2845	107	26	(	(	PUNCT
ajlm-2845	107	27	table	table	NOUN
ajlm-2845	107	28	2	2	NUM
ajlm-2845	107	29	)	)	PUNCT
ajlm-2845	107	30	.	.	PUNCT
ajlm-2845	108	1	table	table	NOUN
ajlm-2845	108	2	2	2	NUM
ajlm-2845	108	3	:	:	PUNCT
ajlm-2845	108	4	 	 	SPACE
ajlm-2845	108	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	108	6	susceptibility	susceptibility	NOUN
ajlm-2845	108	7	patterns	pattern	NOUN
ajlm-2845	108	8	of	of	ADP
ajlm-2845	108	9	pseudomonas	pseudomona	NOUN
ajlm-2845	108	10	aeruginosa	aeruginosa	NOUN
ajlm-2845	108	11	and	and	CCONJ
ajlm-2845	108	12	acinetobacter	acinetobacter	NOUN
ajlm-2845	108	13	baumannii	baumannii	ADJ
ajlm-2845	108	14	in	in	ADP
ajlm-2845	108	15	urine	urine	NOUN
ajlm-2845	108	16	specimens	specimen	NOUN
ajlm-2845	108	17	at	at	ADP
ajlm-2845	108	18	potchefstroom	potchefstroom	NOUN
ajlm-2845	108	19	hospital	hospital	NOUN
ajlm-2845	108	20	,	,	PUNCT
ajlm-2845	108	21	south	south	PROPN
ajlm-2845	108	22	africa	africa	PROPN
ajlm-2845	108	23	,	,	PUNCT
ajlm-2845	108	24	january	january	PROPN
ajlm-2845	108	25	2020	2020	NUM
ajlm-2845	108	26	–	–	PUNCT
ajlm-2845	108	27	december	december	PROPN
ajlm-2845	108	28	2023	2023	NUM
ajlm-2845	108	29	.	.	PUNCT
ajlm-2845	109	1	table	table	NOUN
ajlm-2845	109	2	3	3	NUM
ajlm-2845	109	3	:	:	PUNCT
ajlm-2845	109	4	 	 	SPACE
ajlm-2845	109	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	109	6	susceptibility	susceptibility	NOUN
ajlm-2845	109	7	patterns	pattern	NOUN
ajlm-2845	109	8	of	of	ADP
ajlm-2845	109	9	candida	candida	NOUN
ajlm-2845	109	10	albicans	albican	VERB
ajlm-2845	109	11	species	specie	NOUN
ajlm-2845	109	12	in	in	ADP
ajlm-2845	109	13	urine	urine	NOUN
ajlm-2845	109	14	specimens	specimen	NOUN
ajlm-2845	109	15	at	at	ADP
ajlm-2845	109	16	potchefstroom	potchefstroom	NOUN
ajlm-2845	109	17	hospital	hospital	NOUN
ajlm-2845	109	18	,	,	PUNCT
ajlm-2845	109	19	south	south	PROPN
ajlm-2845	109	20	africa	africa	PROPN
ajlm-2845	109	21	,	,	PUNCT
ajlm-2845	109	22	january	january	PROPN
ajlm-2845	109	23	2020	2020	NUM
ajlm-2845	109	24	–	–	PUNCT
ajlm-2845	109	25	december	december	PROPN
ajlm-2845	109	26	2023	2023	NUM
ajlm-2845	109	27	.	.	PUNCT
ajlm-2845	110	1	there	there	PRON
ajlm-2845	110	2	were	be	VERB
ajlm-2845	110	3	significant	significant	ADJ
ajlm-2845	110	4	changes	change	NOUN
ajlm-2845	110	5	in	in	ADP
ajlm-2845	110	6	trend	trend	NOUN
ajlm-2845	110	7	noted	note	VERB
ajlm-2845	110	8	for	for	ADP
ajlm-2845	110	9	second-	second-	X
ajlm-2845	110	10	,	,	PUNCT
ajlm-2845	110	11	third-	third-	X
ajlm-2845	110	12	,	,	PUNCT
ajlm-2845	110	13	and	and	CCONJ
ajlm-2845	110	14	fourth	fourth	ADJ
ajlm-2845	110	15	generation	generation	NOUN
ajlm-2845	110	16	cephalosporins	cephalosporin	NOUN
ajlm-2845	110	17	,	,	PUNCT
ajlm-2845	110	18	and	and	CCONJ
ajlm-2845	110	19	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	110	20	over	over	ADP
ajlm-2845	110	21	the	the	DET
ajlm-2845	110	22	study	study	NOUN
ajlm-2845	110	23	period	period	NOUN
ajlm-2845	110	24	(	(	PUNCT
ajlm-2845	110	25	table	table	NOUN
ajlm-2845	110	26	4	4	NUM
ajlm-2845	110	27	)	)	PUNCT
ajlm-2845	110	28	.	.	PUNCT
ajlm-2845	111	1	the	the	DET
ajlm-2845	111	2	organisms	organism	NOUN
ajlm-2845	111	3	demonstrated	demonstrate	VERB
ajlm-2845	111	4	an	an	DET
ajlm-2845	111	5	increase	increase	NOUN
ajlm-2845	111	6	in	in	ADP
ajlm-2845	111	7	sensitivity	sensitivity	NOUN
ajlm-2845	111	8	to	to	ADP
ajlm-2845	111	9	cefepime	cefepime	NOUN
ajlm-2845	111	10	,	,	PUNCT
ajlm-2845	111	11	rising	rise	VERB
ajlm-2845	111	12	from	from	ADP
ajlm-2845	111	13	73.6	73.6	NUM
ajlm-2845	111	14	%	%	NOUN
ajlm-2845	111	15	to	to	ADP
ajlm-2845	111	16	78.6	78.6	NUM
ajlm-2845	111	17	%	%	NOUN
ajlm-2845	111	18	(	(	PUNCT
ajlm-2845	111	19	p	p	X
ajlm-2845	111	20	=	=	NOUN
ajlm-2845	111	21	0.033	0.033	NUM
ajlm-2845	111	22	)	)	PUNCT
ajlm-2845	111	23	.	.	PUNCT
ajlm-2845	112	1	in	in	ADP
ajlm-2845	112	2	contrast	contrast	NOUN
ajlm-2845	112	3	,	,	PUNCT
ajlm-2845	112	4	sensitivity	sensitivity	NOUN
ajlm-2845	112	5	to	to	PART
ajlm-2845	112	6	cefotaxime	cefotaxime	VERB
ajlm-2845	112	7	/	/	SYM
ajlm-2845	112	8	ceftriaxone	ceftriaxone	PROPN
ajlm-2845	112	9	and	and	CCONJ
ajlm-2845	112	10	cefuroxime	cefuroxime	PROPN
ajlm-2845	112	11	declined	decline	VERB
ajlm-2845	112	12	over	over	ADP
ajlm-2845	112	13	the	the	DET
ajlm-2845	112	14	study	study	NOUN
ajlm-2845	112	15	period	period	NOUN
ajlm-2845	112	16	,	,	PUNCT
ajlm-2845	112	17	decreasing	decrease	VERB
ajlm-2845	112	18	from	from	ADP
ajlm-2845	112	19	79.5	79.5	NUM
ajlm-2845	112	20	%	%	NOUN
ajlm-2845	112	21	to	to	ADP
ajlm-2845	112	22	75.6	75.6	NUM
ajlm-2845	112	23	%	%	NOUN
ajlm-2845	112	24	(	(	PUNCT
ajlm-2845	112	25	cefotaxime	cefotaxime	NOUN
ajlm-2845	112	26	/	/	SYM
ajlm-2845	112	27	ceftriaxone	ceftriaxone	NOUN
ajlm-2845	112	28	;	;	PUNCT
ajlm-2845	112	29	p	p	X
ajlm-2845	112	30	=	=	NOUN
ajlm-2845	112	31	0.006	0.006	NUM
ajlm-2845	112	32	)	)	PUNCT
ajlm-2845	112	33	and	and	CCONJ
ajlm-2845	112	34	from	from	ADP
ajlm-2845	112	35	68.7	68.7	NUM
ajlm-2845	112	36	%	%	NOUN
ajlm-2845	112	37	to	to	ADP
ajlm-2845	112	38	63.9	63.9	NUM
ajlm-2845	112	39	%	%	NOUN
ajlm-2845	112	40	(	(	PUNCT
ajlm-2845	112	41	cefuroxime	cefuroxime	ADJ
ajlm-2845	112	42	;	;	PUNCT
ajlm-2845	112	43	p	p	X
ajlm-2845	112	44	=	=	NOUN
ajlm-2845	112	45	0.009	0.009	NUM
ajlm-2845	112	46	)	)	PUNCT
ajlm-2845	112	47	.	.	PUNCT
ajlm-2845	113	1	sensitivity	sensitivity	NOUN
ajlm-2845	113	2	to	to	PART
ajlm-2845	113	3	nitrofurantoin	nitrofurantoin	PROPN
ajlm-2845	113	4	also	also	ADV
ajlm-2845	113	5	improved	improve	VERB
ajlm-2845	113	6	over	over	ADP
ajlm-2845	113	7	the	the	DET
ajlm-2845	113	8	study	study	NOUN
ajlm-2845	113	9	period	period	NOUN
ajlm-2845	113	10	,	,	PUNCT
ajlm-2845	113	11	from	from	ADP
ajlm-2845	113	12	32.8	32.8	NUM
ajlm-2845	113	13	%	%	NOUN
ajlm-2845	113	14	in	in	ADP
ajlm-2845	113	15	2020	2020	NUM
ajlm-2845	113	16	to	to	ADP
ajlm-2845	113	17	37.2	37.2	NUM
ajlm-2845	113	18	%	%	NOUN
ajlm-2845	113	19	by	by	ADP
ajlm-2845	113	20	2023	2023	NUM
ajlm-2845	113	21	(	(	PUNCT
ajlm-2845	113	22	p	p	X
ajlm-2845	113	23	=	=	NOUN
ajlm-2845	113	24	0.013	0.013	NUM
ajlm-2845	113	25	)	)	PUNCT
ajlm-2845	113	26	.	.	PUNCT
ajlm-2845	114	1	table	table	NOUN
ajlm-2845	114	2	4	4	NUM
ajlm-2845	114	3	:	:	PUNCT
ajlm-2845	114	4	 	 	SPACE
ajlm-2845	114	5	trend	trend	NOUN
ajlm-2845	114	6	in	in	ADP
ajlm-2845	114	7	cumulative	cumulative	ADJ
ajlm-2845	114	8	antimicrobial	antimicrobial	ADJ
ajlm-2845	114	9	susceptibility	susceptibility	NOUN
ajlm-2845	114	10	rates	rate	NOUN
ajlm-2845	114	11	at	at	ADP
ajlm-2845	114	12	potchefstroom	potchefstroom	NOUN
ajlm-2845	114	13	hospital	hospital	NOUN
ajlm-2845	114	14	,	,	PUNCT
ajlm-2845	114	15	south	south	PROPN
ajlm-2845	114	16	africa	africa	PROPN
ajlm-2845	114	17	,	,	PUNCT
ajlm-2845	114	18	january	january	PROPN
ajlm-2845	114	19	2020	2020	NUM
ajlm-2845	114	20	–	–	PUNCT
ajlm-2845	114	21	december	december	PROPN
ajlm-2845	114	22	2023	2023	NUM
ajlm-2845	114	23	.	.	PUNCT
ajlm-2845	115	1	discussion	discussion	NOUN
ajlm-2845	115	2	the	the	DET
ajlm-2845	115	3	prevalence	prevalence	NOUN
ajlm-2845	115	4	of	of	ADP
ajlm-2845	115	5	the	the	DET
ajlm-2845	115	6	various	various	ADJ
ajlm-2845	115	7	uropathogens	uropathogen	NOUN
ajlm-2845	115	8	identified	identify	VERB
ajlm-2845	115	9	in	in	ADP
ajlm-2845	115	10	this	this	DET
ajlm-2845	115	11	study	study	NOUN
ajlm-2845	115	12	aligns	align	VERB
ajlm-2845	115	13	with	with	ADP
ajlm-2845	115	14	findings	finding	NOUN
ajlm-2845	115	15	from	from	ADP
ajlm-2845	115	16	a	a	DET
ajlm-2845	115	17	recent	recent	ADJ
ajlm-2845	115	18	investigation	investigation	NOUN
ajlm-2845	115	19	at	at	ADP
ajlm-2845	115	20	rk	rk	PROPN
ajlm-2845	115	21	khan	khan	PROPN
ajlm-2845	115	22	hospital	hospital	PROPN
ajlm-2845	115	23	in	in	ADP
ajlm-2845	115	24	kwazulu	kwazulu	PROPN
ajlm-2845	115	25	-	-	PUNCT
ajlm-2845	115	26	natal	natal	ADJ
ajlm-2845	115	27	,	,	PUNCT
ajlm-2845	115	28	south	south	PROPN
ajlm-2845	115	29	africa	africa	PROPN
ajlm-2845	115	30	,	,	PUNCT
ajlm-2845	115	31	which	which	PRON
ajlm-2845	115	32	employed	employ	VERB
ajlm-2845	115	33	a	a	DET
ajlm-2845	115	34	similar	similar	ADJ
ajlm-2845	115	35	sample	sample	NOUN
ajlm-2845	115	36	size	size	NOUN
ajlm-2845	115	37	and	and	CCONJ
ajlm-2845	115	38	methodology	methodology	NOUN
ajlm-2845	115	39	.	.	PUNCT
ajlm-2845	116	1	in	in	ADP
ajlm-2845	116	2	this	this	DET
ajlm-2845	116	3	study	study	NOUN
ajlm-2845	116	4	,	,	PUNCT
ajlm-2845	116	5	e.	e.	PROPN
ajlm-2845	116	6	coli	coli	PROPN
ajlm-2845	116	7	was	be	AUX
ajlm-2845	116	8	the	the	DET
ajlm-2845	116	9	predominant	predominant	ADJ
ajlm-2845	116	10	pathogen	pathogen	NOUN
ajlm-2845	116	11	,	,	PUNCT
ajlm-2845	116	12	followed	follow	VERB
ajlm-2845	116	13	by	by	ADP
ajlm-2845	116	14	k.	k.	PROPN
ajlm-2845	116	15	pneumoniae	pneumoniae	PROPN
ajlm-2845	116	16	and	and	CCONJ
ajlm-2845	116	17	e.	e.	PROPN
ajlm-2845	116	18	faecalis.12	faecalis.12	PROPN
ajlm-2845	116	19	the	the	DET
ajlm-2845	116	20	authors	author	NOUN
ajlm-2845	116	21	of	of	ADP
ajlm-2845	116	22	the	the	DET
ajlm-2845	116	23	rk	rk	PROPN
ajlm-2845	116	24	khan	khan	PROPN
ajlm-2845	116	25	hospital	hospital	PROPN
ajlm-2845	116	26	study	study	NOUN
ajlm-2845	116	27	found	find	VERB
ajlm-2845	116	28	that	that	SCONJ
ajlm-2845	116	29	resistance	resistance	NOUN
ajlm-2845	116	30	rates	rate	NOUN
ajlm-2845	116	31	to	to	PART
ajlm-2845	116	32	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	116	33	were	be	AUX
ajlm-2845	116	34	low	low	ADJ
ajlm-2845	116	35	in	in	ADP
ajlm-2845	116	36	e.	e.	PROPN
ajlm-2845	116	37	coli	coli	PROPN
ajlm-2845	116	38	,	,	PUNCT
ajlm-2845	116	39	at	at	ADP
ajlm-2845	116	40	6.2	6.2	NUM
ajlm-2845	116	41	%	%	NOUN
ajlm-2845	116	42	,	,	PUNCT
ajlm-2845	116	43	and	and	CCONJ
ajlm-2845	116	44	high	high	ADJ
ajlm-2845	116	45	in	in	ADP
ajlm-2845	116	46	k.	k.	PROPN
ajlm-2845	116	47	pneumoniae	pneumoniae	PROPN
ajlm-2845	116	48	,	,	PUNCT
ajlm-2845	116	49	at	at	ADP
ajlm-2845	116	50	61.3%.12	61.3%.12	NUM
ajlm-2845	116	51	these	these	DET
ajlm-2845	116	52	figures	figure	NOUN
ajlm-2845	116	53	reflect	reflect	VERB
ajlm-2845	116	54	our	our	PRON
ajlm-2845	116	55	findings	finding	NOUN
ajlm-2845	116	56	.	.	PUNCT
ajlm-2845	117	1	a	a	DET
ajlm-2845	117	2	multicentre	multicentre	ADJ
ajlm-2845	117	3	local	local	ADJ
ajlm-2845	117	4	study	study	NOUN
ajlm-2845	117	5	conducted	conduct	VERB
ajlm-2845	117	6	by	by	ADP
ajlm-2845	117	7	lewis	lewis	PROPN
ajlm-2845	117	8	et	et	PROPN
ajlm-2845	117	9	al	al	PROPN
ajlm-2845	117	10	.	.	PROPN
ajlm-2845	118	1	in	in	ADP
ajlm-2845	118	2	2013	2013	NUM
ajlm-2845	118	3	forms	form	NOUN
ajlm-2845	118	4	part	part	NOUN
ajlm-2845	118	5	of	of	ADP
ajlm-2845	118	6	the	the	DET
ajlm-2845	118	7	basis	basis	NOUN
ajlm-2845	118	8	of	of	ADP
ajlm-2845	118	9	the	the	DET
ajlm-2845	118	10	neml	neml	ADJ
ajlm-2845	118	11	,	,	PUNCT
ajlm-2845	118	12	in	in	ADP
ajlm-2845	118	13	which	which	PRON
ajlm-2845	118	14	good	good	ADJ
ajlm-2845	118	15	cumulative	cumulative	ADJ
ajlm-2845	118	16	sensitivity	sensitivity	NOUN
ajlm-2845	118	17	to	to	PART
ajlm-2845	118	18	nitrofurantoin	nitrofurantoin	VERB
ajlm-2845	118	19	(	(	PUNCT
ajlm-2845	118	20	91.7	91.7	NUM
ajlm-2845	118	21	%	%	NOUN
ajlm-2845	118	22	)	)	PUNCT
ajlm-2845	118	23	was	be	AUX
ajlm-2845	118	24	noted.13	noted.13	NUM
ajlm-2845	118	25	the	the	DET
ajlm-2845	118	26	markedly	markedly	ADV
ajlm-2845	118	27	reduced	reduce	VERB
ajlm-2845	118	28	sensitivities	sensitivity	NOUN
ajlm-2845	118	29	of	of	ADP
ajlm-2845	118	30	k.	k.	PROPN
ajlm-2845	118	31	pneumoniae	pneumoniae	NOUN
ajlm-2845	118	32	(	(	PUNCT
ajlm-2845	118	33	40	40	NUM
ajlm-2845	118	34	%	%	NOUN
ajlm-2845	118	35	)	)	PUNCT
ajlm-2845	118	36	,	,	PUNCT
ajlm-2845	119	1	e.	e.	PROPN
ajlm-2845	119	2	cloacae	cloacae	PROPN
ajlm-2845	119	3	(	(	PUNCT
ajlm-2845	119	4	23.4	23.4	NUM
ajlm-2845	119	5	%	%	NOUN
ajlm-2845	119	6	)	)	PUNCT
ajlm-2845	119	7	,	,	PUNCT
ajlm-2845	119	8	and	and	CCONJ
ajlm-2845	119	9	p.	p.	PROPN
ajlm-2845	119	10	mirabilis	mirabilis	PROPN
ajlm-2845	119	11	(	(	PUNCT
ajlm-2845	119	12	1.4	1.4	NUM
ajlm-2845	119	13	%	%	NOUN
ajlm-2845	119	14	)	)	PUNCT
ajlm-2845	119	15	highlight	highlight	VERB
ajlm-2845	119	16	emerging	emerge	VERB
ajlm-2845	119	17	resistance	resistance	NOUN
ajlm-2845	119	18	and	and	CCONJ
ajlm-2845	119	19	make	make	VERB
ajlm-2845	119	20	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	119	21	less	less	ADV
ajlm-2845	119	22	useful	useful	ADJ
ajlm-2845	119	23	in	in	ADP
ajlm-2845	119	24	our	our	PRON
ajlm-2845	119	25	setting	setting	NOUN
ajlm-2845	119	26	for	for	ADP
ajlm-2845	119	27	empiric	empiric	ADJ
ajlm-2845	119	28	treatment	treatment	NOUN
ajlm-2845	119	29	.	.	PUNCT
ajlm-2845	120	1	additionally	additionally	ADV
ajlm-2845	120	2	,	,	PUNCT
ajlm-2845	120	3	the	the	DET
ajlm-2845	120	4	clsi	clsi	NOUN
ajlm-2845	120	5	states	state	VERB
ajlm-2845	120	6	that	that	SCONJ
ajlm-2845	120	7	p.	p.	PROPN
ajlm-2845	120	8	mirabilis	mirabilis	PROPN
ajlm-2845	120	9	is	be	AUX
ajlm-2845	120	10	intrinsically	intrinsically	ADV
ajlm-2845	120	11	resistant	resistant	ADJ
ajlm-2845	120	12	to	to	ADP
ajlm-2845	120	13	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	120	14	,	,	PUNCT
ajlm-2845	120	15	which	which	PRON
ajlm-2845	120	16	reflects	reflect	VERB
ajlm-2845	120	17	our	our	PRON
ajlm-2845	120	18	results.14	results.14	PROPN
ajlm-2845	120	19	given	give	VERB
ajlm-2845	120	20	that	that	SCONJ
ajlm-2845	120	21	resistance	resistance	NOUN
ajlm-2845	120	22	patterns	pattern	NOUN
ajlm-2845	120	23	tend	tend	VERB
ajlm-2845	120	24	to	to	PART
ajlm-2845	120	25	differ	differ	VERB
ajlm-2845	120	26	by	by	ADP
ajlm-2845	120	27	geographical	geographical	ADJ
ajlm-2845	120	28	location	location	NOUN
ajlm-2845	120	29	,	,	PUNCT
ajlm-2845	120	30	and	and	CCONJ
ajlm-2845	120	31	the	the	DET
ajlm-2845	120	32	current	current	ADJ
ajlm-2845	120	33	recommendations	recommendation	NOUN
ajlm-2845	120	34	by	by	ADP
ajlm-2845	120	35	the	the	DET
ajlm-2845	120	36	neml	neml	NOUN
ajlm-2845	120	37	are	be	AUX
ajlm-2845	120	38	based	base	VERB
ajlm-2845	120	39	partially	partially	ADV
ajlm-2845	120	40	on	on	ADP
ajlm-2845	120	41	american	american	ADJ
ajlm-2845	120	42	data	data	PROPN
ajlm-2845	120	43	,	,	PUNCT
ajlm-2845	120	44	we	we	PRON
ajlm-2845	120	45	believe	believe	VERB
ajlm-2845	120	46	it	it	PRON
ajlm-2845	120	47	was	be	AUX
ajlm-2845	120	48	necessary	necessary	ADJ
ajlm-2845	120	49	to	to	PART
ajlm-2845	120	50	verify	verify	VERB
ajlm-2845	120	51	the	the	DET
ajlm-2845	120	52	neml	neml	ADJ
ajlm-2845	120	53	recommendations	recommendation	NOUN
ajlm-2845	120	54	for	for	ADP
ajlm-2845	120	55	the	the	DET
ajlm-2845	120	56	use	use	NOUN
ajlm-2845	120	57	of	of	ADP
ajlm-2845	120	58	gentamicin	gentamicin	NOUN
ajlm-2845	120	59	.	.	PUNCT
ajlm-2845	121	1	the	the	DET
ajlm-2845	121	2	suggested	suggest	VERB
ajlm-2845	121	3	utilisation	utilisation	NOUN
ajlm-2845	121	4	of	of	ADP
ajlm-2845	121	5	gentamicin	gentamicin	NOUN
ajlm-2845	121	6	in	in	ADP
ajlm-2845	121	7	the	the	DET
ajlm-2845	121	8	guidelines	guideline	NOUN
ajlm-2845	121	9	was	be	AUX
ajlm-2845	121	10	based	base	VERB
ajlm-2845	121	11	on	on	ADP
ajlm-2845	121	12	a	a	DET
ajlm-2845	121	13	systematic	systematic	ADJ
ajlm-2845	121	14	review	review	NOUN
ajlm-2845	121	15	,	,	PUNCT
ajlm-2845	121	16	published	publish	VERB
ajlm-2845	121	17	in	in	ADP
ajlm-2845	121	18	2018	2018	NUM
ajlm-2845	121	19	,	,	PUNCT
ajlm-2845	121	20	in	in	ADP
ajlm-2845	121	21	arizona	arizona	PROPN
ajlm-2845	121	22	(	(	PUNCT
ajlm-2845	121	23	united	united	PROPN
ajlm-2845	121	24	states	states	PROPN
ajlm-2845	121	25	)	)	PUNCT
ajlm-2845	121	26	which	which	PRON
ajlm-2845	121	27	showed	show	VERB
ajlm-2845	121	28	that	that	SCONJ
ajlm-2845	121	29	94.5	94.5	NUM
ajlm-2845	121	30	%	%	NOUN
ajlm-2845	121	31	of	of	ADP
ajlm-2845	121	32	pathogens	pathogen	NOUN
ajlm-2845	121	33	isolated	isolate	VERB
ajlm-2845	121	34	from	from	ADP
ajlm-2845	121	35	pooled	pooled	ADJ
ajlm-2845	121	36	studies	study	NOUN
ajlm-2845	121	37	were	be	AUX
ajlm-2845	121	38	susceptible	susceptible	ADJ
ajlm-2845	121	39	to	to	ADP
ajlm-2845	121	40	gentamicin.15	gentamicin.15	VERB
ajlm-2845	121	41	at	at	ADP
ajlm-2845	121	42	a	a	DET
ajlm-2845	121	43	local	local	ADJ
ajlm-2845	121	44	level	level	NOUN
ajlm-2845	121	45	,	,	PUNCT
ajlm-2845	121	46	naidoo	naidoo	PROPN
ajlm-2845	121	47	et	et	PROPN
ajlm-2845	121	48	al	al	PROPN
ajlm-2845	121	49	.	.	PROPN
ajlm-2845	122	1	also	also	ADV
ajlm-2845	122	2	noted	note	VERB
ajlm-2845	122	3	a	a	DET
ajlm-2845	122	4	lower	low	ADJ
ajlm-2845	122	5	cumulative	cumulative	ADJ
ajlm-2845	122	6	susceptibility	susceptibility	NOUN
ajlm-2845	122	7	of	of	ADP
ajlm-2845	122	8	65	65	NUM
ajlm-2845	122	9	%	%	NOUN
ajlm-2845	122	10	in	in	ADP
ajlm-2845	122	11	k.	k.	PROPN
ajlm-2845	122	12	pneumoniae.12	pneumoniae.12	PROPN
ajlm-2845	122	13	in	in	ADP
ajlm-2845	122	14	this	this	DET
ajlm-2845	122	15	study	study	NOUN
ajlm-2845	122	16	,	,	PUNCT
ajlm-2845	122	17	k.	k.	PROPN
ajlm-2845	122	18	pneumoniae	pneumoniae	PROPN
ajlm-2845	122	19	was	be	AUX
ajlm-2845	122	20	sensitive	sensitive	ADJ
ajlm-2845	122	21	to	to	ADP
ajlm-2845	122	22	gentamicin	gentamicin	NOUN
ajlm-2845	122	23	in	in	ADP
ajlm-2845	122	24	77.7	77.7	NUM
ajlm-2845	122	25	%	%	NOUN
ajlm-2845	122	26	of	of	ADP
ajlm-2845	122	27	isolates	isolate	NOUN
ajlm-2845	122	28	,	,	PUNCT
ajlm-2845	122	29	a	a	DET
ajlm-2845	122	30	12.7	12.7	NUM
ajlm-2845	122	31	%	%	NOUN
ajlm-2845	122	32	higher	high	ADJ
ajlm-2845	122	33	sensitivity	sensitivity	NOUN
ajlm-2845	122	34	rate	rate	NOUN
ajlm-2845	122	35	when	when	SCONJ
ajlm-2845	122	36	compared	compare	VERB
ajlm-2845	122	37	to	to	ADP
ajlm-2845	122	38	naidoo	naidoo	PROPN
ajlm-2845	122	39	et	et	PROPN
ajlm-2845	122	40	al	al	PROPN
ajlm-2845	122	41	.	.	PUNCT
ajlm-2845	123	1	the	the	DET
ajlm-2845	123	2	use	use	NOUN
ajlm-2845	123	3	of	of	ADP
ajlm-2845	123	4	gentamicin	gentamicin	NOUN
ajlm-2845	123	5	may	may	AUX
ajlm-2845	123	6	still	still	ADV
ajlm-2845	123	7	be	be	AUX
ajlm-2845	123	8	an	an	DET
ajlm-2845	123	9	effective	effective	ADJ
ajlm-2845	123	10	empiric	empiric	ADJ
ajlm-2845	123	11	antimicrobial	antimicrobial	NOUN
ajlm-2845	123	12	in	in	ADP
ajlm-2845	123	13	our	our	PRON
ajlm-2845	123	14	setting	setting	NOUN
ajlm-2845	123	15	,	,	PUNCT
ajlm-2845	123	16	as	as	SCONJ
ajlm-2845	123	17	this	this	DET
ajlm-2845	123	18	study	study	NOUN
ajlm-2845	123	19	revealed	reveal	VERB
ajlm-2845	123	20	an	an	DET
ajlm-2845	123	21	87.8	87.8	NUM
ajlm-2845	123	22	%	%	NOUN
ajlm-2845	123	23	cumulative	cumulative	ADJ
ajlm-2845	123	24	sensitivity	sensitivity	NOUN
ajlm-2845	123	25	overall	overall	ADJ
ajlm-2845	123	26	.	.	PUNCT
ajlm-2845	124	1	the	the	DET
ajlm-2845	124	2	infectious	infectious	ADJ
ajlm-2845	124	3	diseases	disease	NOUN
ajlm-2845	124	4	society	society	NOUN
ajlm-2845	124	5	of	of	ADP
ajlm-2845	124	6	america	america	PROPN
ajlm-2845	124	7	guidelines	guideline	NOUN
ajlm-2845	124	8	recommend	recommend	VERB
ajlm-2845	124	9	that	that	SCONJ
ajlm-2845	124	10	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2845	124	11	be	be	AUX
ajlm-2845	124	12	used	use	VERB
ajlm-2845	124	13	as	as	ADP
ajlm-2845	124	14	empiric	empiric	ADJ
ajlm-2845	124	15	therapy	therapy	NOUN
ajlm-2845	124	16	for	for	ADP
ajlm-2845	124	17	complicated	complicated	ADJ
ajlm-2845	124	18	utis	utis	NOUN
ajlm-2845	124	19	,	,	PUNCT
ajlm-2845	124	20	only	only	ADV
ajlm-2845	124	21	if	if	SCONJ
ajlm-2845	124	22	resistance	resistance	NOUN
ajlm-2845	124	23	rates	rate	NOUN
ajlm-2845	124	24	are	be	AUX
ajlm-2845	124	25	below	below	ADP
ajlm-2845	124	26	10%.16	10%.16	NUM
ajlm-2845	124	27	lewis	lewis	PROPN
ajlm-2845	124	28	et	et	PROPN
ajlm-2845	124	29	al	al	PROPN
ajlm-2845	124	30	.	.	PROPN
ajlm-2845	124	31	noted	note	VERB
ajlm-2845	124	32	that	that	SCONJ
ajlm-2845	124	33	cumulative	cumulative	ADJ
ajlm-2845	124	34	sensitivity	sensitivity	NOUN
ajlm-2845	124	35	to	to	ADP
ajlm-2845	124	36	fluoroquinolones	fluoroquinolone	NOUN
ajlm-2845	124	37	(	(	PUNCT
ajlm-2845	124	38	94.1	94.1	NUM
ajlm-2845	124	39	%	%	NOUN
ajlm-2845	124	40	)	)	PUNCT
ajlm-2845	124	41	had	have	AUX
ajlm-2845	124	42	been	be	AUX
ajlm-2845	124	43	maintained	maintain	VERB
ajlm-2845	124	44	;	;	PUNCT
ajlm-2845	124	45	however	however	ADV
ajlm-2845	124	46	,	,	PUNCT
ajlm-2845	124	47	naidoo	naidoo	PROPN
ajlm-2845	124	48	et	et	PROPN
ajlm-2845	124	49	al	al	PROPN
ajlm-2845	124	50	.	.	PROPN
ajlm-2845	124	51	published	publish	VERB
ajlm-2845	124	52	alarming	alarming	ADJ
ajlm-2845	124	53	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2845	124	54	sensitivity	sensitivity	NOUN
ajlm-2845	124	55	rates	rate	NOUN
ajlm-2845	124	56	,	,	PUNCT
ajlm-2845	124	57	with	with	ADP
ajlm-2845	124	58	only	only	ADV
ajlm-2845	124	59	62	62	NUM
ajlm-2845	124	60	%	%	NOUN
ajlm-2845	124	61	of	of	ADP
ajlm-2845	124	62	e.	e.	PROPN
ajlm-2845	124	63	coli	coli	PROPN
ajlm-2845	124	64	and	and	CCONJ
ajlm-2845	124	65	70	70	NUM
ajlm-2845	124	66	%	%	NOUN
ajlm-2845	124	67	of	of	ADP
ajlm-2845	124	68	klebsiella	klebsiella	PROPN
ajlm-2845	124	69	spp	spp	PROPN
ajlm-2845	124	70	.	.	PUNCT
ajlm-2845	124	71	found	find	VERB
ajlm-2845	124	72	to	to	PART
ajlm-2845	124	73	be	be	AUX
ajlm-2845	124	74	sensitive.12,13	sensitive.12,13	VERB
ajlm-2845	124	75	the	the	DET
ajlm-2845	124	76	authors	author	NOUN
ajlm-2845	124	77	highlighted	highlight	VERB
ajlm-2845	124	78	that	that	SCONJ
ajlm-2845	124	79	the	the	DET
ajlm-2845	124	80	reduced	reduced	ADJ
ajlm-2845	124	81	sensitivity	sensitivity	NOUN
ajlm-2845	124	82	would	would	AUX
ajlm-2845	124	83	lead	lead	VERB
ajlm-2845	124	84	to	to	ADP
ajlm-2845	124	85	high	high	ADJ
ajlm-2845	124	86	treatment	treatment	NOUN
ajlm-2845	124	87	failure	failure	NOUN
ajlm-2845	124	88	rates	rate	NOUN
ajlm-2845	124	89	with	with	ADP
ajlm-2845	124	90	empiric	empiric	ADJ
ajlm-2845	124	91	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2845	124	92	use.12	use.12	ADJ
ajlm-2845	124	93	another	another	DET
ajlm-2845	124	94	study	study	NOUN
ajlm-2845	124	95	conducted	conduct	VERB
ajlm-2845	124	96	at	at	ADP
ajlm-2845	124	97	3	3	NUM
ajlm-2845	124	98	military	military	ADJ
ajlm-2845	124	99	hospital	hospital	NOUN
ajlm-2845	124	100	(	(	PUNCT
ajlm-2845	124	101	bloemfontein	bloemfontein	PROPN
ajlm-2845	124	102	)	)	PUNCT
ajlm-2845	124	103	in	in	ADP
ajlm-2845	124	104	2011	2011	NUM
ajlm-2845	124	105	also	also	ADV
ajlm-2845	124	106	demonstrated	demonstrate	VERB
ajlm-2845	124	107	that	that	SCONJ
ajlm-2845	124	108	cultures	culture	NOUN
ajlm-2845	124	109	in	in	ADP
ajlm-2845	124	110	complicated	complicated	ADJ
ajlm-2845	124	111	utis	utis	NOUN
ajlm-2845	124	112	showed	show	VERB
ajlm-2845	124	113	a	a	DET
ajlm-2845	124	114	reduced	reduced	ADJ
ajlm-2845	124	115	sensitivity	sensitivity	NOUN
ajlm-2845	124	116	to	to	ADP
ajlm-2845	124	117	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	124	118	(	(	PUNCT
ajlm-2845	124	119	41%),17	41%),17	NOUN
ajlm-2845	124	120	and	and	CCONJ
ajlm-2845	124	121	the	the	DET
ajlm-2845	124	122	authors	author	NOUN
ajlm-2845	124	123	recommended	recommend	VERB
ajlm-2845	124	124	against	against	ADP
ajlm-2845	124	125	its	its	PRON
ajlm-2845	124	126	use	use	NOUN
ajlm-2845	124	127	at	at	ADP
ajlm-2845	124	128	that	that	PRON
ajlm-2845	124	129	hospital.17	hospital.17	PROPN
ajlm-2845	124	130	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	124	131	has	have	AUX
ajlm-2845	124	132	been	be	AUX
ajlm-2845	124	133	reported	report	VERB
ajlm-2845	124	134	to	to	PART
ajlm-2845	124	135	promote	promote	VERB
ajlm-2845	124	136	resistance	resistance	NOUN
ajlm-2845	124	137	through	through	ADP
ajlm-2845	124	138	horizontal	horizontal	ADJ
ajlm-2845	124	139	transmission	transmission	NOUN
ajlm-2845	124	140	of	of	ADP
ajlm-2845	124	141	resistance	resistance	NOUN
ajlm-2845	124	142	genes	gene	NOUN
ajlm-2845	124	143	.	.	PUNCT
ajlm-2845	125	1	contributing	contribute	VERB
ajlm-2845	125	2	collateral	collateral	ADJ
ajlm-2845	125	3	damage	damage	NOUN
ajlm-2845	125	4	with	with	ADP
ajlm-2845	125	5	higher	high	ADJ
ajlm-2845	125	6	resistance	resistance	NOUN
ajlm-2845	125	7	rates	rate	NOUN
ajlm-2845	125	8	in	in	ADP
ajlm-2845	125	9	other	other	ADJ
ajlm-2845	125	10	classes	class	NOUN
ajlm-2845	125	11	of	of	ADP
ajlm-2845	125	12	antimicrobials.17,18	antimicrobials.17,18	NOUN
ajlm-2845	125	13	emerging	emerge	VERB
ajlm-2845	125	14	resistance	resistance	NOUN
ajlm-2845	125	15	to	to	ADP
ajlm-2845	125	16	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	125	17	was	be	AUX
ajlm-2845	125	18	noted	note	VERB
ajlm-2845	125	19	in	in	ADP
ajlm-2845	125	20	four	four	NUM
ajlm-2845	125	21	of	of	ADP
ajlm-2845	125	22	the	the	DET
ajlm-2845	125	23	five	five	NUM
ajlm-2845	125	24	common	common	ADJ
ajlm-2845	125	25	pathogens	pathogen	NOUN
ajlm-2845	125	26	in	in	ADP
ajlm-2845	125	27	the	the	DET
ajlm-2845	125	28	current	current	ADJ
ajlm-2845	125	29	study	study	NOUN
ajlm-2845	125	30	,	,	PUNCT
ajlm-2845	125	31	specifically	specifically	ADV
ajlm-2845	125	32	e.	e.	PROPN
ajlm-2845	125	33	cloacae	cloacae	PROPN
ajlm-2845	125	34	(	(	PUNCT
ajlm-2845	125	35	79	79	NUM
ajlm-2845	125	36	%	%	NOUN
ajlm-2845	125	37	)	)	PUNCT
ajlm-2845	125	38	,	,	PUNCT
ajlm-2845	125	39	k.	k.	PROPN
ajlm-2845	126	1	pneumoniae	pneumoniae	ADJ
ajlm-2845	126	2	(	(	PUNCT
ajlm-2845	126	3	78	78	NUM
ajlm-2845	126	4	%	%	NOUN
ajlm-2845	126	5	)	)	PUNCT
ajlm-2845	126	6	,	,	PUNCT
ajlm-2845	126	7	e.	e.	PROPN
ajlm-2845	126	8	faecalis	faecalis	PROPN
ajlm-2845	126	9	(	(	PUNCT
ajlm-2845	126	10	77	77	NUM
ajlm-2845	126	11	%	%	NOUN
ajlm-2845	126	12	)	)	PUNCT
ajlm-2845	126	13	and	and	CCONJ
ajlm-2845	126	14	e.	e.	PROPN
ajlm-2845	126	15	coli	coli	PROPN
ajlm-2845	126	16	(	(	PUNCT
ajlm-2845	126	17	74	74	NUM
ajlm-2845	126	18	%	%	NOUN
ajlm-2845	126	19	)	)	PUNCT
ajlm-2845	126	20	,	,	PUNCT
ajlm-2845	126	21	with	with	ADP
ajlm-2845	126	22	p.	p.	PROPN
ajlm-2845	126	23	mirabilis	mirabilis	PROPN
ajlm-2845	126	24	remaining	remain	VERB
ajlm-2845	126	25	susceptible	susceptible	ADJ
ajlm-2845	126	26	,	,	PUNCT
ajlm-2845	126	27	at	at	ADP
ajlm-2845	126	28	92.5	92.5	NUM
ajlm-2845	126	29	%	%	NOUN
ajlm-2845	126	30	.	.	PUNCT
ajlm-2845	127	1	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	127	2	was	be	AUX
ajlm-2845	127	3	once	once	ADV
ajlm-2845	127	4	the	the	DET
ajlm-2845	127	5	preferred	preferred	ADJ
ajlm-2845	127	6	treatment	treatment	NOUN
ajlm-2845	127	7	for	for	ADP
ajlm-2845	127	8	utis	utis	NOUN
ajlm-2845	127	9	,	,	PUNCT
ajlm-2845	127	10	but	but	CCONJ
ajlm-2845	127	11	this	this	PRON
ajlm-2845	127	12	is	be	AUX
ajlm-2845	127	13	no	no	ADV
ajlm-2845	127	14	longer	long	ADV
ajlm-2845	127	15	the	the	DET
ajlm-2845	127	16	case	case	NOUN
ajlm-2845	127	17	in	in	ADP
ajlm-2845	127	18	our	our	PRON
ajlm-2845	127	19	setting	setting	NOUN
ajlm-2845	127	20	.	.	PUNCT
ajlm-2845	128	1	lewis	lewis	PROPN
ajlm-2845	128	2	et	et	PROPN
ajlm-2845	128	3	al	al	PROPN
ajlm-2845	128	4	.	.	PROPN
ajlm-2845	128	5	also	also	ADV
ajlm-2845	128	6	reported	report	VERB
ajlm-2845	128	7	reduced	reduce	VERB
ajlm-2845	128	8	cumulative	cumulative	ADJ
ajlm-2845	128	9	sensitivity	sensitivity	NOUN
ajlm-2845	128	10	rates	rate	NOUN
ajlm-2845	128	11	of	of	ADP
ajlm-2845	128	12	82.8	82.8	NUM
ajlm-2845	128	13	%	%	NOUN
ajlm-2845	128	14	to	to	ADP
ajlm-2845	128	15	amoxicillin	amoxicillin	NOUN
ajlm-2845	128	16	–	–	PUNCT
ajlm-2845	128	17	clavulanate	clavulanate	NOUN
ajlm-2845	128	18	in	in	ADP
ajlm-2845	128	19	2013,13	2013,13	PROPN
ajlm-2845	128	20	and	and	CCONJ
ajlm-2845	128	21	similarly	similarly	ADV
ajlm-2845	128	22	,	,	PUNCT
ajlm-2845	128	23	naidoo	naidoo	PROPN
ajlm-2845	128	24	et	et	PROPN
ajlm-2845	128	25	al	al	PROPN
ajlm-2845	128	26	.	.	PROPN
ajlm-2845	128	27	found	find	VERB
ajlm-2845	128	28	low	low	ADJ
ajlm-2845	128	29	sensitivity	sensitivity	NOUN
ajlm-2845	128	30	in	in	ADP
ajlm-2845	128	31	both	both	DET
ajlm-2845	128	32	k.	k.	NOUN
ajlm-2845	128	33	pneumoniae	pneumoniae	ADJ
ajlm-2845	128	34	(	(	PUNCT
ajlm-2845	128	35	58	58	NUM
ajlm-2845	128	36	%	%	NOUN
ajlm-2845	128	37	)	)	PUNCT
ajlm-2845	128	38	and	and	CCONJ
ajlm-2845	128	39	e.	e.	PROPN
ajlm-2845	128	40	coli	coli	PROPN
ajlm-2845	128	41	(	(	PUNCT
ajlm-2845	128	42	70%).12	70%).12	NUM
ajlm-2845	128	43	a	a	DET
ajlm-2845	128	44	high	high	ADJ
ajlm-2845	128	45	level	level	NOUN
ajlm-2845	128	46	of	of	ADP
ajlm-2845	128	47	resistance	resistance	NOUN
ajlm-2845	128	48	towards	towards	ADP
ajlm-2845	128	49	amoxicillin	amoxicillin	PROPN
ajlm-2845	128	50	clavulanate	clavulanate	NOUN
ajlm-2845	128	51	,	,	PUNCT
ajlm-2845	128	52	with	with	ADP
ajlm-2845	128	53	reduced	reduced	ADJ
ajlm-2845	128	54	cumulative	cumulative	ADJ
ajlm-2845	128	55	sensitivity	sensitivity	NOUN
ajlm-2845	128	56	of	of	ADP
ajlm-2845	128	57	72.3	72.3	NUM
ajlm-2845	128	58	%	%	NOUN
ajlm-2845	128	59	,	,	PUNCT
ajlm-2845	128	60	was	be	AUX
ajlm-2845	128	61	also	also	ADV
ajlm-2845	128	62	noted	note	VERB
ajlm-2845	128	63	in	in	ADP
ajlm-2845	128	64	our	our	PRON
ajlm-2845	128	65	study	study	NOUN
ajlm-2845	128	66	,	,	PUNCT
ajlm-2845	128	67	indicating	indicate	VERB
ajlm-2845	128	68	that	that	SCONJ
ajlm-2845	128	69	these	these	DET
ajlm-2845	128	70	agents	agent	NOUN
ajlm-2845	128	71	may	may	AUX
ajlm-2845	128	72	not	not	PART
ajlm-2845	128	73	be	be	AUX
ajlm-2845	128	74	effective	effective	ADJ
ajlm-2845	128	75	towards	towards	ADP
ajlm-2845	128	76	the	the	DET
ajlm-2845	128	77	two	two	NUM
ajlm-2845	128	78	most	most	ADV
ajlm-2845	128	79	prevalent	prevalent	ADJ
ajlm-2845	128	80	uropathogens	uropathogen	NOUN
ajlm-2845	128	81	,	,	PUNCT
ajlm-2845	128	82	namely	namely	ADV
ajlm-2845	128	83	e.	e.	PROPN
ajlm-2845	128	84	coli	coli	PROPN
ajlm-2845	128	85	and	and	CCONJ
ajlm-2845	128	86	k.	k.	NOUN
ajlm-2845	128	87	pneumoniae	pneumoniae	NOUN
ajlm-2845	128	88	.	.	PUNCT
ajlm-2845	129	1	whereas	whereas	SCONJ
ajlm-2845	129	2	lewis	lewis	PROPN
ajlm-2845	129	3	et	et	PROPN
ajlm-2845	129	4	al	al	PROPN
ajlm-2845	129	5	.	.	PROPN
ajlm-2845	129	6	reported	report	VERB
ajlm-2845	129	7	a	a	DET
ajlm-2845	129	8	high	high	ADJ
ajlm-2845	129	9	rate	rate	NOUN
ajlm-2845	129	10	of	of	ADP
ajlm-2845	129	11	sensitivity	sensitivity	NOUN
ajlm-2845	129	12	to	to	PART
ajlm-2845	129	13	cefuroxime	cefuroxime	VERB
ajlm-2845	129	14	(	(	PUNCT
ajlm-2845	129	15	93.4	93.4	NUM
ajlm-2845	129	16	%	%	NOUN
ajlm-2845	129	17	)	)	PUNCT
ajlm-2845	129	18	in	in	ADP
ajlm-2845	129	19	2013,13	2013,13	PROPN
ajlm-2845	129	20	naidoo	naidoo	PROPN
ajlm-2845	129	21	et	et	PROPN
ajlm-2845	129	22	al	al	PROPN
ajlm-2845	129	23	.	.	PROPN
ajlm-2845	129	24	showed	show	VERB
ajlm-2845	129	25	that	that	SCONJ
ajlm-2845	129	26	sensitivity	sensitivity	NOUN
ajlm-2845	129	27	to	to	ADP
ajlm-2845	129	28	third	third	ADJ
ajlm-2845	129	29	-	-	PUNCT
ajlm-2845	129	30	generation	generation	NOUN
ajlm-2845	129	31	cephalosporins	cephalosporin	NOUN
ajlm-2845	129	32	was	be	AUX
ajlm-2845	129	33	only	only	ADV
ajlm-2845	129	34	74	74	NUM
ajlm-2845	129	35	%	%	NOUN
ajlm-2845	129	36	in	in	ADP
ajlm-2845	129	37	e.	e.	PROPN
ajlm-2845	129	38	coli	coli	PROPN
ajlm-2845	129	39	,	,	PUNCT
ajlm-2845	129	40	and	and	CCONJ
ajlm-2845	129	41	58	58	NUM
ajlm-2845	129	42	%	%	NOUN
ajlm-2845	129	43	in	in	ADP
ajlm-2845	129	44	k.	k.	PROPN
ajlm-2845	129	45	pneumoniae	pneumoniae	PROPN
ajlm-2845	129	46	,	,	PUNCT
ajlm-2845	129	47	which	which	PRON
ajlm-2845	129	48	correlated	correlate	VERB
ajlm-2845	129	49	with	with	ADP
ajlm-2845	129	50	the	the	DET
ajlm-2845	129	51	reduced	reduce	VERB
ajlm-2845	129	52	sensitivities	sensitivity	NOUN
ajlm-2845	129	53	in	in	ADP
ajlm-2845	129	54	this	this	DET
ajlm-2845	129	55	study.12	study.12	NOUN
ajlm-2845	129	56	the	the	DET
ajlm-2845	129	57	inherent	inherent	ADJ
ajlm-2845	129	58	resistance	resistance	NOUN
ajlm-2845	129	59	to	to	ADP
ajlm-2845	129	60	cephalosporins	cephalosporin	NOUN
ajlm-2845	129	61	found	find	VERB
ajlm-2845	129	62	in	in	ADP
ajlm-2845	129	63	e.	e.	PROPN
ajlm-2845	129	64	faecalis	faecalis	PROPN
ajlm-2845	129	65	has	have	AUX
ajlm-2845	129	66	led	lead	VERB
ajlm-2845	129	67	the	the	DET
ajlm-2845	129	68	nhls	nhls	NOUN
ajlm-2845	129	69	to	to	PART
ajlm-2845	129	70	forgo	forgo	VERB
ajlm-2845	129	71	susceptibility	susceptibility	NOUN
ajlm-2845	129	72	testing	testing	NOUN
ajlm-2845	129	73	to	to	PART
ajlm-2845	129	74	cephalosporins.19	cephalosporins.19	VERB
ajlm-2845	129	75	enterobacter	enterobacter	ADJ
ajlm-2845	129	76	cloacae	cloacae	NOUN
ajlm-2845	129	77	has	have	AUX
ajlm-2845	129	78	been	be	AUX
ajlm-2845	129	79	reported	report	VERB
ajlm-2845	129	80	to	to	PART
ajlm-2845	129	81	be	be	AUX
ajlm-2845	129	82	intrinsically	intrinsically	ADV
ajlm-2845	129	83	resistant	resistant	ADJ
ajlm-2845	129	84	to	to	ADP
ajlm-2845	129	85	amoxicillin	amoxicillin	NOUN
ajlm-2845	129	86	–	–	PUNCT
ajlm-2845	129	87	clavulanate	clavulanate	NOUN
ajlm-2845	129	88	by	by	ADP
ajlm-2845	129	89	the	the	DET
ajlm-2845	129	90	clsi	clsi	NOUN
ajlm-2845	129	91	,	,	PUNCT
ajlm-2845	129	92	which	which	PRON
ajlm-2845	129	93	is	be	AUX
ajlm-2845	129	94	in	in	ADP
ajlm-2845	129	95	line	line	NOUN
ajlm-2845	129	96	with	with	ADP
ajlm-2845	129	97	our	our	PRON
ajlm-2845	129	98	study	study	NOUN
ajlm-2845	129	99	(	(	PUNCT
ajlm-2845	129	100	96.4%).14	96.4%).14	NUM
ajlm-2845	129	101	furthermore	furthermore	ADV
ajlm-2845	129	102	,	,	PUNCT
ajlm-2845	129	103	this	this	DET
ajlm-2845	129	104	organism	organism	NOUN
ajlm-2845	129	105	is	be	AUX
ajlm-2845	129	106	an	an	DET
ajlm-2845	129	107	ampc	ampc	NOUN
ajlm-2845	129	108	-	-	PUNCT
ajlm-2845	129	109	producer	producer	NOUN
ajlm-2845	129	110	and	and	CCONJ
ajlm-2845	129	111	is	be	AUX
ajlm-2845	129	112	therefore	therefore	ADV
ajlm-2845	129	113	at	at	ADP
ajlm-2845	129	114	high	high	ADJ
ajlm-2845	129	115	risk	risk	NOUN
ajlm-2845	129	116	of	of	ADP
ajlm-2845	129	117	developing	develop	VERB
ajlm-2845	129	118	ampc	ampc	ADJ
ajlm-2845	129	119	enzyme	enzyme	NOUN
ajlm-2845	129	120	overproduction	overproduction	NOUN
ajlm-2845	129	121	,	,	PUNCT
ajlm-2845	129	122	subsequently	subsequently	ADV
ajlm-2845	129	123	leading	lead	VERB
ajlm-2845	129	124	to	to	ADP
ajlm-2845	129	125	third	third	ADJ
ajlm-2845	129	126	-	-	PUNCT
ajlm-2845	129	127	generation	generation	NOUN
ajlm-2845	129	128	cephalosporin	cephalosporin	NOUN
ajlm-2845	129	129	resistance.14	resistance.14	PROPN
ajlm-2845	129	130	although	although	SCONJ
ajlm-2845	129	131	we	we	PRON
ajlm-2845	129	132	have	have	VERB
ajlm-2845	129	133	variable	variable	ADJ
ajlm-2845	129	134	sensitivities	sensitivity	NOUN
ajlm-2845	129	135	in	in	ADP
ajlm-2845	129	136	our	our	PRON
ajlm-2845	129	137	beta	beta	NOUN
ajlm-2845	129	138	-	-	PUNCT
ajlm-2845	129	139	lactams	lactam	NOUN
ajlm-2845	129	140	,	,	PUNCT
ajlm-2845	129	141	clsi	clsi	NOUN
ajlm-2845	129	142	recommend	recommend	VERB
ajlm-2845	129	143	against	against	ADP
ajlm-2845	129	144	the	the	DET
ajlm-2845	129	145	use	use	NOUN
ajlm-2845	129	146	of	of	ADP
ajlm-2845	129	147	third	third	ADJ
ajlm-2845	129	148	-	-	PUNCT
ajlm-2845	129	149	generation	generation	NOUN
ajlm-2845	129	150	cephalosporins	cephalosporin	NOUN
ajlm-2845	129	151	and	and	CCONJ
ajlm-2845	129	152	piperacillin	piperacillin	NOUN
ajlm-2845	129	153	–	–	PUNCT
ajlm-2845	129	154	tazobactam	tazobactam	NOUN
ajlm-2845	129	155	because	because	SCONJ
ajlm-2845	129	156	of	of	ADP
ajlm-2845	129	157	the	the	DET
ajlm-2845	129	158	risk	risk	NOUN
ajlm-2845	129	159	of	of	ADP
ajlm-2845	129	160	treatment	treatment	NOUN
ajlm-2845	129	161	failure.14	failure.14	PROPN
ajlm-2845	129	162	naidoo	naidoo	PROPN
ajlm-2845	129	163	et	et	PROPN
ajlm-2845	129	164	al	al	PROPN
ajlm-2845	129	165	.	.	PROPN
ajlm-2845	129	166	demonstrated	demonstrate	VERB
ajlm-2845	129	167	meropenem	meropenem	PROPN
ajlm-2845	129	168	sensitivities	sensitivity	NOUN
ajlm-2845	129	169	of	of	ADP
ajlm-2845	129	170	95	95	NUM
ajlm-2845	129	171	%	%	NOUN
ajlm-2845	129	172	for	for	ADP
ajlm-2845	129	173	k.	k.	NOUN
ajlm-2845	129	174	pneumonia	pneumonia	NOUN
ajlm-2845	129	175	and	and	CCONJ
ajlm-2845	129	176	100	100	NUM
ajlm-2845	129	177	%	%	NOUN
ajlm-2845	129	178	for	for	ADP
ajlm-2845	129	179	e.	e.	PROPN
ajlm-2845	129	180	coli.12	coli.12	PROPN
ajlm-2845	129	181	these	these	DET
ajlm-2845	129	182	findings	finding	NOUN
ajlm-2845	129	183	mirrored	mirror	VERB
ajlm-2845	129	184	the	the	DET
ajlm-2845	129	185	cumulative	cumulative	ADJ
ajlm-2845	129	186	sensitivity	sensitivity	NOUN
ajlm-2845	129	187	of	of	ADP
ajlm-2845	129	188	our	our	PRON
ajlm-2845	129	189	study	study	NOUN
ajlm-2845	129	190	,	,	PUNCT
ajlm-2845	129	191	of	of	ADP
ajlm-2845	129	192	94.1	94.1	NUM
ajlm-2845	129	193	%	%	NOUN
ajlm-2845	129	194	overall	overall	ADJ
ajlm-2845	129	195	.	.	PUNCT
ajlm-2845	130	1	similarly	similarly	ADV
ajlm-2845	130	2	,	,	PUNCT
ajlm-2845	130	3	the	the	DET
ajlm-2845	130	4	authors	author	NOUN
ajlm-2845	130	5	reported	report	VERB
ajlm-2845	130	6	the	the	DET
ajlm-2845	130	7	sensitivity	sensitivity	NOUN
ajlm-2845	130	8	to	to	ADP
ajlm-2845	130	9	piperacillin	piperacillin	VERB
ajlm-2845	130	10	–	–	PUNCT
ajlm-2845	130	11	tazobactam	tazobactam	NOUN
ajlm-2845	130	12	to	to	PART
ajlm-2845	130	13	be	be	AUX
ajlm-2845	130	14	76	76	NUM
ajlm-2845	130	15	%	%	NOUN
ajlm-2845	130	16	for	for	ADP
ajlm-2845	130	17	k.	k.	NOUN
ajlm-2845	130	18	pneumoniae	pneumoniae	NOUN
ajlm-2845	130	19	and	and	CCONJ
ajlm-2845	130	20	95	95	NUM
ajlm-2845	130	21	%	%	NOUN
ajlm-2845	130	22	for	for	ADP
ajlm-2845	130	23	e.	e.	PROPN
ajlm-2845	130	24	coli	coli	PROPN
ajlm-2845	130	25	,	,	PUNCT
ajlm-2845	130	26	which	which	PRON
ajlm-2845	130	27	is	be	AUX
ajlm-2845	130	28	consistent	consistent	ADJ
ajlm-2845	130	29	with	with	ADP
ajlm-2845	130	30	our	our	PRON
ajlm-2845	130	31	findings	finding	NOUN
ajlm-2845	130	32	of	of	ADP
ajlm-2845	130	33	76.5	76.5	NUM
ajlm-2845	130	34	%	%	NOUN
ajlm-2845	130	35	for	for	ADP
ajlm-2845	130	36	k.	k.	NOUN
ajlm-2845	130	37	pneumoniae	pneumoniae	NOUN
ajlm-2845	130	38	and	and	CCONJ
ajlm-2845	130	39	89.4	89.4	NUM
ajlm-2845	130	40	%	%	NOUN
ajlm-2845	130	41	for	for	ADP
ajlm-2845	130	42	e.	e.	PROPN
ajlm-2845	130	43	coli.12	coli.12	PROPN
ajlm-2845	130	44	there	there	PRON
ajlm-2845	130	45	was	be	VERB
ajlm-2845	130	46	a	a	DET
ajlm-2845	130	47	reduced	reduce	VERB
ajlm-2845	130	48	cumulative	cumulative	ADJ
ajlm-2845	130	49	sensitivity	sensitivity	NOUN
ajlm-2845	130	50	to	to	PART
ajlm-2845	130	51	trimethoprim	trimethoprim	VERB
ajlm-2845	130	52	–	–	PUNCT
ajlm-2845	130	53	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-2845	130	54	at	at	ADP
ajlm-2845	130	55	42.8	42.8	NUM
ajlm-2845	130	56	%	%	NOUN
ajlm-2845	130	57	.	.	PUNCT
ajlm-2845	131	1	these	these	DET
ajlm-2845	131	2	figures	figure	NOUN
ajlm-2845	131	3	were	be	AUX
ajlm-2845	131	4	mirrored	mirror	VERB
ajlm-2845	131	5	by	by	ADP
ajlm-2845	131	6	lewis	lewis	PROPN
ajlm-2845	131	7	et	et	PROPN
ajlm-2845	131	8	al	al	PROPN
ajlm-2845	131	9	.	.	PROPN
ajlm-2845	131	10	,	,	PUNCT
ajlm-2845	131	11	with	with	ADP
ajlm-2845	131	12	a	a	DET
ajlm-2845	131	13	cumulative	cumulative	ADJ
ajlm-2845	131	14	sensitivity	sensitivity	NOUN
ajlm-2845	131	15	of	of	ADP
ajlm-2845	131	16	44.3	44.3	NUM
ajlm-2845	131	17	%	%	NOUN
ajlm-2845	131	18	,	,	PUNCT
ajlm-2845	131	19	and	and	CCONJ
ajlm-2845	131	20	naidoo	naidoo	PROPN
ajlm-2845	131	21	et	et	PROPN
ajlm-2845	131	22	al	al	PROPN
ajlm-2845	131	23	.	.	PROPN
ajlm-2845	131	24	,	,	PUNCT
ajlm-2845	131	25	with	with	ADP
ajlm-2845	131	26	39	39	NUM
ajlm-2845	131	27	%	%	NOUN
ajlm-2845	131	28	e.	e.	PROPN
ajlm-2845	131	29	coli	coli	PROPN
ajlm-2845	131	30	and	and	CCONJ
ajlm-2845	131	31	52	52	NUM
ajlm-2845	131	32	%	%	NOUN
ajlm-2845	131	33	k.	k.	PROPN
ajlm-2845	132	1	pneumoniae	pneumoniae	PROPN
ajlm-2845	132	2	susceptibility.12,13	susceptibility.12,13	VERB
ajlm-2845	132	3	the	the	DET
ajlm-2845	132	4	infectious	infectious	ADJ
ajlm-2845	132	5	diseases	disease	NOUN
ajlm-2845	132	6	society	society	NOUN
ajlm-2845	132	7	of	of	ADP
ajlm-2845	132	8	america	america	PROPN
ajlm-2845	132	9	guidelines	guideline	NOUN
ajlm-2845	132	10	recommend	recommend	VERB
ajlm-2845	132	11	the	the	DET
ajlm-2845	132	12	use	use	NOUN
ajlm-2845	132	13	of	of	ADP
ajlm-2845	132	14	trimethoprim	trimethoprim	ADJ
ajlm-2845	132	15	–	–	PUNCT
ajlm-2845	132	16	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-2845	132	17	for	for	ADP
ajlm-2845	132	18	empiric	empiric	ADJ
ajlm-2845	132	19	therapy	therapy	NOUN
ajlm-2845	132	20	for	for	ADP
ajlm-2845	132	21	uncomplicated	uncomplicated	ADJ
ajlm-2845	132	22	utis	utis	NOUN
ajlm-2845	132	23	only	only	ADV
ajlm-2845	132	24	if	if	SCONJ
ajlm-2845	132	25	local	local	ADJ
ajlm-2845	132	26	uropathogen	uropathogen	NOUN
ajlm-2845	132	27	resistance	resistance	NOUN
ajlm-2845	132	28	rates	rate	NOUN
ajlm-2845	132	29	do	do	AUX
ajlm-2845	132	30	not	not	PART
ajlm-2845	132	31	exceed	exceed	VERB
ajlm-2845	132	32	20%.16	20%.16	NUM
ajlm-2845	132	33	in	in	ADP
ajlm-2845	132	34	our	our	PRON
ajlm-2845	132	35	setting	setting	NOUN
ajlm-2845	132	36	,	,	PUNCT
ajlm-2845	132	37	and	and	CCONJ
ajlm-2845	132	38	considering	consider	VERB
ajlm-2845	132	39	sensitivities	sensitivity	NOUN
ajlm-2845	132	40	from	from	ADP
ajlm-2845	132	41	other	other	ADJ
ajlm-2845	132	42	local	local	ADJ
ajlm-2845	132	43	studies	study	NOUN
ajlm-2845	132	44	,	,	PUNCT
ajlm-2845	132	45	trimethoprim	trimethoprim	ADJ
ajlm-2845	132	46	–	–	PUNCT
ajlm-2845	132	47	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-2845	132	48	would	would	AUX
ajlm-2845	132	49	unlikely	unlikely	ADV
ajlm-2845	132	50	be	be	AUX
ajlm-2845	132	51	suitable	suitable	ADJ
ajlm-2845	132	52	as	as	SCONJ
ajlm-2845	132	53	an	an	DET
ajlm-2845	132	54	empiric	empiric	ADJ
ajlm-2845	132	55	agent.12,15,17	agent.12,15,17	ADJ
ajlm-2845	132	56	fosfomycin	fosfomycin	PROPN
ajlm-2845	132	57	susceptibility	susceptibility	NOUN
ajlm-2845	132	58	testing	testing	NOUN
ajlm-2845	132	59	is	be	AUX
ajlm-2845	132	60	not	not	PART
ajlm-2845	132	61	routinely	routinely	ADV
ajlm-2845	132	62	performed	perform	VERB
ajlm-2845	132	63	by	by	ADP
ajlm-2845	132	64	nhls	nhls	PROPN
ajlm-2845	132	65	north	north	PROPN
ajlm-2845	132	66	west	west	PROPN
ajlm-2845	132	67	,	,	PUNCT
ajlm-2845	132	68	and	and	CCONJ
ajlm-2845	132	69	thus	thus	ADV
ajlm-2845	132	70	no	no	DET
ajlm-2845	132	71	analysis	analysis	NOUN
ajlm-2845	132	72	was	be	AUX
ajlm-2845	132	73	performed	perform	VERB
ajlm-2845	132	74	.	.	PUNCT
ajlm-2845	133	1	future	future	ADJ
ajlm-2845	133	2	therapies	therapy	NOUN
ajlm-2845	133	3	include	include	VERB
ajlm-2845	133	4	the	the	DET
ajlm-2845	133	5	possibility	possibility	NOUN
ajlm-2845	133	6	of	of	ADP
ajlm-2845	133	7	using	use	VERB
ajlm-2845	133	8	vaccines	vaccine	NOUN
ajlm-2845	133	9	to	to	PART
ajlm-2845	133	10	prevent	prevent	VERB
ajlm-2845	133	11	recurrent	recurrent	ADJ
ajlm-2845	133	12	utis	utis	NOUN
ajlm-2845	133	13	.	.	PUNCT
ajlm-2845	134	1	a	a	DET
ajlm-2845	134	2	meta	meta	ADJ
ajlm-2845	134	3	-	-	PUNCT
ajlm-2845	134	4	analysis	analysis	NOUN
ajlm-2845	134	5	by	by	ADP
ajlm-2845	134	6	mak	mak	PROPN
ajlm-2845	134	7	et	et	PROPN
ajlm-2845	134	8	al	al	PROPN
ajlm-2845	134	9	.	.	PROPN
ajlm-2845	135	1	in	in	ADP
ajlm-2845	135	2	2024	2024	NUM
ajlm-2845	135	3	,	,	PUNCT
ajlm-2845	135	4	showed	show	VERB
ajlm-2845	135	5	limited	limited	ADJ
ajlm-2845	135	6	evidence	evidence	NOUN
ajlm-2845	135	7	for	for	ADP
ajlm-2845	135	8	this	this	DET
ajlm-2845	135	9	approach	approach	NOUN
ajlm-2845	135	10	,	,	PUNCT
ajlm-2845	135	11	but	but	CCONJ
ajlm-2845	135	12	that	that	SCONJ
ajlm-2845	135	13	more	more	ADV
ajlm-2845	135	14	rigorous	rigorous	ADJ
ajlm-2845	135	15	research	research	NOUN
ajlm-2845	135	16	is	be	AUX
ajlm-2845	135	17	needed	need	VERB
ajlm-2845	135	18	in	in	ADP
ajlm-2845	135	19	order	order	NOUN
ajlm-2845	135	20	to	to	PART
ajlm-2845	135	21	determine	determine	VERB
ajlm-2845	135	22	the	the	DET
ajlm-2845	135	23	value	value	NOUN
ajlm-2845	135	24	of	of	ADP
ajlm-2845	135	25	vaccines	vaccine	NOUN
ajlm-2845	135	26	and	and	CCONJ
ajlm-2845	135	27	oral	oral	ADJ
ajlm-2845	135	28	bacterial	bacterial	ADJ
ajlm-2845	135	29	lysates	lysate	NOUN
ajlm-2845	135	30	immunostimulants	immunostimulant	NOUN
ajlm-2845	135	31	as	as	ADP
ajlm-2845	135	32	an	an	DET
ajlm-2845	135	33	option	option	NOUN
ajlm-2845	135	34	for	for	ADP
ajlm-2845	135	35	prophylactic	prophylactic	ADJ
ajlm-2845	135	36	treatment.20	treatment.20	NOUN
ajlm-2845	135	37	we	we	PRON
ajlm-2845	135	38	recommend	recommend	VERB
ajlm-2845	135	39	that	that	SCONJ
ajlm-2845	135	40	e.	e.	PROPN
ajlm-2845	135	41	coli	coli	PROPN
ajlm-2845	135	42	be	be	AUX
ajlm-2845	135	43	considered	consider	VERB
ajlm-2845	135	44	as	as	ADP
ajlm-2845	135	45	the	the	DET
ajlm-2845	135	46	culprit	culprit	PROPN
ajlm-2845	135	47	pathogen	pathogen	NOUN
ajlm-2845	135	48	in	in	ADP
ajlm-2845	135	49	both	both	CCONJ
ajlm-2845	135	50	in	in	ADP
ajlm-2845	135	51	-	-	PUNCT
ajlm-2845	135	52	and	and	CCONJ
ajlm-2845	135	53	outpatient	outpatient	NOUN
ajlm-2845	135	54	utis	utis	NOUN
ajlm-2845	135	55	and	and	CCONJ
ajlm-2845	135	56	,	,	PUNCT
ajlm-2845	135	57	in	in	ADP
ajlm-2845	135	58	compliance	compliance	NOUN
ajlm-2845	135	59	with	with	ADP
ajlm-2845	135	60	most	most	ADJ
ajlm-2845	135	61	international	international	ADJ
ajlm-2845	135	62	guidelines	guideline	NOUN
ajlm-2845	135	63	,	,	PUNCT
ajlm-2845	135	64	nitrofurantoin	nitrofurantoin	PROPN
ajlm-2845	135	65	should	should	AUX
ajlm-2845	135	66	be	be	AUX
ajlm-2845	135	67	used	use	VERB
ajlm-2845	135	68	as	as	ADP
ajlm-2845	135	69	first	first	ADJ
ajlm-2845	135	70	-	-	PUNCT
ajlm-2845	135	71	line	line	NOUN
ajlm-2845	135	72	agent	agent	NOUN
ajlm-2845	135	73	.	.	PUNCT
ajlm-2845	136	1	this	this	PRON
ajlm-2845	136	2	does	do	AUX
ajlm-2845	136	3	not	not	PART
ajlm-2845	136	4	negate	negate	VERB
ajlm-2845	136	5	the	the	DET
ajlm-2845	136	6	need	need	NOUN
ajlm-2845	136	7	for	for	ADP
ajlm-2845	136	8	culture	culture	NOUN
ajlm-2845	136	9	and	and	CCONJ
ajlm-2845	136	10	sensitivity	sensitivity	NOUN
ajlm-2845	136	11	to	to	PART
ajlm-2845	136	12	be	be	AUX
ajlm-2845	136	13	performed	perform	VERB
ajlm-2845	136	14	,	,	PUNCT
ajlm-2845	136	15	as	as	ADV
ajlm-2845	136	16	well	well	ADV
ajlm-2845	136	17	as	as	ADP
ajlm-2845	136	18	de	de	NOUN
ajlm-2845	136	19	-	-	NOUN
ajlm-2845	136	20	escalation	escalation	NOUN
ajlm-2845	136	21	or	or	CCONJ
ajlm-2845	136	22	escalation	escalation	NOUN
ajlm-2845	136	23	of	of	ADP
ajlm-2845	136	24	therapy	therapy	NOUN
ajlm-2845	136	25	,	,	PUNCT
ajlm-2845	136	26	as	as	SCONJ
ajlm-2845	136	27	needed	need	VERB
ajlm-2845	136	28	.	.	PUNCT
ajlm-2845	137	1	if	if	SCONJ
ajlm-2845	137	2	parenteral	parenteral	ADJ
ajlm-2845	137	3	therapy	therapy	NOUN
ajlm-2845	137	4	is	be	AUX
ajlm-2845	137	5	necessary	necessary	ADJ
ajlm-2845	137	6	,	,	PUNCT
ajlm-2845	137	7	most	most	ADJ
ajlm-2845	137	8	organisms	organism	NOUN
ajlm-2845	137	9	remain	remain	VERB
ajlm-2845	137	10	susceptible	susceptible	ADJ
ajlm-2845	137	11	to	to	ADP
ajlm-2845	137	12	gentamicin	gentamicin	NOUN
ajlm-2845	137	13	,	,	PUNCT
ajlm-2845	137	14	and	and	CCONJ
ajlm-2845	137	15	although	although	SCONJ
ajlm-2845	137	16	we	we	PRON
ajlm-2845	137	17	do	do	AUX
ajlm-2845	137	18	not	not	PART
ajlm-2845	137	19	have	have	VERB
ajlm-2845	137	20	data	datum	NOUN
ajlm-2845	137	21	for	for	ADP
ajlm-2845	137	22	fosfomycin	fosfomycin	PROPN
ajlm-2845	137	23	at	at	ADP
ajlm-2845	137	24	potchefstroom	potchefstroom	NOUN
ajlm-2845	137	25	hospital	hospital	NOUN
ajlm-2845	137	26	,	,	PUNCT
ajlm-2845	137	27	other	other	ADJ
ajlm-2845	137	28	local	local	ADJ
ajlm-2845	137	29	data	datum	NOUN
ajlm-2845	137	30	support	support	VERB
ajlm-2845	137	31	its	its	PRON
ajlm-2845	137	32	use	use	NOUN
ajlm-2845	137	33	for	for	ADP
ajlm-2845	137	34	empiric	empiric	ADJ
ajlm-2845	137	35	therapy	therapy	NOUN
ajlm-2845	137	36	.	.	PUNCT
ajlm-2845	138	1	limitations	limitation	NOUN
ajlm-2845	138	2	this	this	DET
ajlm-2845	138	3	study	study	NOUN
ajlm-2845	138	4	was	be	AUX
ajlm-2845	138	5	a	a	DET
ajlm-2845	138	6	retrospective	retrospective	ADJ
ajlm-2845	138	7	analysis	analysis	NOUN
ajlm-2845	138	8	and	and	CCONJ
ajlm-2845	138	9	some	some	PRON
ajlm-2845	138	10	of	of	ADP
ajlm-2845	138	11	the	the	DET
ajlm-2845	138	12	samples	sample	NOUN
ajlm-2845	138	13	were	be	AUX
ajlm-2845	138	14	processed	process	VERB
ajlm-2845	138	15	at	at	ADP
ajlm-2845	138	16	various	various	ADJ
ajlm-2845	138	17	sites	site	NOUN
ajlm-2845	138	18	which	which	PRON
ajlm-2845	138	19	could	could	AUX
ajlm-2845	138	20	have	have	AUX
ajlm-2845	138	21	affected	affect	VERB
ajlm-2845	138	22	the	the	DET
ajlm-2845	138	23	results	result	NOUN
ajlm-2845	138	24	.	.	PUNCT
ajlm-2845	139	1	while	while	SCONJ
ajlm-2845	139	2	the	the	DET
ajlm-2845	139	3	study	study	NOUN
ajlm-2845	139	4	has	have	VERB
ajlm-2845	139	5	a	a	DET
ajlm-2845	139	6	significant	significant	ADJ
ajlm-2845	139	7	sample	sample	NOUN
ajlm-2845	139	8	size	size	NOUN
ajlm-2845	139	9	,	,	PUNCT
ajlm-2845	139	10	the	the	DET
ajlm-2845	139	11	data	datum	NOUN
ajlm-2845	139	12	was	be	AUX
ajlm-2845	139	13	collected	collect	VERB
ajlm-2845	139	14	from	from	ADP
ajlm-2845	139	15	a	a	DET
ajlm-2845	139	16	single	single	ADJ
ajlm-2845	139	17	site	site	NOUN
ajlm-2845	139	18	and	and	CCONJ
ajlm-2845	139	19	is	be	AUX
ajlm-2845	139	20	only	only	ADV
ajlm-2845	139	21	truly	truly	ADV
ajlm-2845	139	22	descriptive	descriptive	ADJ
ajlm-2845	139	23	of	of	ADP
ajlm-2845	139	24	the	the	DET
ajlm-2845	139	25	microbiome	microbiome	NOUN
ajlm-2845	139	26	at	at	ADP
ajlm-2845	139	27	potchefstroom	potchefstroom	NOUN
ajlm-2845	139	28	hospital	hospital	NOUN
ajlm-2845	139	29	,	,	PUNCT
ajlm-2845	139	30	and	and	CCONJ
ajlm-2845	139	31	these	these	DET
ajlm-2845	139	32	findings	finding	NOUN
ajlm-2845	139	33	may	may	AUX
ajlm-2845	139	34	not	not	PART
ajlm-2845	139	35	be	be	AUX
ajlm-2845	139	36	generalisable	generalisable	ADJ
ajlm-2845	139	37	to	to	ADP
ajlm-2845	139	38	other	other	ADJ
ajlm-2845	139	39	institutions	institution	NOUN
ajlm-2845	139	40	or	or	CCONJ
ajlm-2845	139	41	to	to	ADP
ajlm-2845	139	42	the	the	DET
ajlm-2845	139	43	broader	broad	ADJ
ajlm-2845	139	44	population	population	NOUN
ajlm-2845	139	45	.	.	PUNCT
ajlm-2845	140	1	similarly	similarly	ADV
ajlm-2845	140	2	,	,	PUNCT
ajlm-2845	140	3	data	datum	NOUN
ajlm-2845	140	4	were	be	AUX
ajlm-2845	140	5	collected	collect	VERB
ajlm-2845	140	6	from	from	ADP
ajlm-2845	140	7	patients	patient	NOUN
ajlm-2845	140	8	and	and	CCONJ
ajlm-2845	140	9	samples	sample	NOUN
ajlm-2845	140	10	at	at	ADP
ajlm-2845	140	11	a	a	DET
ajlm-2845	140	12	regional	regional	ADJ
ajlm-2845	140	13	hospital	hospital	NOUN
ajlm-2845	140	14	and	and	CCONJ
ajlm-2845	140	15	,	,	PUNCT
ajlm-2845	140	16	therefore	therefore	ADV
ajlm-2845	140	17	,	,	PUNCT
ajlm-2845	140	18	may	may	AUX
ajlm-2845	140	19	not	not	PART
ajlm-2845	140	20	be	be	AUX
ajlm-2845	140	21	fully	fully	ADV
ajlm-2845	140	22	representative	representative	ADJ
ajlm-2845	140	23	of	of	ADP
ajlm-2845	140	24	the	the	DET
ajlm-2845	140	25	type	type	NOUN
ajlm-2845	140	26	of	of	ADP
ajlm-2845	140	27	infections	infection	NOUN
ajlm-2845	140	28	that	that	PRON
ajlm-2845	140	29	would	would	AUX
ajlm-2845	140	30	be	be	AUX
ajlm-2845	140	31	encountered	encounter	VERB
ajlm-2845	140	32	in	in	ADP
ajlm-2845	140	33	the	the	DET
ajlm-2845	140	34	primary	primary	ADJ
ajlm-2845	140	35	healthcare	healthcare	NOUN
ajlm-2845	140	36	setting	setting	NOUN
ajlm-2845	140	37	.	.	PUNCT
ajlm-2845	141	1	furthermore	furthermore	ADV
ajlm-2845	141	2	,	,	PUNCT
ajlm-2845	141	3	carbapenemase	carbapenemase	NOUN
ajlm-2845	141	4	-	-	PUNCT
ajlm-2845	141	5	resistant	resistant	ADJ
ajlm-2845	141	6	enterobacterales	enterobacterale	NOUN
ajlm-2845	141	7	and	and	CCONJ
ajlm-2845	141	8	extended	extend	VERB
ajlm-2845	141	9	spectrum	spectrum	NOUN
ajlm-2845	141	10	beta	beta	NOUN
ajlm-2845	141	11	-	-	PUNCT
ajlm-2845	141	12	lactamase	lactamase	NOUN
ajlm-2845	141	13	organisms	organism	NOUN
ajlm-2845	141	14	were	be	AUX
ajlm-2845	141	15	not	not	PART
ajlm-2845	141	16	analysed	analyse	VERB
ajlm-2845	141	17	,	,	PUNCT
ajlm-2845	141	18	as	as	SCONJ
ajlm-2845	141	19	it	it	PRON
ajlm-2845	141	20	was	be	AUX
ajlm-2845	141	21	beyond	beyond	ADP
ajlm-2845	141	22	the	the	DET
ajlm-2845	141	23	scope	scope	NOUN
ajlm-2845	141	24	of	of	ADP
ajlm-2845	141	25	our	our	PRON
ajlm-2845	141	26	article	article	NOUN
ajlm-2845	141	27	.	.	PUNCT
ajlm-2845	142	1	further	further	ADJ
ajlm-2845	142	2	research	research	NOUN
ajlm-2845	142	3	is	be	AUX
ajlm-2845	142	4	recommended	recommend	VERB
ajlm-2845	142	5	to	to	PART
ajlm-2845	142	6	evaluate	evaluate	VERB
ajlm-2845	142	7	the	the	DET
ajlm-2845	142	8	prevalence	prevalence	NOUN
ajlm-2845	142	9	and	and	CCONJ
ajlm-2845	142	10	morbidity	morbidity	NOUN
ajlm-2845	142	11	of	of	ADP
ajlm-2845	142	12	these	these	DET
ajlm-2845	142	13	organisms	organism	NOUN
ajlm-2845	142	14	.	.	PUNCT
ajlm-2845	143	1	being	be	AUX
ajlm-2845	143	2	a	a	DET
ajlm-2845	143	3	laboratory	laboratory	NOUN
ajlm-2845	143	4	-	-	PUNCT
ajlm-2845	143	5	based	base	VERB
ajlm-2845	143	6	study	study	NOUN
ajlm-2845	143	7	,	,	PUNCT
ajlm-2845	143	8	demographic	demographic	ADJ
ajlm-2845	143	9	and	and	CCONJ
ajlm-2845	143	10	clinical	clinical	ADJ
ajlm-2845	143	11	data	datum	NOUN
ajlm-2845	143	12	were	be	AUX
ajlm-2845	143	13	not	not	PART
ajlm-2845	143	14	collated	collate	VERB
ajlm-2845	143	15	and	and	CCONJ
ajlm-2845	143	16	as	as	ADP
ajlm-2845	143	17	such	such	ADJ
ajlm-2845	143	18	,	,	PUNCT
ajlm-2845	143	19	we	we	PRON
ajlm-2845	143	20	can	can	AUX
ajlm-2845	143	21	not	not	PART
ajlm-2845	143	22	make	make	VERB
ajlm-2845	143	23	recommendations	recommendation	NOUN
ajlm-2845	143	24	with	with	ADP
ajlm-2845	143	25	regard	regard	NOUN
ajlm-2845	143	26	to	to	ADP
ajlm-2845	143	27	tailoring	tailoring	NOUN
ajlm-2845	143	28	of	of	ADP
ajlm-2845	143	29	antimicrobial	antimicrobial	ADJ
ajlm-2845	143	30	therapy	therapy	NOUN
ajlm-2845	143	31	to	to	ADP
ajlm-2845	143	32	specific	specific	ADJ
ajlm-2845	143	33	clinical	clinical	ADJ
ajlm-2845	143	34	scenarios	scenario	NOUN
ajlm-2845	143	35	.	.	PUNCT
ajlm-2845	144	1	in	in	ADP
ajlm-2845	144	2	addition	addition	NOUN
ajlm-2845	144	3	,	,	PUNCT
ajlm-2845	144	4	it	it	PRON
ajlm-2845	144	5	was	be	AUX
ajlm-2845	144	6	not	not	PART
ajlm-2845	144	7	possible	possible	ADJ
ajlm-2845	144	8	to	to	PART
ajlm-2845	144	9	differentiate	differentiate	VERB
ajlm-2845	144	10	between	between	ADP
ajlm-2845	144	11	organism	organism	NOUN
ajlm-2845	144	12	colonisation	colonisation	NOUN
ajlm-2845	144	13	or	or	CCONJ
ajlm-2845	144	14	contamination	contamination	NOUN
ajlm-2845	144	15	,	,	PUNCT
ajlm-2845	144	16	asymptomatic	asymptomatic	ADJ
ajlm-2845	144	17	bacteriuria	bacteriuria	NOUN
ajlm-2845	144	18	,	,	PUNCT
ajlm-2845	144	19	and	and	CCONJ
ajlm-2845	144	20	true	true	ADJ
ajlm-2845	144	21	infection	infection	NOUN
ajlm-2845	144	22	,	,	PUNCT
ajlm-2845	144	23	and	and	CCONJ
ajlm-2845	144	24	whether	whether	SCONJ
ajlm-2845	144	25	they	they	PRON
ajlm-2845	144	26	were	be	AUX
ajlm-2845	144	27	communityor	communityor	NOUN
ajlm-2845	144	28	hospital	hospital	NOUN
ajlm-2845	144	29	-	-	PUNCT
ajlm-2845	144	30	acquired	acquire	VERB
ajlm-2845	144	31	isolates	isolate	NOUN
ajlm-2845	144	32	.	.	PUNCT
ajlm-2845	145	1	conclusion	conclusion	NOUN
ajlm-2845	145	2	in	in	ADP
ajlm-2845	145	3	this	this	DET
ajlm-2845	145	4	study	study	NOUN
ajlm-2845	145	5	,	,	PUNCT
ajlm-2845	145	6	we	we	PRON
ajlm-2845	145	7	have	have	AUX
ajlm-2845	145	8	determined	determine	VERB
ajlm-2845	145	9	the	the	DET
ajlm-2845	145	10	prevalence	prevalence	NOUN
ajlm-2845	145	11	of	of	ADP
ajlm-2845	145	12	the	the	DET
ajlm-2845	145	13	most	most	ADV
ajlm-2845	145	14	common	common	ADJ
ajlm-2845	145	15	uropathogens	uropathogen	NOUN
ajlm-2845	145	16	isolated	isolate	VERB
ajlm-2845	145	17	from	from	ADP
ajlm-2845	145	18	samples	sample	NOUN
ajlm-2845	145	19	submitted	submit	VERB
ajlm-2845	145	20	to	to	PART
ajlm-2845	145	21	potchefstroom	potchefstroom	VERB
ajlm-2845	145	22	hospital	hospital	NOUN
ajlm-2845	145	23	.	.	PUNCT
ajlm-2845	146	1	escherichia	escherichia	NOUN
ajlm-2845	146	2	coli	coli	NOUN
ajlm-2845	146	3	remains	remain	VERB
ajlm-2845	146	4	the	the	DET
ajlm-2845	146	5	most	most	ADV
ajlm-2845	146	6	prevalent	prevalent	ADJ
ajlm-2845	146	7	uropathogen	uropathogen	NOUN
ajlm-2845	146	8	;	;	PUNCT
ajlm-2845	146	9	however	however	ADV
ajlm-2845	146	10	,	,	PUNCT
ajlm-2845	146	11	our	our	PRON
ajlm-2845	146	12	findings	finding	NOUN
ajlm-2845	146	13	show	show	VERB
ajlm-2845	146	14	that	that	SCONJ
ajlm-2845	146	15	e.	e.	PROPN
ajlm-2845	146	16	coli	coli	PROPN
ajlm-2845	146	17	and	and	CCONJ
ajlm-2845	146	18	most	most	ADJ
ajlm-2845	146	19	other	other	ADJ
ajlm-2845	146	20	organisms	organism	NOUN
ajlm-2845	146	21	isolated	isolate	VERB
ajlm-2845	146	22	from	from	ADP
ajlm-2845	146	23	urine	urine	NOUN
ajlm-2845	146	24	samples	sample	NOUN
ajlm-2845	146	25	at	at	ADP
ajlm-2845	146	26	potchefstroom	potchefstroom	NOUN
ajlm-2845	146	27	hospital	hospital	NOUN
ajlm-2845	146	28	were	be	AUX
ajlm-2845	146	29	not	not	PART
ajlm-2845	146	30	susceptible	susceptible	ADJ
ajlm-2845	146	31	to	to	ADP
ajlm-2845	146	32	the	the	DET
ajlm-2845	146	33	first	first	ADJ
ajlm-2845	146	34	-	-	PUNCT
ajlm-2845	146	35	line	line	NOUN
ajlm-2845	146	36	antimicrobial	antimicrobial	ADJ
ajlm-2845	146	37	agents	agent	NOUN
ajlm-2845	146	38	as	as	SCONJ
ajlm-2845	146	39	suggested	suggest	VERB
ajlm-2845	146	40	by	by	ADP
ajlm-2845	146	41	the	the	DET
ajlm-2845	146	42	neml	neml	PROPN
ajlm-2845	146	43	.	.	PUNCT
ajlm-2845	147	1	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2845	147	2	is	be	AUX
ajlm-2845	147	3	not	not	PART
ajlm-2845	147	4	recommended	recommend	VERB
ajlm-2845	147	5	as	as	ADP
ajlm-2845	147	6	the	the	DET
ajlm-2845	147	7	first	first	ADJ
ajlm-2845	147	8	-	-	PUNCT
ajlm-2845	147	9	line	line	NOUN
ajlm-2845	147	10	agent	agent	NOUN
ajlm-2845	147	11	for	for	ADP
ajlm-2845	147	12	any	any	DET
ajlm-2845	147	13	uti	uti	PROPN
ajlm-2845	147	14	at	at	ADP
ajlm-2845	147	15	potchefstroom	potchefstroom	NOUN
ajlm-2845	147	16	hospital	hospital	NOUN
ajlm-2845	147	17	,	,	PUNCT
ajlm-2845	147	18	unless	unless	SCONJ
ajlm-2845	147	19	susceptibility	susceptibility	NOUN
ajlm-2845	147	20	is	be	AUX
ajlm-2845	147	21	proven	prove	VERB
ajlm-2845	147	22	.	.	PUNCT
ajlm-2845	148	1	this	this	DET
ajlm-2845	148	2	study	study	NOUN
ajlm-2845	148	3	also	also	ADV
ajlm-2845	148	4	provides	provide	VERB
ajlm-2845	148	5	some	some	DET
ajlm-2845	148	6	recommendations	recommendation	NOUN
ajlm-2845	148	7	for	for	ADP
ajlm-2845	148	8	secondand	secondand	NOUN
ajlm-2845	148	9	third	third	ADJ
ajlm-2845	148	10	-	-	PUNCT
ajlm-2845	148	11	line	line	NOUN
ajlm-2845	148	12	antimicrobials	antimicrobial	NOUN
ajlm-2845	148	13	while	while	SCONJ
ajlm-2845	148	14	awaiting	await	VERB
ajlm-2845	148	15	susceptibility	susceptibility	NOUN
ajlm-2845	148	16	testing	testing	NOUN
ajlm-2845	148	17	.	.	PUNCT
ajlm-2845	149	1	in	in	ADP
ajlm-2845	149	2	general	general	ADJ
ajlm-2845	149	3	,	,	PUNCT
ajlm-2845	149	4	the	the	DET
ajlm-2845	149	5	other	other	ADJ
ajlm-2845	149	6	recommended	recommend	VERB
ajlm-2845	149	7	first	first	ADJ
ajlm-2845	149	8	-	-	PUNCT
ajlm-2845	149	9	line	line	NOUN
ajlm-2845	149	10	antimicrobial	antimicrobial	ADJ
ajlm-2845	149	11	agents	agent	NOUN
ajlm-2845	149	12	,	,	PUNCT
ajlm-2845	149	13	gentamicin	gentamicin	NOUN
ajlm-2845	149	14	,	,	PUNCT
ajlm-2845	149	15	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2845	149	16	,	,	PUNCT
ajlm-2845	149	17	and	and	CCONJ
ajlm-2845	149	18	fosfomycin	fosfomycin	PROPN
ajlm-2845	149	19	are	be	AUX
ajlm-2845	149	20	likely	likely	ADJ
ajlm-2845	149	21	to	to	PART
ajlm-2845	149	22	treat	treat	VERB
ajlm-2845	149	23	most	most	ADV
ajlm-2845	149	24	utis	utis	NOUN
ajlm-2845	149	25	empirically	empirically	ADV
ajlm-2845	149	26	.	.	PUNCT
ajlm-2845	150	1	given	give	VERB
ajlm-2845	150	2	the	the	DET
ajlm-2845	150	3	high	high	ADJ
ajlm-2845	150	4	rate	rate	NOUN
ajlm-2845	150	5	of	of	ADP
ajlm-2845	150	6	drug	drug	NOUN
ajlm-2845	150	7	-	-	PUNCT
ajlm-2845	150	8	resistant	resistant	ADJ
ajlm-2845	150	9	uropathogens	uropathogen	NOUN
ajlm-2845	150	10	,	,	PUNCT
ajlm-2845	150	11	careful	careful	ADJ
ajlm-2845	150	12	selection	selection	NOUN
ajlm-2845	150	13	of	of	ADP
ajlm-2845	150	14	empiric	empiric	ADJ
ajlm-2845	150	15	therapy	therapy	NOUN
ajlm-2845	150	16	is	be	AUX
ajlm-2845	150	17	vital	vital	ADJ
ajlm-2845	150	18	to	to	PART
ajlm-2845	150	19	ensure	ensure	VERB
ajlm-2845	150	20	acceptable	acceptable	ADJ
ajlm-2845	150	21	clinical	clinical	ADJ
ajlm-2845	150	22	outcomes	outcome	NOUN
ajlm-2845	150	23	and	and	CCONJ
ajlm-2845	150	24	to	to	PART
ajlm-2845	150	25	prevent	prevent	VERB
ajlm-2845	150	26	further	further	ADJ
ajlm-2845	150	27	development	development	NOUN
ajlm-2845	150	28	of	of	ADP
ajlm-2845	150	29	amr	amr	PROPN
ajlm-2845	150	30	.	.	PUNCT
ajlm-2845	151	1	this	this	DET
ajlm-2845	151	2	study	study	NOUN
ajlm-2845	151	3	has	have	AUX
ajlm-2845	151	4	provided	provide	VERB
ajlm-2845	151	5	an	an	DET
ajlm-2845	151	6	updated	update	VERB
ajlm-2845	151	7	antibiogram	antibiogram	NOUN
ajlm-2845	151	8	for	for	ADP
ajlm-2845	151	9	uropathogens	uropathogen	NOUN
ajlm-2845	151	10	isolated	isolate	VERB
ajlm-2845	151	11	at	at	ADP
ajlm-2845	151	12	potchefstroom	potchefstroom	NOUN
ajlm-2845	151	13	hospital	hospital	NOUN
ajlm-2845	151	14	in	in	ADP
ajlm-2845	151	15	the	the	DET
ajlm-2845	151	16	north	north	NOUN
ajlm-2845	151	17	west	west	PROPN
ajlm-2845	151	18	province	province	PROPN
ajlm-2845	151	19	.	.	PUNCT
ajlm-2845	152	1	acknowledgements	acknowledgement	NOUN
ajlm-2845	152	2	competing	compete	VERB
ajlm-2845	152	3	interests	interest	NOUN
ajlm-2845	152	4	the	the	DET
ajlm-2845	152	5	authors	author	NOUN
ajlm-2845	152	6	declare	declare	VERB
ajlm-2845	152	7	that	that	SCONJ
ajlm-2845	152	8	they	they	PRON
ajlm-2845	152	9	have	have	VERB
ajlm-2845	152	10	no	no	DET
ajlm-2845	152	11	financial	financial	ADJ
ajlm-2845	152	12	or	or	CCONJ
ajlm-2845	152	13	personal	personal	ADJ
ajlm-2845	152	14	relationships	relationship	NOUN
ajlm-2845	152	15	that	that	PRON
ajlm-2845	152	16	may	may	AUX
ajlm-2845	152	17	have	have	AUX
ajlm-2845	152	18	inappropriately	inappropriately	ADV
ajlm-2845	152	19	influenced	influence	VERB
ajlm-2845	152	20	them	they	PRON
ajlm-2845	152	21	in	in	ADP
ajlm-2845	152	22	writing	write	VERB
ajlm-2845	152	23	this	this	DET
ajlm-2845	152	24	article	article	NOUN
ajlm-2845	152	25	.	.	PUNCT
ajlm-2845	153	1	credit	credit	NOUN
ajlm-2845	153	2	authorship	authorship	NOUN
ajlm-2845	153	3	contribution	contribution	NOUN
ajlm-2845	153	4	miguel	miguel	PROPN
ajlm-2845	153	5	j.	j.	PROPN
ajlm-2845	153	6	teixeira	teixeira	PROPN
ajlm-2845	153	7	:	:	PUNCT
ajlm-2845	153	8	conceptualisation	conceptualisation	NOUN
ajlm-2845	153	9	,	,	PUNCT
ajlm-2845	153	10	data	datum	NOUN
ajlm-2845	153	11	analysis	analysis	NOUN
ajlm-2845	153	12	,	,	PUNCT
ajlm-2845	153	13	writing	writing	NOUN
ajlm-2845	153	14	–	–	PUNCT
ajlm-2845	153	15	review	review	NOUN
ajlm-2845	153	16	&	&	CCONJ
ajlm-2845	153	17	editing	editing	NOUN
ajlm-2845	153	18	.	.	PUNCT
ajlm-2845	154	1	vian	vian	PROPN
ajlm-2845	154	2	pretorius	pretorius	PROPN
ajlm-2845	154	3	;	;	PUNCT
ajlm-2845	154	4	project	project	NOUN
ajlm-2845	154	5	administration	administration	NOUN
ajlm-2845	154	6	,	,	PUNCT
ajlm-2845	154	7	data	data	NOUN
ajlm-2845	154	8	curation	curation	NOUN
ajlm-2845	154	9	,	,	PUNCT
ajlm-2845	154	10	resources	resource	NOUN
ajlm-2845	154	11	,	,	PUNCT
ajlm-2845	154	12	formal	formal	ADJ
ajlm-2845	154	13	analysis	analysis	NOUN
ajlm-2845	154	14	,	,	PUNCT
ajlm-2845	154	15	writing	writing	NOUN
ajlm-2845	154	16	–	–	PUNCT
ajlm-2845	154	17	original	original	ADJ
ajlm-2845	154	18	draft	draft	NOUN
ajlm-2845	154	19	.	.	PUNCT
ajlm-2845	155	1	robert	robert	PROPN
ajlm-2845	155	2	c.j.g	c.j.g	PROPN
ajlm-2845	155	3	.	.	PUNCT
ajlm-2845	155	4	hunt	hunt	PROPN
ajlm-2845	155	5	:	:	PUNCT
ajlm-2845	155	6	data	datum	NOUN
ajlm-2845	155	7	curation	curation	NOUN
ajlm-2845	155	8	,	,	PUNCT
ajlm-2845	155	9	writing	write	VERB
ajlm-2845	155	10	original	original	ADJ
ajlm-2845	155	11	draft	draft	NOUN
ajlm-2845	155	12	.	.	PUNCT
ajlm-2845	156	1	sanam	sanam	PROPN
ajlm-2845	156	2	morar	morar	PROPN
ajlm-2845	156	3	:	:	PUNCT
ajlm-2845	156	4	data	datum	NOUN
ajlm-2845	156	5	curation	curation	NOUN
ajlm-2845	156	6	,	,	PUNCT
ajlm-2845	156	7	writing	write	VERB
ajlm-2845	156	8	original	original	ADJ
ajlm-2845	156	9	draft	draft	NOUN
ajlm-2845	156	10	.	.	PUNCT
ajlm-2845	157	1	jamie	jamie	PROPN
ajlm-2845	157	2	l.	l.	PROPN
ajlm-2845	157	3	colloty	colloty	PROPN
ajlm-2845	157	4	:	:	PUNCT
ajlm-2845	157	5	writing	writing	NOUN
ajlm-2845	157	6	–	–	PUNCT
ajlm-2845	157	7	review	review	NOUN
ajlm-2845	157	8	&	&	CCONJ
ajlm-2845	157	9	editing	editing	NOUN
ajlm-2845	157	10	.	.	PUNCT
ajlm-2845	158	1	caleb	caleb	PROPN
ajlm-2845	158	2	m.	m.	PROPN
ajlm-2845	158	3	radebe	radebe	PROPN
ajlm-2845	158	4	:	:	PUNCT
ajlm-2845	158	5	writing	write	VERB
ajlm-2845	158	6	–	–	PUNCT
ajlm-2845	158	7	review	review	NOUN
ajlm-2845	158	8	&	&	CCONJ
ajlm-2845	158	9	editing	editing	NOUN
ajlm-2845	158	10	,	,	PUNCT
ajlm-2845	158	11	supervision	supervision	NOUN
ajlm-2845	158	12	.	.	PUNCT
ajlm-2845	159	1	rajen	rajen	PROPN
ajlm-2845	159	2	morar	morar	PROPN
ajlm-2845	159	3	:	:	PUNCT
ajlm-2845	159	4	writing	writing	NOUN
ajlm-2845	159	5	–	–	PUNCT
ajlm-2845	159	6	review	review	NOUN
ajlm-2845	159	7	&	&	CCONJ
ajlm-2845	159	8	editing	editing	NOUN
ajlm-2845	159	9	,	,	PUNCT
ajlm-2845	159	10	supervision	supervision	NOUN
ajlm-2845	159	11	.	.	PUNCT
ajlm-2845	160	1	all	all	DET
ajlm-2845	160	2	authors	author	NOUN
ajlm-2845	160	3	reviewed	review	VERB
ajlm-2845	160	4	the	the	DET
ajlm-2845	160	5	article	article	NOUN
ajlm-2845	160	6	,	,	PUNCT
ajlm-2845	160	7	contributed	contribute	VERB
ajlm-2845	160	8	to	to	ADP
ajlm-2845	160	9	the	the	DET
ajlm-2845	160	10	discussion	discussion	NOUN
ajlm-2845	160	11	of	of	ADP
ajlm-2845	160	12	results	result	NOUN
ajlm-2845	160	13	,	,	PUNCT
ajlm-2845	160	14	approved	approve	VERB
ajlm-2845	160	15	the	the	DET
ajlm-2845	160	16	final	final	ADJ
ajlm-2845	160	17	version	version	NOUN
ajlm-2845	160	18	for	for	ADP
ajlm-2845	160	19	submission	submission	NOUN
ajlm-2845	160	20	and	and	CCONJ
ajlm-2845	160	21	publication	publication	NOUN
ajlm-2845	160	22	,	,	PUNCT
ajlm-2845	160	23	and	and	CCONJ
ajlm-2845	160	24	take	take	VERB
ajlm-2845	160	25	responsibility	responsibility	NOUN
ajlm-2845	160	26	for	for	ADP
ajlm-2845	160	27	the	the	DET
ajlm-2845	160	28	integrity	integrity	NOUN
ajlm-2845	160	29	of	of	ADP
ajlm-2845	160	30	its	its	PRON
ajlm-2845	160	31	findings	finding	NOUN
ajlm-2845	160	32	.	.	PUNCT
ajlm-2845	161	1	sources	source	NOUN
ajlm-2845	161	2	of	of	ADP
ajlm-2845	161	3	support	support	NOUN
ajlm-2845	161	4	this	this	DET
ajlm-2845	161	5	research	research	NOUN
ajlm-2845	161	6	received	receive	VERB
ajlm-2845	161	7	no	no	DET
ajlm-2845	161	8	specific	specific	ADJ
ajlm-2845	161	9	grant	grant	NOUN
ajlm-2845	161	10	from	from	ADP
ajlm-2845	161	11	any	any	DET
ajlm-2845	161	12	funding	funding	NOUN
ajlm-2845	161	13	agency	agency	NOUN
ajlm-2845	161	14	in	in	ADP
ajlm-2845	161	15	the	the	DET
ajlm-2845	161	16	public	public	ADJ
ajlm-2845	161	17	,	,	PUNCT
ajlm-2845	161	18	commercial	commercial	ADJ
ajlm-2845	161	19	,	,	PUNCT
ajlm-2845	161	20	or	or	CCONJ
ajlm-2845	161	21	not	not	PART
ajlm-2845	161	22	-	-	PUNCT
ajlm-2845	161	23	for	for	ADP
ajlm-2845	161	24	-	-	PUNCT
ajlm-2845	161	25	profit	profit	NOUN
ajlm-2845	161	26	sectors	sector	NOUN
ajlm-2845	161	27	data	datum	NOUN
ajlm-2845	161	28	availability	availability	NOUN
ajlm-2845	161	29	the	the	DET
ajlm-2845	161	30	data	datum	NOUN
ajlm-2845	161	31	that	that	PRON
ajlm-2845	161	32	support	support	VERB
ajlm-2845	161	33	the	the	DET
ajlm-2845	161	34	findings	finding	NOUN
ajlm-2845	161	35	of	of	ADP
ajlm-2845	161	36	this	this	DET
ajlm-2845	161	37	study	study	NOUN
ajlm-2845	161	38	are	be	AUX
ajlm-2845	161	39	not	not	PART
ajlm-2845	161	40	openly	openly	ADV
ajlm-2845	161	41	available	available	ADJ
ajlm-2845	161	42	due	due	ADP
ajlm-2845	161	43	to	to	ADP
ajlm-2845	161	44	reasons	reason	NOUN
ajlm-2845	161	45	of	of	ADP
ajlm-2845	161	46	sensitivity	sensitivity	NOUN
ajlm-2845	161	47	and	and	CCONJ
ajlm-2845	161	48	are	be	AUX
ajlm-2845	161	49	available	available	ADJ
ajlm-2845	161	50	from	from	ADP
ajlm-2845	161	51	the	the	DET
ajlm-2845	161	52	corresponding	corresponding	ADJ
ajlm-2845	161	53	author	author	NOUN
ajlm-2845	161	54	,	,	PUNCT
ajlm-2845	161	55	m.j.t	m.j.t	NOUN
ajlm-2845	161	56	.	.	PUNCT
ajlm-2845	161	57	upon	upon	SCONJ
ajlm-2845	161	58	reasonable	reasonable	ADJ
ajlm-2845	161	59	request	request	NOUN
ajlm-2845	161	60	.	.	PUNCT
ajlm-2845	162	1	disclaimer	disclaimer	VERB
ajlm-2845	162	2	the	the	DET
ajlm-2845	162	3	views	view	NOUN
ajlm-2845	162	4	and	and	CCONJ
ajlm-2845	162	5	opinions	opinion	NOUN
ajlm-2845	162	6	expressed	express	VERB
ajlm-2845	162	7	in	in	ADP
ajlm-2845	162	8	this	this	DET
ajlm-2845	162	9	article	article	NOUN
ajlm-2845	162	10	are	be	AUX
ajlm-2845	162	11	those	those	PRON
ajlm-2845	162	12	of	of	ADP
ajlm-2845	162	13	the	the	DET
ajlm-2845	162	14	authors	author	NOUN
ajlm-2845	162	15	and	and	CCONJ
ajlm-2845	162	16	are	be	AUX
ajlm-2845	162	17	the	the	DET
ajlm-2845	162	18	product	product	NOUN
ajlm-2845	162	19	of	of	ADP
ajlm-2845	162	20	professional	professional	ADJ
ajlm-2845	162	21	research	research	NOUN
ajlm-2845	162	22	.	.	PUNCT
ajlm-2845	163	1	the	the	DET
ajlm-2845	163	2	article	article	NOUN
ajlm-2845	163	3	does	do	AUX
ajlm-2845	163	4	not	not	PART
ajlm-2845	163	5	necessarily	necessarily	ADV
ajlm-2845	163	6	reflect	reflect	VERB
ajlm-2845	163	7	the	the	DET
ajlm-2845	163	8	official	official	ADJ
ajlm-2845	163	9	policy	policy	NOUN
ajlm-2845	163	10	or	or	CCONJ
ajlm-2845	163	11	position	position	NOUN
ajlm-2845	163	12	of	of	ADP
ajlm-2845	163	13	any	any	DET
ajlm-2845	163	14	affiliated	affiliated	ADJ
ajlm-2845	163	15	institution	institution	NOUN
ajlm-2845	163	16	,	,	PUNCT
ajlm-2845	163	17	funder	funder	NOUN
ajlm-2845	163	18	,	,	PUNCT
ajlm-2845	163	19	agency	agency	NOUN
ajlm-2845	163	20	,	,	PUNCT
ajlm-2845	163	21	or	or	CCONJ
ajlm-2845	163	22	that	that	PRON
ajlm-2845	163	23	of	of	ADP
ajlm-2845	163	24	the	the	DET
ajlm-2845	163	25	publisher	publisher	NOUN
ajlm-2845	163	26	.	.	PUNCT
ajlm-2845	164	1	the	the	DET
ajlm-2845	164	2	authors	author	NOUN
ajlm-2845	164	3	are	be	AUX
ajlm-2845	164	4	responsible	responsible	ADJ
ajlm-2845	164	5	for	for	ADP
ajlm-2845	164	6	this	this	DET
ajlm-2845	164	7	article	article	NOUN
ajlm-2845	164	8	’s	’s	PART
ajlm-2845	164	9	results	result	NOUN
ajlm-2845	164	10	,	,	PUNCT
ajlm-2845	164	11	findings	finding	NOUN
ajlm-2845	164	12	,	,	PUNCT
ajlm-2845	164	13	and	and	CCONJ
ajlm-2845	164	14	content	content	NOUN
ajlm-2845	164	15	.	.	PUNCT
ajlm-2845	165	1	references	reference	NOUN
ajlm-2845	165	2	zeng	zeng	PROPN
ajlm-2845	165	3	z	z	PROPN
ajlm-2845	165	4	,	,	PUNCT
ajlm-2845	165	5	zhan	zhan	PROPN
ajlm-2845	165	6	j	j	PROPN
ajlm-2845	165	7	,	,	PUNCT
ajlm-2845	165	8	zhang	zhang	PROPN
ajlm-2845	165	9	k	k	PROPN
ajlm-2845	165	10	,	,	PUNCT
ajlm-2845	165	11	chen	chen	PROPN
ajlm-2845	165	12	h	h	PROPN
ajlm-2845	165	13	,	,	PUNCT
ajlm-2845	165	14	cheng	cheng	PROPN
ajlm-2845	165	15	s.	s.	PROPN
ajlm-2845	165	16	global	global	PROPN
ajlm-2845	165	17	,	,	PUNCT
ajlm-2845	165	18	regional	regional	ADJ
ajlm-2845	165	19	,	,	PUNCT
ajlm-2845	165	20	and	and	CCONJ
ajlm-2845	165	21	national	national	ADJ
ajlm-2845	165	22	burden	burden	NOUN
ajlm-2845	165	23	of	of	ADP
ajlm-2845	165	24	urinary	urinary	ADJ
ajlm-2845	165	25	tract	tract	NOUN
ajlm-2845	165	26	infections	infection	NOUN
ajlm-2845	165	27	from	from	ADP
ajlm-2845	165	28	1990	1990	NUM
ajlm-2845	165	29	to	to	ADP
ajlm-2845	165	30	2019	2019	NUM
ajlm-2845	165	31	:	:	PUNCT
ajlm-2845	165	32	an	an	DET
ajlm-2845	165	33	analysis	analysis	NOUN
ajlm-2845	165	34	of	of	ADP
ajlm-2845	165	35	the	the	DET
ajlm-2845	165	36	global	global	ADJ
ajlm-2845	165	37	burden	burden	NOUN
ajlm-2845	165	38	of	of	ADP
ajlm-2845	165	39	disease	disease	NOUN
ajlm-2845	165	40	study	study	NOUN
ajlm-2845	165	41	2019	2019	NUM
ajlm-2845	165	42	.	.	PUNCT
ajlm-2845	166	1	world	world	PROPN
ajlm-2845	166	2	j	j	PROPN
ajlm-2845	166	3	urol	urol	PROPN
ajlm-2845	166	4	.	.	PUNCT
ajlm-2845	167	1	2022;40(3):755–763	2022;40(3):755–763	NUM
ajlm-2845	167	2	.	.	NOUN
ajlm-2845	167	3	https://doi.org/10.1007/s00345-021-03913-0	https://doi.org/10.1007/s00345-021-03913-0	PROPN
ajlm-2845	167	4	mwang’onde	mwang’onde	NOUN
ajlm-2845	167	5	bj	bj	NOUN
ajlm-2845	167	6	,	,	PUNCT
ajlm-2845	167	7	mchami	mchami	PROPN
ajlm-2845	167	8	ji	ji	PROPN
ajlm-2845	167	9	.	.	PUNCT
ajlm-2845	168	1	the	the	DET
ajlm-2845	168	2	aetiology	aetiology	NOUN
ajlm-2845	168	3	and	and	CCONJ
ajlm-2845	168	4	prevalence	prevalence	NOUN
ajlm-2845	168	5	of	of	ADP
ajlm-2845	168	6	urinary	urinary	ADJ
ajlm-2845	168	7	tract	tract	NOUN
ajlm-2845	168	8	infections	infection	NOUN
ajlm-2845	168	9	in	in	ADP
ajlm-2845	168	10	sub	sub	ADJ
ajlm-2845	168	11	-	-	ADJ
ajlm-2845	168	12	saharan	saharan	ADJ
ajlm-2845	168	13	africa	africa	PROPN
ajlm-2845	168	14	:	:	PUNCT
ajlm-2845	168	15	a	a	DET
ajlm-2845	168	16	systematic	systematic	ADJ
ajlm-2845	168	17	review	review	NOUN
ajlm-2845	168	18	.	.	PUNCT
ajlm-2845	169	1	j	j	PROPN
ajlm-2845	169	2	health	health	PROPN
ajlm-2845	169	3	biol	biol	PROPN
ajlm-2845	169	4	sci	sci	PROPN
ajlm-2845	169	5	.	.	PUNCT
ajlm-2845	170	1	2022;10(1):1–7	2022;10(1):1–7	X
ajlm-2845	170	2	.	.	PUNCT
ajlm-2845	171	1	https://doi.org/10.12662/2317-3076jhbs.v10i1.4501.p1-7.2022	https://doi.org/10.12662/2317-3076jhbs.v10i1.4501.p1-7.2022	PROPN
ajlm-2845	171	2	fourie	fourie	PROPN
ajlm-2845	171	3	jl	jl	PROPN
ajlm-2845	171	4	,	,	PUNCT
ajlm-2845	171	5	claassen	claassen	PROPN
ajlm-2845	171	6	fm	fm	PROPN
ajlm-2845	171	7	,	,	PUNCT
ajlm-2845	171	8	myburgh	myburgh	PROPN
ajlm-2845	171	9	jj	jj	PROPN
ajlm-2845	171	10	.	.	PROPN
ajlm-2845	171	11	causative	causative	ADJ
ajlm-2845	171	12	pathogens	pathogen	NOUN
ajlm-2845	171	13	and	and	CCONJ
ajlm-2845	171	14	antimicrobial	antimicrobial	ADJ
ajlm-2845	171	15	resistance	resistance	NOUN
ajlm-2845	171	16	in	in	ADP
ajlm-2845	171	17	community	community	NOUN
ajlm-2845	171	18	-	-	PUNCT
ajlm-2845	171	19	acquired	acquire	VERB
ajlm-2845	171	20	urinary	urinary	ADJ
ajlm-2845	171	21	tract	tract	NOUN
ajlm-2845	171	22	infections	infection	NOUN
ajlm-2845	171	23	in	in	ADP
ajlm-2845	171	24	central	central	PROPN
ajlm-2845	171	25	south	south	PROPN
ajlm-2845	171	26	africa	africa	PROPN
ajlm-2845	171	27	.	.	PUNCT
ajlm-2845	172	1	s	s	PROPN
ajlm-2845	172	2	afr	afr	PROPN
ajlm-2845	172	3	med	med	PROPN
ajlm-2845	172	4	j.	j.	PROPN
ajlm-2845	172	5	2021;111(2):124–128	2021;111(2):124–128	PROPN
ajlm-2845	172	6	.	.	PUNCT
ajlm-2845	173	1	https://doi.org/10.7196/samj.2021.v111i2.14905	https://doi.org/10.7196/samj.2021.v111i2.14905	PROPN
ajlm-2845	173	2	paul	paul	PROPN
ajlm-2845	173	3	r.	r.	PROPN
ajlm-2845	173	4	state	state	PROPN
ajlm-2845	173	5	of	of	ADP
ajlm-2845	173	6	the	the	DET
ajlm-2845	173	7	globe	globe	NOUN
ajlm-2845	173	8	:	:	PUNCT
ajlm-2845	173	9	rising	rise	VERB
ajlm-2845	173	10	antimicrobial	antimicrobial	ADJ
ajlm-2845	173	11	resistance	resistance	NOUN
ajlm-2845	173	12	of	of	ADP
ajlm-2845	173	13	pathogens	pathogen	NOUN
ajlm-2845	173	14	in	in	ADP
ajlm-2845	173	15	urinary	urinary	ADJ
ajlm-2845	173	16	tract	tract	NOUN
ajlm-2845	173	17	infection	infection	NOUN
ajlm-2845	173	18	.	.	PUNCT
ajlm-2845	174	1	j	j	PROPN
ajlm-2845	174	2	glob	glob	PROPN
ajlm-2845	174	3	infect	infect	PROPN
ajlm-2845	174	4	dis	dis	PROPN
ajlm-2845	174	5	.	.	PUNCT
ajlm-2845	175	1	2018;10(3):117–118	2018;10(3):117–118	X
ajlm-2845	175	2	.	.	PUNCT
ajlm-2845	175	3	https://doi.org/10.4103/jgid.jgid_104_17	https://doi.org/10.4103/jgid.jgid_104_17	PROPN
ajlm-2845	175	4	laxminarayan	laxminarayan	PROPN
ajlm-2845	175	5	r.	r.	PROPN
ajlm-2845	175	6	the	the	DET
ajlm-2845	175	7	overlooked	overlook	VERB
ajlm-2845	175	8	pandemic	pandemic	NOUN
ajlm-2845	175	9	of	of	ADP
ajlm-2845	175	10	antimicrobial	antimicrobial	ADJ
ajlm-2845	175	11	resistance	resistance	NOUN
ajlm-2845	175	12	.	.	PUNCT
ajlm-2845	176	1	lancet	lancet	PROPN
ajlm-2845	176	2	.	.	PUNCT
ajlm-2845	177	1	2022;399(10325):606–607	2022;399(10325):606–607	NUM
ajlm-2845	177	2	.	.	PUNCT
ajlm-2845	178	1	https://doi.org/10.1016/s0140-6736(22)00087-3	https://doi.org/10.1016/s0140-6736(22)00087-3	PROPN
ajlm-2845	178	2	williams	williams	PROPN
ajlm-2845	178	3	dn	dn	PROPN
ajlm-2845	178	4	.	.	PROPN
ajlm-2845	178	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	178	6	resistance	resistance	NOUN
ajlm-2845	178	7	:	:	PUNCT
ajlm-2845	178	8	are	be	AUX
ajlm-2845	178	9	we	we	PRON
ajlm-2845	178	10	at	at	ADP
ajlm-2845	178	11	the	the	DET
ajlm-2845	178	12	dawn	dawn	NOUN
ajlm-2845	178	13	of	of	ADP
ajlm-2845	178	14	the	the	DET
ajlm-2845	178	15	post	post	ADJ
ajlm-2845	178	16	-	-	ADJ
ajlm-2845	178	17	antimicrobial	antimicrobial	ADJ
ajlm-2845	178	18	era	era	NOUN
ajlm-2845	178	19	?	?	PUNCT
ajlm-2845	179	1	j	j	PROPN
ajlm-2845	179	2	r	r	PROPN
ajlm-2845	179	3	coll	coll	PROPN
ajlm-2845	179	4	physicians	physician	NOUN
ajlm-2845	179	5	edinb	edinb	NOUN
ajlm-2845	179	6	.	.	PUNCT
ajlm-2845	180	1	2016;46(3):150–156	2016;46(3):150–156	NOUN
ajlm-2845	180	2	.	.	PUNCT
ajlm-2845	181	1	https://doi.org/10.4997/jrcpe.2016.302	https://doi.org/10.4997/jrcpe.2016.302	ADJ
ajlm-2845	181	2	gbd	gbd	NOUN
ajlm-2845	181	3	2021	2021	NUM
ajlm-2845	181	4	antimicrobial	antimicrobial	ADJ
ajlm-2845	181	5	resistance	resistance	NOUN
ajlm-2845	181	6	collaborators	collaborator	NOUN
ajlm-2845	181	7	.	.	PUNCT
ajlm-2845	182	1	global	global	ADJ
ajlm-2845	182	2	burden	burden	NOUN
ajlm-2845	182	3	of	of	ADP
ajlm-2845	182	4	bacterial	bacterial	ADJ
ajlm-2845	182	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	182	6	resistance	resistance	NOUN
ajlm-2845	182	7	1990–2021	1990–2021	NUM
ajlm-2845	182	8	:	:	PUNCT
ajlm-2845	182	9	a	a	DET
ajlm-2845	182	10	systematic	systematic	ADJ
ajlm-2845	182	11	analysis	analysis	NOUN
ajlm-2845	182	12	with	with	ADP
ajlm-2845	182	13	forecasts	forecast	NOUN
ajlm-2845	182	14	to	to	ADP
ajlm-2845	182	15	2050	2050	NUM
ajlm-2845	182	16	.	.	PUNCT
ajlm-2845	183	1	lancet	lancet	NOUN
ajlm-2845	183	2	.	.	PUNCT
ajlm-2845	184	1	2024;404(10459):1199–1226	2024;404(10459):1199–1226	X
ajlm-2845	184	2	.	.	PUNCT
ajlm-2845	185	1	https://doi.org/10.1016/s0140-6736(24)01867-1	https://doi.org/10.1016/s0140-6736(24)01867-1	VERB
ajlm-2845	185	2	antimicrobial	antimicrobial	ADJ
ajlm-2845	185	3	resistance	resistance	NOUN
ajlm-2845	185	4	collaborators	collaborator	NOUN
ajlm-2845	185	5	.	.	PUNCT
ajlm-2845	186	1	global	global	ADJ
ajlm-2845	186	2	burden	burden	NOUN
ajlm-2845	186	3	of	of	ADP
ajlm-2845	186	4	bacterial	bacterial	ADJ
ajlm-2845	186	5	antimicrobial	antimicrobial	ADJ
ajlm-2845	186	6	resistance	resistance	NOUN
ajlm-2845	186	7	in	in	ADP
ajlm-2845	186	8	2019	2019	NUM
ajlm-2845	186	9	:	:	PUNCT
ajlm-2845	186	10	a	a	DET
ajlm-2845	186	11	systematic	systematic	ADJ
ajlm-2845	186	12	analysis	analysis	NOUN
ajlm-2845	186	13	.	.	PUNCT
ajlm-2845	187	1	lancet	lancet	NOUN
ajlm-2845	187	2	.	.	PUNCT
ajlm-2845	188	1	2022;399(10325):629–655	2022;399(10325):629–655	X
ajlm-2845	188	2	.	.	PUNCT
ajlm-2845	189	1	https://doi.org/10.1016/s0140-6736(21)02724-0	https://doi.org/10.1016/s0140-6736(21)02724-0	NOUN
ajlm-2845	189	2	barlam	barlam	PROPN
ajlm-2845	189	3	tf	tf	PROPN
ajlm-2845	189	4	,	,	PUNCT
ajlm-2845	189	5	cosgrove	cosgrove	PROPN
ajlm-2845	189	6	se	se	PROPN
ajlm-2845	189	7	,	,	PUNCT
ajlm-2845	189	8	abbo	abbo	PROPN
ajlm-2845	189	9	lm	lm	PROPN
ajlm-2845	189	10	,	,	PUNCT
ajlm-2845	189	11	et	et	PROPN
ajlm-2845	189	12	al	al	PROPN
ajlm-2845	189	13	.	.	PUNCT
ajlm-2845	190	1	implementing	implement	VERB
ajlm-2845	190	2	an	an	DET
ajlm-2845	190	3	antimicrobial	antimicrobial	ADJ
ajlm-2845	190	4	stewardship	stewardship	NOUN
ajlm-2845	190	5	program	program	NOUN
ajlm-2845	190	6	:	:	PUNCT
ajlm-2845	190	7	guidelines	guideline	NOUN
ajlm-2845	190	8	by	by	ADP
ajlm-2845	190	9	the	the	DET
ajlm-2845	190	10	infectious	infectious	ADJ
ajlm-2845	190	11	diseases	disease	NOUN
ajlm-2845	190	12	society	society	NOUN
ajlm-2845	190	13	of	of	ADP
ajlm-2845	190	14	america	america	PROPN
ajlm-2845	190	15	and	and	CCONJ
ajlm-2845	190	16	the	the	DET
ajlm-2845	190	17	society	society	NOUN
ajlm-2845	190	18	for	for	ADP
ajlm-2845	190	19	healthcare	healthcare	PROPN
ajlm-2845	190	20	epidemiology	epidemiology	PROPN
ajlm-2845	190	21	of	of	ADP
ajlm-2845	190	22	america	america	PROPN
ajlm-2845	190	23	.	.	PUNCT
ajlm-2845	191	1	clin	clin	PROPN
ajlm-2845	191	2	infect	infect	PROPN
ajlm-2845	191	3	dis	dis	PROPN
ajlm-2845	191	4	.	.	PUNCT
ajlm-2845	192	1	2016;62(10):e51	2016;62(10):e51	X
ajlm-2845	192	2	–	–	PUNCT
ajlm-2845	192	3	e77	e77	NOUN
ajlm-2845	192	4	.	.	PUNCT
ajlm-2845	193	1	https://doi.org/10.1093/cid/ciw118	https://doi.org/10.1093/cid/ciw118	PROPN
ajlm-2845	193	2	south	south	PROPN
ajlm-2845	193	3	african	african	PROPN
ajlm-2845	193	4	national	national	PROPN
ajlm-2845	193	5	department	department	PROPN
ajlm-2845	193	6	of	of	ADP
ajlm-2845	193	7	health	health	PROPN
ajlm-2845	193	8	.	.	PUNCT
ajlm-2845	194	1	standard	standard	ADJ
ajlm-2845	194	2	treatment	treatment	NOUN
ajlm-2845	194	3	guidelines	guideline	NOUN
ajlm-2845	194	4	and	and	CCONJ
ajlm-2845	194	5	essential	essential	ADJ
ajlm-2845	194	6	medicines	medicine	NOUN
ajlm-2845	194	7	list	list	NOUN
ajlm-2845	194	8	for	for	ADP
ajlm-2845	194	9	south	south	PROPN
ajlm-2845	194	10	africa	africa	PROPN
ajlm-2845	194	11	:	:	PUNCT
ajlm-2845	194	12	hospital	hospital	NOUN
ajlm-2845	194	13	level	level	NOUN
ajlm-2845	194	14	adults	adult	NOUN
ajlm-2845	195	1	[	[	X
ajlm-2845	195	2	homepage	homepage	NOUN
ajlm-2845	195	3	on	on	ADP
ajlm-2845	195	4	the	the	DET
ajlm-2845	195	5	internet	internet	NOUN
ajlm-2845	195	6	]	]	PUNCT
ajlm-2845	195	7	.	.	PUNCT
ajlm-2845	196	1	5th	5th	ADJ
ajlm-2845	196	2	ed	ed	NOUN
ajlm-2845	196	3	.	.	PROPN
ajlm-2845	196	4	2019	2019	NUM
ajlm-2845	197	1	[	[	X
ajlm-2845	197	2	cited	cite	VERB
ajlm-2845	197	3	2024	2024	NUM
ajlm-2845	197	4	oct	oct	NOUN
ajlm-2845	197	5	10	10	NUM
ajlm-2845	197	6	]	]	PUNCT
ajlm-2845	197	7	.	.	PUNCT
ajlm-2845	198	1	available	available	ADJ
ajlm-2845	198	2	from	from	ADP
ajlm-2845	198	3	:	:	PUNCT
ajlm-2845	198	4	https://www.gov.za/documents/standard-treatment-guidelines-and-essential-medicines-list-south-africa-hospital-level	https://www.gov.za/documents/standard-treatment-guidelines-and-essential-medicines-list-south-africa-hospital-level	VERB
ajlm-2845	198	5	clinical	clinical	ADJ
ajlm-2845	198	6	and	and	CCONJ
ajlm-2845	198	7	laboratory	laboratory	NOUN
ajlm-2845	198	8	standards	standard	NOUN
ajlm-2845	198	9	institute	institute	PROPN
ajlm-2845	198	10	(	(	PUNCT
ajlm-2845	198	11	clsi	clsi	PROPN
ajlm-2845	198	12	)	)	PUNCT
ajlm-2845	198	13	.	.	PUNCT
ajlm-2845	199	1	m39	m39	X
ajlm-2845	199	2	:	:	PUNCT
ajlm-2845	199	3	analysis	analysis	NOUN
ajlm-2845	199	4	and	and	CCONJ
ajlm-2845	199	5	presentation	presentation	NOUN
ajlm-2845	199	6	of	of	ADP
ajlm-2845	199	7	cumulative	cumulative	ADJ
ajlm-2845	199	8	antimicrobial	antimicrobial	ADJ
ajlm-2845	199	9	susceptibility	susceptibility	NOUN
ajlm-2845	199	10	test	test	NOUN
ajlm-2845	199	11	data	datum	NOUN
ajlm-2845	199	12	.	.	PUNCT
ajlm-2845	200	1	5th	5th	ADJ
ajlm-2845	200	2	ed	ed	NOUN
ajlm-2845	200	3	.	.	PUNCT
ajlm-2845	201	1	wayne	wayne	PROPN
ajlm-2845	201	2	,	,	PUNCT
ajlm-2845	201	3	pa	pa	PROPN
ajlm-2845	201	4	:	:	PUNCT
ajlm-2845	201	5	clsi	clsi	ADJ
ajlm-2845	201	6	;	;	PUNCT
ajlm-2845	201	7	2022	2022	NUM
ajlm-2845	201	8	.	.	PUNCT
ajlm-2845	202	1	naidoo	naidoo	PROPN
ajlm-2845	202	2	a	a	PROPN
ajlm-2845	202	3	,	,	PUNCT
ajlm-2845	202	4	kajee	kajee	NOUN
ajlm-2845	202	5	a	a	NOUN
ajlm-2845	202	6	,	,	PUNCT
ajlm-2845	202	7	mvelase	mvelase	PROPN
ajlm-2845	202	8	nr	nr	PROPN
ajlm-2845	202	9	,	,	PUNCT
ajlm-2845	202	10	swe	swe	PROPN
ajlm-2845	202	11	-	-	PUNCT
ajlm-2845	202	12	han	han	PROPN
ajlm-2845	202	13	ks	ks	PROPN
ajlm-2845	202	14	.	.	PROPN
ajlm-2845	202	15	antimicrobial	antimicrobial	ADJ
ajlm-2845	202	16	susceptibility	susceptibility	NOUN
ajlm-2845	202	17	of	of	ADP
ajlm-2845	202	18	bacterial	bacterial	ADJ
ajlm-2845	202	19	uropathogens	uropathogen	NOUN
ajlm-2845	202	20	in	in	ADP
ajlm-2845	202	21	a	a	DET
ajlm-2845	202	22	south	south	ADJ
ajlm-2845	202	23	african	african	ADJ
ajlm-2845	202	24	regional	regional	ADJ
ajlm-2845	202	25	hospital	hospital	NOUN
ajlm-2845	202	26	.	.	PUNCT
ajlm-2845	203	1	afr	afr	PROPN
ajlm-2845	203	2	j	j	PROPN
ajlm-2845	203	3	lab	lab	PROPN
ajlm-2845	203	4	med	me	VERB
ajlm-2845	203	5	.	.	PUNCT
ajlm-2845	204	1	2023;12(1	2023;12(1	NUM
ajlm-2845	204	2	):	):	PUNCT
ajlm-2845	204	3	1920	1920	NUM
ajlm-2845	204	4	.	.	PUNCT
ajlm-2845	205	1	https://doi.org/10.4102/ajlm.v12i1.1920	https://doi.org/10.4102/ajlm.v12i1.1920	PROPN
ajlm-2845	205	2	lewis	lewis	PROPN
ajlm-2845	205	3	da	da	PROPN
ajlm-2845	205	4	,	,	PUNCT
ajlm-2845	205	5	gumede	gumede	NOUN
ajlm-2845	205	6	lye	lye	NOUN
ajlm-2845	205	7	,	,	PUNCT
ajlm-2845	205	8	van	van	PROPN
ajlm-2845	205	9	der	der	PROPN
ajlm-2845	205	10	hoven	hoven	PROPN
ajlm-2845	205	11	la	la	PROPN
ajlm-2845	205	12	,	,	PUNCT
ajlm-2845	205	13	et	et	PROPN
ajlm-2845	205	14	al	al	PROPN
ajlm-2845	205	15	.	.	PROPN
ajlm-2845	206	1	antimicrobial	antimicrobial	ADJ
ajlm-2845	206	2	susceptibility	susceptibility	NOUN
ajlm-2845	206	3	of	of	ADP
ajlm-2845	206	4	organisms	organism	NOUN
ajlm-2845	206	5	causing	cause	VERB
ajlm-2845	206	6	community	community	NOUN
ajlm-2845	206	7	-	-	PUNCT
ajlm-2845	206	8	acquired	acquire	VERB
ajlm-2845	206	9	urinary	urinary	ADJ
ajlm-2845	206	10	tract	tract	NOUN
ajlm-2845	206	11	infections	infection	NOUN
ajlm-2845	206	12	in	in	ADP
ajlm-2845	206	13	gauteng	gauteng	PROPN
ajlm-2845	206	14	province	province	PROPN
ajlm-2845	206	15	,	,	PUNCT
ajlm-2845	206	16	south	south	PROPN
ajlm-2845	206	17	africa	africa	PROPN
ajlm-2845	206	18	.	.	PUNCT
ajlm-2845	207	1	s	s	PROPN
ajlm-2845	207	2	afr	afr	PROPN
ajlm-2845	207	3	med	med	PROPN
ajlm-2845	207	4	j.	j.	PROPN
ajlm-2845	207	5	2013;103(6):377–381	2013;103(6):377–381	PROPN
ajlm-2845	207	6	.	.	PUNCT
ajlm-2845	208	1	https://doi.org/10.7196/samj.6722	https://doi.org/10.7196/samj.6722	ADJ
ajlm-2845	208	2	clinical	clinical	ADJ
ajlm-2845	208	3	and	and	CCONJ
ajlm-2845	208	4	laboratory	laboratory	NOUN
ajlm-2845	208	5	standards	standard	NOUN
ajlm-2845	208	6	institute	institute	PROPN
ajlm-2845	208	7	(	(	PUNCT
ajlm-2845	208	8	clsi	clsi	PROPN
ajlm-2845	208	9	)	)	PUNCT
ajlm-2845	208	10	.	.	PUNCT
ajlm-2845	209	1	performance	performance	NOUN
ajlm-2845	209	2	standards	standard	NOUN
ajlm-2845	209	3	for	for	ADP
ajlm-2845	209	4	antimicrobial	antimicrobial	ADJ
ajlm-2845	209	5	susceptibility	susceptibility	NOUN
ajlm-2845	209	6	testing	testing	NOUN
ajlm-2845	209	7	.	.	PUNCT
ajlm-2845	210	1	35th	35th	ADJ
ajlm-2845	210	2	ed	ed	NOUN
ajlm-2845	210	3	.	.	PUNCT
ajlm-2845	210	4	clsi	clsi	PROPN
ajlm-2845	210	5	supplement	supplement	NOUN
ajlm-2845	210	6	m100	m100	PROPN
ajlm-2845	210	7	.	.	PUNCT
ajlm-2845	210	8	wayne	wayne	PROPN
ajlm-2845	210	9	,	,	PUNCT
ajlm-2845	210	10	pa	pa	PROPN
ajlm-2845	210	11	:	:	PUNCT
ajlm-2845	210	12	clsi	clsi	ADJ
ajlm-2845	210	13	;	;	PUNCT
ajlm-2845	210	14	2025	2025	NUM
ajlm-2845	210	15	.	.	PUNCT
ajlm-2845	211	1	goodlet	goodlet	PROPN
ajlm-2845	211	2	kj	kj	PROPN
ajlm-2845	211	3	,	,	PUNCT
ajlm-2845	211	4	benhalima	benhalima	PROPN
ajlm-2845	211	5	fz	fz	PROPN
ajlm-2845	211	6	,	,	PUNCT
ajlm-2845	211	7	nailor	nailor	PROPN
ajlm-2845	211	8	md	md	PROPN
ajlm-2845	211	9	.	.	PUNCT
ajlm-2845	212	1	a	a	DET
ajlm-2845	212	2	systematic	systematic	ADJ
ajlm-2845	212	3	review	review	NOUN
ajlm-2845	212	4	of	of	ADP
ajlm-2845	212	5	single	single	ADJ
ajlm-2845	212	6	-	-	PUNCT
ajlm-2845	212	7	dose	dose	VERB
ajlm-2845	212	8	aminoglycoside	aminoglycoside	ADJ
ajlm-2845	212	9	therapy	therapy	NOUN
ajlm-2845	212	10	for	for	ADP
ajlm-2845	212	11	urinary	urinary	ADJ
ajlm-2845	212	12	tract	tract	NOUN
ajlm-2845	212	13	infection	infection	NOUN
ajlm-2845	212	14	:	:	PUNCT
ajlm-2845	212	15	is	be	AUX
ajlm-2845	212	16	it	it	PRON
ajlm-2845	212	17	time	time	NOUN
ajlm-2845	212	18	to	to	PART
ajlm-2845	212	19	resurrect	resurrect	VERB
ajlm-2845	212	20	an	an	DET
ajlm-2845	212	21	old	old	ADJ
ajlm-2845	212	22	strategy	strategy	NOUN
ajlm-2845	212	23	?	?	PUNCT
ajlm-2845	213	1	antimicrob	antimicrob	PROPN
ajlm-2845	213	2	agents	agents	PROPN
ajlm-2845	213	3	chemother	chemother	PROPN
ajlm-2845	213	4	.	.	PUNCT
ajlm-2845	214	1	2019;63(1):e02165	2019;63(1):e02165	NUM
ajlm-2845	214	2	-	-	SYM
ajlm-2845	214	3	18	18	NUM
ajlm-2845	214	4	.	.	PUNCT
ajlm-2845	215	1	https://doi.org/10.1128/aac.02165-18	https://doi.org/10.1128/aac.02165-18	PROPN
ajlm-2845	215	2	gupta	gupta	PROPN
ajlm-2845	215	3	k	k	PROPN
ajlm-2845	215	4	,	,	PUNCT
ajlm-2845	215	5	hooton	hooton	PROPN
ajlm-2845	215	6	tm	tm	PROPN
ajlm-2845	215	7	,	,	PUNCT
ajlm-2845	215	8	naber	naber	PROPN
ajlm-2845	215	9	kg	kg	PROPN
ajlm-2845	215	10	,	,	PUNCT
ajlm-2845	215	11	et	et	PROPN
ajlm-2845	215	12	al	al	PROPN
ajlm-2845	215	13	.	.	PUNCT
ajlm-2845	216	1	international	international	ADJ
ajlm-2845	216	2	clinical	clinical	ADJ
ajlm-2845	216	3	practice	practice	NOUN
ajlm-2845	216	4	guidelines	guideline	NOUN
ajlm-2845	216	5	for	for	ADP
ajlm-2845	216	6	the	the	DET
ajlm-2845	216	7	treatment	treatment	NOUN
ajlm-2845	216	8	of	of	ADP
ajlm-2845	216	9	acute	acute	ADJ
ajlm-2845	216	10	uncomplicated	uncomplicated	ADJ
ajlm-2845	216	11	cystitis	cystitis	NOUN
ajlm-2845	216	12	and	and	CCONJ
ajlm-2845	216	13	pyelonephritis	pyelonephritis	NOUN
ajlm-2845	216	14	in	in	ADP
ajlm-2845	216	15	women	woman	NOUN
ajlm-2845	216	16	:	:	PUNCT
ajlm-2845	216	17	a	a	DET
ajlm-2845	216	18	2010	2010	NUM
ajlm-2845	216	19	update	update	NOUN
ajlm-2845	216	20	by	by	ADP
ajlm-2845	216	21	the	the	DET
ajlm-2845	216	22	infectious	infectious	ADJ
ajlm-2845	216	23	diseases	disease	NOUN
ajlm-2845	216	24	society	society	NOUN
ajlm-2845	216	25	of	of	ADP
ajlm-2845	216	26	america	america	PROPN
ajlm-2845	216	27	and	and	CCONJ
ajlm-2845	216	28	the	the	DET
ajlm-2845	216	29	european	european	ADJ
ajlm-2845	216	30	society	society	PROPN
ajlm-2845	216	31	for	for	ADP
ajlm-2845	216	32	microbiology	microbiology	NOUN
ajlm-2845	216	33	and	and	CCONJ
ajlm-2845	216	34	infectious	infectious	ADJ
ajlm-2845	216	35	diseases	disease	NOUN
ajlm-2845	216	36	.	.	PUNCT
ajlm-2845	217	1	clin	clin	PROPN
ajlm-2845	217	2	infect	infect	PROPN
ajlm-2845	217	3	dis	dis	PROPN
ajlm-2845	217	4	.	.	PUNCT
ajlm-2845	217	5	2011;52(5):e103	2011;52(5):e103	NOUN
ajlm-2845	217	6	–	–	PUNCT
ajlm-2845	217	7	e120	e120	NUM
ajlm-2845	217	8	.	.	PUNCT
ajlm-2845	218	1	https://doi.org/10.1093/cid/ciq257	https://doi.org/10.1093/cid/ciq257	NOUN
ajlm-2845	218	2	bosch	bosch	PROPN
ajlm-2845	218	3	fj	fj	PROPN
ajlm-2845	218	4	,	,	PUNCT
ajlm-2845	218	5	van	van	PROPN
ajlm-2845	218	6	vuuren	vuuren	PROPN
ajlm-2845	218	7	c	c	PROPN
ajlm-2845	218	8	,	,	PUNCT
ajlm-2845	218	9	joubert	joubert	PROPN
ajlm-2845	218	10	g.	g.	PROPN
ajlm-2845	218	11	antimicrobial	antimicrobial	PROPN
ajlm-2845	218	12	resistance	resistance	NOUN
ajlm-2845	218	13	patterns	pattern	NOUN
ajlm-2845	218	14	in	in	ADP
ajlm-2845	218	15	outpatient	outpatient	NOUN
ajlm-2845	218	16	urinary	urinary	ADJ
ajlm-2845	218	17	tract	tract	NOUN
ajlm-2845	218	18	infections	infection	NOUN
ajlm-2845	218	19	–	–	PUNCT
ajlm-2845	218	20	the	the	DET
ajlm-2845	218	21	constant	constant	ADJ
ajlm-2845	218	22	need	need	NOUN
ajlm-2845	218	23	to	to	PART
ajlm-2845	218	24	revise	revise	VERB
ajlm-2845	218	25	prescribing	prescribing	NOUN
ajlm-2845	218	26	habits	habit	NOUN
ajlm-2845	218	27	.	.	PUNCT
ajlm-2845	219	1	s	s	PROPN
ajlm-2845	219	2	afr	afr	PROPN
ajlm-2845	219	3	med	med	PROPN
ajlm-2845	219	4	j.	j.	PROPN
ajlm-2845	219	5	2011;101(5):328–331	2011;101(5):328–331	PROPN
ajlm-2845	219	6	.	.	PUNCT
ajlm-2845	220	1	https://doi.org/10.7196/samj.4346	https://doi.org/10.7196/samj.4346	ADJ
ajlm-2845	220	2	dalhoff	dalhoff	PROPN
ajlm-2845	220	3	a.	a.	PROPN
ajlm-2845	220	4	global	global	ADJ
ajlm-2845	220	5	fluoroquinolone	fluoroquinolone	NOUN
ajlm-2845	220	6	resistance	resistance	NOUN
ajlm-2845	220	7	epidemiology	epidemiology	NOUN
ajlm-2845	220	8	and	and	CCONJ
ajlm-2845	220	9	implications	implication	NOUN
ajlm-2845	220	10	for	for	ADP
ajlm-2845	220	11	clinical	clinical	ADJ
ajlm-2845	220	12	use	use	NOUN
ajlm-2845	220	13	.	.	PUNCT
ajlm-2845	221	1	interdiscip	interdiscip	NOUN
ajlm-2845	221	2	perspect	perspect	VERB
ajlm-2845	221	3	infect	infect	ADJ
ajlm-2845	221	4	dis	dis	PROPN
ajlm-2845	221	5	.	.	PUNCT
ajlm-2845	222	1	2012;2012:976273	2012;2012:976273	NUM
ajlm-2845	222	2	.	.	PUNCT
ajlm-2845	223	1	https://doi.org/10.1155/2012/976273	https://doi.org/10.1155/2012/976273	PROPN
ajlm-2845	223	2	spacek	spacek	PROPN
ajlm-2845	223	3	la	la	PROPN
ajlm-2845	223	4	.	.	PROPN
ajlm-2845	224	1	johns	johns	PROPN
ajlm-2845	224	2	hopkins	hopkins	PROPN
ajlm-2845	224	3	abx	abx	PROPN
ajlm-2845	224	4	guide	guide	NOUN
ajlm-2845	224	5	|	|	ADV
ajlm-2845	224	6	enterococcus	enterococcus	VERB
ajlm-2845	225	1	[	[	X
ajlm-2845	225	2	homepage	homepage	NOUN
ajlm-2845	225	3	on	on	ADP
ajlm-2845	225	4	the	the	DET
ajlm-2845	225	5	internet	internet	NOUN
ajlm-2845	225	6	]	]	PUNCT
ajlm-2845	225	7	.	.	PUNCT
ajlm-2845	226	1	2022	2022	NUM
ajlm-2845	227	1	[	[	X
ajlm-2845	227	2	cited	cite	VERB
ajlm-2845	227	3	2024	2024	NUM
ajlm-2845	227	4	oct	oct	NOUN
ajlm-2845	227	5	10	10	NUM
ajlm-2845	227	6	]	]	PUNCT
ajlm-2845	227	7	.	.	PUNCT
ajlm-2845	228	1	available	available	ADJ
ajlm-2845	228	2	from	from	ADP
ajlm-2845	228	3	:	:	PUNCT
ajlm-2845	228	4	https://www.hopkinsguides.com/hopkins/view/johns_hopkins_abx_guide/540203/all/enterococcus?refer=true	https://www.hopkinsguides.com/hopkins/view/johns_hopkins_abx_guide/540203/all/enterococcus?refer=true	PROPN
ajlm-2845	228	5	mak	mak	PROPN
ajlm-2845	228	6	q	q	NOUN
ajlm-2845	228	7	,	,	PUNCT
ajlm-2845	228	8	greig	greig	PROPN
ajlm-2845	228	9	j	j	PROPN
ajlm-2845	228	10	,	,	PUNCT
ajlm-2845	228	11	dasgupta	dasgupta	PROPN
ajlm-2845	228	12	p	p	PROPN
ajlm-2845	228	13	,	,	PUNCT
ajlm-2845	228	14	malde	malde	PROPN
ajlm-2845	228	15	s	s	PROPN
ajlm-2845	228	16	,	,	PUNCT
ajlm-2845	228	17	raison	raison	PROPN
ajlm-2845	228	18	n.	n.	PROPN
ajlm-2845	228	19	bacterial	bacterial	ADJ
ajlm-2845	228	20	vaccines	vaccine	NOUN
ajlm-2845	228	21	for	for	ADP
ajlm-2845	228	22	the	the	DET
ajlm-2845	228	23	management	management	NOUN
ajlm-2845	228	24	of	of	ADP
ajlm-2845	228	25	recurrent	recurrent	ADJ
ajlm-2845	228	26	urinary	urinary	ADJ
ajlm-2845	228	27	tract	tract	NOUN
ajlm-2845	228	28	infections	infection	NOUN
ajlm-2845	228	29	:	:	PUNCT
ajlm-2845	228	30	a	a	DET
ajlm-2845	228	31	systematic	systematic	ADJ
ajlm-2845	228	32	review	review	NOUN
ajlm-2845	228	33	and	and	CCONJ
ajlm-2845	228	34	meta	meta	ADJ
ajlm-2845	228	35	-	-	PUNCT
ajlm-2845	228	36	analysis	analysis	NOUN
ajlm-2845	228	37	.	.	PUNCT
ajlm-2845	229	1	eur	eur	PROPN
ajlm-2845	229	2	urol	urol	ADJ
ajlm-2845	229	3	focus	focus	NOUN
ajlm-2845	229	4	.	.	PUNCT
ajlm-2845	230	1	2024;10(5):761–769	2024;10(5):761–769	X
ajlm-2845	230	2	.	.	PUNCT
ajlm-2845	231	1	https://doi.org10.1016	https://doi.org10.1016	PROPN
ajlm-2845	231	2	/	/	SYM
ajlm-2845	231	3	j.euf.2024.04.002	j.euf.2024.04.002	NOUN